<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><style scope="figure-callout">figure-callout:not([filenames=""]) a.figure-callout {
  cursor: zoom-in;
  text-decoration: underline;
  text-decoration-color: #ddd;
}</style><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><style scope="image-carousel">image-carousel {
  display: block;
}

.thumbnails.image-carousel {
  display: block;
        background-color: transparent;
        padding: 7px;
        white-space: nowrap;
        overflow: auto;
        font-size: 0;
}

.thumbnails.image-carousel img.image-carousel {
  margin-right: 7px;
        cursor: zoom-in;
}

.thumbnails.image-carousel img[selected].image-carousel {
  outline: solid 3px #4285f4;
}

.thumbnails.image-carousel img.image-carousel:last-of-type {
  margin-right: 0;
}</style><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: "…"
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>US5843636A - Hepatitis C virus epitopes 
        - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/US5843636A/en">
    <meta name="description" content="
     Peptide antigens which are immunoreactive with sera from individuals infected with hepatitis C virus (HCV) are disclosed. Several of the antigens are immunologically reactive with antibodies present in individuals identified as having chronic and acute HCV infection. The antigens are useful in diagnostic methods for detecting HCV infection in humans. Also disclosed are corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic peptides. 
   
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="Hepatitis C virus epitopes 
       ">
    <meta name="DC.date" content="1995-03-17" scheme="dateSubmitted">
    <meta name="DC.description" content="
     Peptide antigens which are immunoreactive with sera from individuals infected with hepatitis C virus (HCV) are disclosed. Several of the antigens are immunologically reactive with antibodies present in individuals identified as having chronic and acute HCV infection. The antigens are useful in diagnostic methods for detecting HCV infection in humans. Also disclosed are corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic peptides. 
   
   ">
    <meta name="citation_patent_application_number" content="US:08/407,410">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/93/52/d3/d561969430b4cf/US5843636.pdf">
    <meta name="citation_patent_number" content="US:5843636">
    <meta name="DC.date" content="1998-12-01" scheme="issue">
    <meta name="DC.contributor" content="Gregory R. Reyes" scheme="inventor">
    <meta name="DC.contributor" content="Jungsuh P. Kim" scheme="inventor">
    <meta name="DC.contributor" content="Randolph Moeckli" scheme="inventor">
    <meta name="DC.contributor" content="Christian C. Simonsen" scheme="inventor">
    <meta name="DC.contributor" content="Genelabs Technologies Inc" scheme="assignee">
    <meta name="DC.relation" content="US:5350671" scheme="references">
    <meta name="DC.relation" content="US:5371017" scheme="references">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            Hepatitis C virus epitopes 
       </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA37852043" lang="EN" load-source="patent-office" class="style-scope patent-text">
    <div class="abstract style-scope patent-text">Peptide antigens which are immunoreactive with sera from individuals infected with hepatitis C virus (HCV) are disclosed. Several of the antigens are immunologically reactive with antibodies present in individuals identified as having chronic and acute HCV infection. The antigens are useful in diagnostic methods for detecting HCV infection in humans. Also disclosed are corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic peptides.</div>
  </abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              
                <section id="thumbnails" class="style-scope patent-result">
                  <h3 class="style-scope patent-result">Images (<span class="style-scope patent-result">21</span>)</h3>
                  <image-carousel id="figures" class="style-scope patent-result">
    
    
      <div class="thumbnails style-scope image-carousel">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/4b/d6/75/a7b9b444f74bfe/US5843636-drawings-page-2.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/de/cb/39/b9c2124bc9d94e/US5843636-drawings-page-3.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/04/34/46/52da91ef2ae8be/US5843636-drawings-page-4.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/d8/44/4b/d88190ff38805d/US5843636-drawings-page-5.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/68/a0/61/7dbb9f0c34e139/US5843636-drawings-page-6.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/0c/4b/bc/8c489741195e20/US5843636-drawings-page-7.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/e3/35/2a/520d20d261932f/US5843636-drawings-page-8.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/47/d2/93/b7e2e61bb3d62c/US5843636-drawings-page-9.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/b0/dd/18/1ecb9f4ef6d77a/US5843636-drawings-page-10.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/8b/dc/27/beecc7da3a5f71/US5843636-drawings-page-11.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/78/a6/2a/b14ea66fda0edb/US5843636-drawings-page-12.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/b3/f2/db/e99aa935ba4ba8/US5843636-drawings-page-13.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/04/70/bd/0cd8d5dbcbc7c8/US5843636-drawings-page-14.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/99/b7/8b/f73ef369b058d5/US5843636-drawings-page-15.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/e1/07/d7/8f29946a7a470b/US5843636-drawings-page-16.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/7f/1c/ce/3a3a473d6fe536/US5843636-drawings-page-17.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/c7/54/55/8aa4c771708810/US5843636-drawings-page-18.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/bd/37/75/39390c03cf974e/US5843636-drawings-page-19.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/7c/5f/64/cea3cfc2922686/US5843636-drawings-page-20.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/0d/b4/22/3b6c634c35ae42/US5843636-drawings-page-21.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/d5/3d/68/e3ecb9396a07a9/US5843636-drawings-page-22.png">
        <template is="dom-repeat" as="img" class="style-scope image-carousel"></template>
      </div>
    <template is="dom-if" class="style-scope image-carousel"></template>
  </image-carousel>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/00"><a id="link" href="#" class="style-scope state-modifier">C07K14/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="C07K14/005"><a id="link" href="#" class="style-scope state-modifier">C07K14/005</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="A61K38/00"><a id="link" href="#" class="style-scope state-modifier">A61K38/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations containing peptides</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N2770/00"><a id="link" href="#" class="style-scope state-modifier">C12N2770/00</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N2770/00011"><a id="link" href="#" class="style-scope state-modifier">C12N2770/00011</a></state-modifier>
                  <span class="description style-scope classification-tree">Details</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N2770/24011"><a id="link" href="#" class="style-scope state-modifier">C12N2770/24011</a></state-modifier>
                  <span class="description style-scope classification-tree">Flaviviridae</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N2770/24211"><a id="link" href="#" class="style-scope state-modifier">C12N2770/24211</a></state-modifier>
                  <span class="description style-scope classification-tree">Hepacivirus, e.g. hepatitis C virus, hepatitis G virus</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C12N2770/24222"><a id="link" href="#" class="style-scope state-modifier">C12N2770/24222</a></state-modifier>
                  <span class="description style-scope classification-tree">New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y"><a id="link" href="#" class="style-scope state-modifier">Y</a></state-modifier>
                  <span class="description style-scope classification-tree">GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y10"><a id="link" href="#" class="style-scope state-modifier">Y10</a></state-modifier>
                  <span class="description style-scope classification-tree">TECHNICAL SUBJECTS COVERED BY FORMER USPC</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y10S"><a id="link" href="#" class="style-scope state-modifier">Y10S</a></state-modifier>
                  <span class="description style-scope classification-tree">TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y10S530/00"><a id="link" href="#" class="style-scope state-modifier">Y10S530/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y10S530/82"><a id="link" href="#" class="style-scope state-modifier">Y10S530/82</a></state-modifier>
                  <span class="description style-scope classification-tree">Proteins from microorganisms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="Y10S530/826"><a id="link" href="#" class="style-scope state-modifier">Y10S530/826</a></state-modifier>
                  <span class="description style-scope classification-tree">Viruses</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 3 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Chemical &amp; Material Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Chemical &amp; Material Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Organic Chemistry"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Organic Chemistry
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">US5843636A</h2>
                  <p class="tagline style-scope patent-result">United States</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Patent</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/93/52/d3/d561969430b4cf/US5843636.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;hcv&quot;,&quot;seq&quot;,&quot;sera&quot;,&quot;sequence&quot;,&quot;hepatitis&quot;]" data-before="19900406"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/US5843636A"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Gregory R. Reyes"><a id="link" href="#" class="style-scope state-modifier">Gregory R. Reyes</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Jungsuh P. Kim"><a id="link" href="#" class="style-scope state-modifier">Jungsuh P. Kim</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Randolph Moeckli"><a id="link" href="#" class="style-scope state-modifier">Randolph Moeckli</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Christian C. Simonsen"><a id="link" href="#" class="style-scope state-modifier">Christian C. Simonsen</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  
                  <dt class="style-scope patent-result">
                    <span class="tooltip-hint style-scope patent-result" id="assigneeWarning">Current Assignee</span>
                    <overlay-tooltip positioning-target="#assigneeWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                      The listed assignees may be inaccurate.<br class="style-scope patent-result">
                      Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.
                    
    </div>
  </overlay-tooltip>
                  </dt>
                  <dd class="style-scope patent-result">
                    
    GlaxoSmithKline LLC
  
                  </dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1991</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO1991015516A2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/US1991/002370</div>
                <div class="style-scope application-timeline">Filing date: 1991-04-05</div>
                <div class="style-scope application-timeline">Legal status: IP Right Grant</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP0527815B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP91908451A</div>
                <div class="style-scope application-timeline">Filing date: 1991-04-05</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP1018558A3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP99204321A</div>
                <div class="style-scope application-timeline">Filing date: 1991-04-05</div>
                <div class="style-scope application-timeline">Legal status: Withdrawn</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU660925B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AU77434/91A</div>
                <div class="style-scope application-timeline">Filing date: 1991-04-05</div>
                <div class="style-scope application-timeline">Legal status: Expired</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CA2079912C/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">CA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CA002079912A</div>
                <div class="style-scope application-timeline">Filing date: 1991-04-05</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ATE194844T1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AT</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AT91908451T</div>
                <div class="style-scope application-timeline">Filing date: 1991-04-05</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/KR100217483B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">KR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: KR1019920702453A</div>
                <div class="style-scope application-timeline">Filing date: 1991-04-05</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ES2152922T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">ES</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ES91908451T</div>
                <div class="style-scope application-timeline">Filing date: 1991-04-05</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/DE69132332T2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">DE</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: DE69132332T</div>
                <div class="style-scope application-timeline">Filing date: 1991-04-05</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JPH05506230A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP91508019A</div>
                <div class="style-scope application-timeline">Filing date: 1991-04-05</div>
                <div class="style-scope application-timeline">Legal status: Pending</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/DK0527815T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">DK</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: DK91908451T</div>
                <div class="style-scope application-timeline">Filing date: 1991-04-05</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US5443965A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US07/681,703</div>
                <div class="style-scope application-timeline">Filing date: 1991-04-05</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/IE20010572A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">IE</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: IE20010572A</div>
                <div class="style-scope application-timeline">Filing date: 1991-04-08</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/IE911173A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">IE</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: IE117391A</div>
                <div class="style-scope application-timeline">Filing date: 1991-04-08</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/NZ237740A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">NZ</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: NZ237740A</div>
                <div class="style-scope application-timeline">Filing date: 1991-04-08</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/TW279178B/zh"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">TW</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: TW080103067A</div>
                <div class="style-scope application-timeline">Filing date: 1991-04-20</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1992</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US5436318A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US07/853,985</div>
                <div class="style-scope application-timeline">Filing date: 1992-03-20</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1994</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US5538865A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US08/184,236</div>
                <div class="style-scope application-timeline">Filing date: 1994-01-19</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1995</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US5843636A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline" this="">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US08/407,410</div>
                <div class="style-scope application-timeline">Filing date: 1995-03-17</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US5843639A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US08/485,500</div>
                <div class="style-scope application-timeline">Filing date: 1995-06-07</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1998</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/HK1014004A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">HK</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: HK98115113A</div>
                <div class="style-scope application-timeline">Filing date: 1998-12-23</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2000</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/GR3034547T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">GR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: GR20000402237T</div>
                <div class="style-scope application-timeline">Filing date: 2000-10-04</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2001</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP2001269185A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP2001032759A</div>
                <div class="style-scope application-timeline">Filing date: 2001-02-08</div>
                <div class="style-scope application-timeline">Legal status: Pending</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application US08/407,410 events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="litigation style-scope application-timeline"></div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><a target="_blank" class="style-scope application-timeline" href="https://patents.darts-ip.com/?family=27055191&amp;utm_source=google_patent&amp;utm_medium=platform_link&amp;utm_campaign=public_patent_search&amp;patent=US5843636(A)"><span class="title-text style-scope application-timeline">First worldwide family litigation filed</span></a><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><iron-icon id="icon" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><overlay-tooltip positioning-target="#icon" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      <div class="description-item style-scope application-timeline">"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.</div><template is="dom-repeat" class="style-scope application-timeline"></template>
    </div>
  </overlay-tooltip><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">1995-03-17</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="Genelabs Technologies Inc"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by Genelabs Technologies Inc</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="priority style-scope application-timeline">1995-03-17</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US5843636A/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Priority to US08/407,410</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline"><div date="" class="priority style-scope application-timeline">1995-06-07</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US5843639A/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Priority to US08/485,500</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="granted style-scope application-timeline">1998-12-01</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Application granted</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">1998-12-01</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US5843636A/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of US5843636A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline"><div date="" class="reassignment style-scope application-timeline">2010-03-22</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="GLAXOSMITHKLINE LLC"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Assigned to GLAXOSMITHKLINE LLC</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><iron-icon id="icon" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><overlay-tooltip positioning-target="#icon" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      <div class="description-item style-scope application-timeline">ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).</div><div class="description-item style-scope application-timeline">Assignors: GENELABS TECHNOLOGIES INC</div><template is="dom-repeat" class="style-scope application-timeline"></template>
    </div>
  </overlay-tooltip><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="legal-status style-scope application-timeline">2015-12-01</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Anticipated expiration</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" current="" critical=""><div date="" class="legal-status style-scope application-timeline">Status</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Expired - Lifetime</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (21)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (133)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&amp;Sect2=HITOFF&amp;p=1&amp;u=/netahtml/PTO/srchnum.html&amp;r=1&amp;f=G&amp;l=50&amp;d=PALL&amp;s1=5843636.PN.">USPTO</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patentcenter.uspto.gov/applications/08407410">USPTO PatentCenter</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://assignment.uspto.gov/patent/index.html#/patent/search/resultFilter?searchInput=5843636">USPTO Assignment</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=US&amp;NR=5843636A&amp;KC=A&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/patent/US/5843636/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/US5843636">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><div mxw-id="PDES317768766" lang="EN" load-source="patent-office" class="description style-scope patent-text">
    
    <div class="description-paragraph style-scope patent-text">The present application is a division of application Ser. No. 07/681,703, filed Apr. 5, 1991, now U.S. Pat. No. 5,445,965 herein incorporated by reference, now allowed, which is a continuation-in-part of U.S. patent application Ser. No. 07/594,854, filed Oct. 10, 1990, abandoned which is a continuation-in-part of Ser. No. 07/505,611, filed Apr. 6, 1990 abandoned.</div>
    
    
    <heading class="style-scope patent-text">1. FIELD OF INVENTION</heading>
    <div class="description-paragraph style-scope patent-text">This invention relates to specific peptide viral antigens which are immunoreactive with sera from patients infected with parenterally transmitted non-A, non-B hepatitis virus (PT-NANBH, now called Hepatitis C Virus), to polynucleotide sequences which encode the peptides, to an expression system capable of producing the peptides, and to methods of using the peptides for detecting PT-NANBH infection in human sera.</div>
    <heading class="style-scope patent-text">2. REFERENCES</heading>
    <div class="description-paragraph style-scope patent-text">Atkins, et al., Cell 62:413-423 (1990).</div>
    <div class="description-paragraph style-scope patent-text">Ausubel, F. M., et al., Current Protocols in Molecular Biology, John Wiley and Sons, Inc., Media PA.</div>
    <div class="description-paragraph style-scope patent-text">Bradley, D. W., et al., J. Infec. Dis., 148:2 (1983).</div>
    <div class="description-paragraph style-scope patent-text">Bradley, D. W., et al., J Gen. Virol., 69:1 (1988).</div>
    <div class="description-paragraph style-scope patent-text">Bradley, D. W. et al., Proc. Nat. Acad. Sci., USA, 84:6277 (1987).</div>
    <div class="description-paragraph style-scope patent-text">Chomczynski, P., et al., Anal Biochem, 162:156 (1987).</div>
    <div class="description-paragraph style-scope patent-text">Choo, Q.-L., et al, Science, 244:359 (1989).</div>
    <div class="description-paragraph style-scope patent-text">Current Protocols in Molecular Biology, Wiley Interscience, <figure-callout id="10" label="Chapter" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Chapter</a></figure-callout> 10.</div>
    <div class="description-paragraph style-scope patent-text">Dienstag, J. L., et al, Sem Liver Disease, 6:67 (1986)</div>
    <div class="description-paragraph style-scope patent-text">Feramisco, J. R., et al., J. Biol. Chem. 257(18):11024 (1982).</div>
    <div class="description-paragraph style-scope patent-text">Gubler, U., et al, Gene, 25:263 (1983).</div>
    <div class="description-paragraph style-scope patent-text">Hunyh, T. V., et al, in DNA Cloning Techniques: A Practical Approach (D. Glover, ed.) IRL Press (1985).</div>
    <div class="description-paragraph style-scope patent-text">Klein, P., et al., Biochem. Biophys. ACTA 815:468 (1985).</div>
    <div class="description-paragraph style-scope patent-text">Kuo, G., et al., Science, 244:362 (1989).</div>
    <div class="description-paragraph style-scope patent-text">Kyte, J., et al., J. Mol. Biol. 157:105 (1982).</div>
    <div class="description-paragraph style-scope patent-text">Maniatis, T., et al. Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory (1982).</div>
    <div class="description-paragraph style-scope patent-text">Miller, J. H., Experiments in Molecular Genetics., Cold Spring Harbor Laboratories, Cold Spring Harbor, N.Y. (1972).</div>
    <div class="description-paragraph style-scope patent-text">Mullis, K., U.S. Pat. No. 4,683,202, issued Jul. 28, 1987.</div>
    <div class="description-paragraph style-scope patent-text">Mullis, K., et al., U.S. Pat. No. 4,683,195, issued Jul. 28, 1987.</div>
    <div class="description-paragraph style-scope patent-text">Reyes, G., et al, Science, 247:1335 (1990).</div>
    <div class="description-paragraph style-scope patent-text">Sanger, F., et al., Proc. Natl. Acad. Sci. USA 74:5463 (1977).</div>
    <div class="description-paragraph style-scope patent-text">Scharf, S. J., et al., Science 233:1076 (1986).</div>
    <div class="description-paragraph style-scope patent-text">Selected Method in Cellular Immunology, (Mishell, B. D., et al. eds) W. H. Freeman and Co., pp416-440 (1980).</div>
    <div class="description-paragraph style-scope patent-text">Smith. D. B., et al, Gene, 67:31 (1988).</div>
    <div class="description-paragraph style-scope patent-text">Southern, E., Methods in Enzymology 69:152 (1980).</div>
    <div class="description-paragraph style-scope patent-text">Tijssen, P., Practice and Theory of Immunoassays, Scientific Publishing Co., NY, N.Y., 1985, p. 335.</div>
    <div class="description-paragraph style-scope patent-text">Wilson, W., et al., Cell 55:1159-1169 (1988).</div>
    <div class="description-paragraph style-scope patent-text">Woo, S. L. C., Methods in Enzymology 68:389 (1979).</div>
    <div class="description-paragraph style-scope patent-text">Young, R. A. and R. W. Davis, Proc. Natl. Acad. Sci. USA 80, 1194-1198 (1983).</div>
    <heading class="style-scope patent-text">3. BACKGROUND</heading>
    <div class="description-paragraph style-scope patent-text">Viral hepatitis resulting from a virus other than hepatitis A virus (HAV) and hepatitis B virus (HBV) has been referred to as non-A, non-B hepatitis (NANBH). More recently, it has become clear that NANBH encompasses at least two, and perhaps more, quite distinct viruses. One of these, known as enterically transmitted NANBH or ET-NANBH, is contracted predominantly in poor-sanitation areas where food and drinking water have been contaminated by fecal matter. The molecular cloning of a portion of this virus, referred to as the hepatitis E virus (HEV), has recently been described (Reyes et al.).</div>
    <div class="description-paragraph style-scope patent-text">The second NANB virus type, known as parenterally transmitted NANBH, or PT-NANBH, is transmitted by parenteral routes, typically by exposure to blood or blood products. Approximately 10% of transfusions cause PT-NANBH infection, and about half of these go on to a chronic disease state (Dienstag).</div>
    <div class="description-paragraph style-scope patent-text">Human sera documented as having produced post-transfusion NANBH in human recipients has been used successfully to produce PT-NANBH infection in chimpanzees (Bradley). RNA isolated from infected chimpanzee sera has been used to construct cDNA libraries in an expression vector for immunoscreening with chronic-state human PT-NANBH serum. This procedure identified a PT-NANBH specific cDNA clone and the viral sequence was then used as a probe to identify fragments making up 7,300 contiguous basepairs of a PT-NANBH viral agent (EPO patent application 88310922.5, filed Nov. 18, 1988). The same procedure was used by the present inventors to derive two of the PT-NANBH peptide and polynucleotide sequences disclosed herein. The sequenced viral agent has been named HCV (HCV) (above EPO patent application).</div>
    <div class="description-paragraph style-scope patent-text">Heretofore, one immunogenic peptide encoded by the HCV viral agent has been reported (Choo, Kuo, EPO application 88310922.5). This peptide, designated C-100, has been used in immunoassays of PT-NANBH sera and found to react immunospecifically with up to 80% of chronic NANBH samples, and about 15% of acute NANBH samples (Kuo).</div>
    <div class="description-paragraph style-scope patent-text">It is desirable to provide one or a collection of peptide antigens which are immunoreactive with a greater percentage of PT-NANBH-infected blood, including both acute and chronic PT-NANBH infection.</div>
    <heading class="style-scope patent-text">4. SUMMARY OF THE INVENTION</heading>
    <div class="description-paragraph style-scope patent-text">It is one general object of the invention to provide recombinant polypeptides immunoreactive with sera from humans infected with hepatitis C virus (HCV), including a peptide which is immunoreactive with a high percentage of sera from chronic HCV-infected individuals, and peptides which are immunoreactive with sera associated with acute HCV infection.</div>
    <div class="description-paragraph style-scope patent-text">It is another object of the invention to provide an HCV polynucleotide sequence encoding a sequence for recombinant production of the peptide antigens, and a diagnostic method for detecting HCV-infected human sera using the peptide antigens.</div>
    <div class="description-paragraph style-scope patent-text">The invention includes, in one aspect, a peptide antigen which is immunoreactive with sera from humans infected with HCV. One peptide antigen in the invention includes an immunoreactive portion of an HCV polypeptide which:</div>
    <div class="description-paragraph style-scope patent-text">a) is encoded by an HCV coding sequence;</div>
    <div class="description-paragraph style-scope patent-text">b) has 504 amino acid residues; and</div>
    <div class="description-paragraph style-scope patent-text">c) has the carboxy-terminal sequence presented as SEQ ID NO:4.</div>
    <div class="description-paragraph style-scope patent-text">Other peptide antigens of the invention include an immunoreactive portion of any one of the following sequences: SEQ ID NO:2, SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:12, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:22, SEQ ID NO:24, and SEQ ID NO:26.</div>
    <div class="description-paragraph style-scope patent-text">In another aspect, the invention includes diagnostic kits for use in screening human blood containing antibodies specific against HCV infection. The kit includes at least one peptide antigen which is immunoreactive with sera from humans infected with hepatitis C virus (HCV): specific peptide antigens for use in the kit are given above.</div>
    <div class="description-paragraph style-scope patent-text">One preferred embodiment of the present invention is a diagnostic kit containing the 409-1-1(c-a) (SEQ ID NO:8) and one of the HCV-capsid derived proteins (SEQ ID NOs:12, 14, 16, 18, 20, 22, 24, and 26): two particular embodiments being 409-1-1(c-a) with the <figure-callout id="450" label="C1NC" filenames="US5843636-drawings-page-12.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C1NC</a></figure-callout> 450 capsid-derived peptide, and 409-1-1(c-a) with the <figure-callout id="360" label="C1NC" filenames="US5843636-drawings-page-12.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C1NC</a></figure-callout> 360 capsid-derived peptide.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment of the present invention, the antigen is immobilized on a solid support. The binding of HCV-specific antibodies to the immobilized antigen is detected by a reporter-labeled anti-human antibody which acts to label the solid support with a detectable reporter.</div>
    <div class="description-paragraph style-scope patent-text">The kit is used in a method for detecting HCV infection in an individual by: (i) reacting serum from an HCV-infected test individual with the above peptide antigen, and (ii) examining the antigen for the presence of bound antibody.</div>
    <div class="description-paragraph style-scope patent-text">The peptide antigens are produced, in accordance with another aspect of the invention, using an expression system for expressing a recombinant peptide antigen which is immunoreactive with sera from humans infected with hepatitis C virus (HCV). A selected expression vector containing an open reading frame (ORF) of a polynucleotide which encodes the peptide is introduced into a suitable host, which is cultured under conditions which promote expression of the ORF in the expression vector.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the polynucleotide is inserted into an expression site in a lambda gt11 phage vector, and the vector is introduced into an E. coli host. The following E. coil hosts have been deposited which contain vectors including the coding sequences of the antigens shown in parenthesis: ATCC No 40901 (SEQ ID NO:3), ATCC NO. 40893 (SEQ ID NO:1), and ATCC No. 40792 (SEQ ID NO:7), and ATCC No. 40876 (SEQ ID NO:9). pGEX and pET are two other vectors which have been used to express HCV antigens. It will be appreciated that determination of other appropriate vector and host combinations for the expression of the above sequences are within the ability of one of ordinary skill in the art.</div>
    <div class="description-paragraph style-scope patent-text">Also forming part of the invention are polynucleotides which encode polypeptides immunoreactive with sera from humans infected with hepatitis C virus (HCV). One polynucleotide of the present invention encodes a polypeptide wherein the polypeptide includes an immunoreactive portion of a peptide sequence which:</div>
    <div class="description-paragraph style-scope patent-text">a) is encoded by an HCV coding sequence;</div>
    <div class="description-paragraph style-scope patent-text">b) has 504 amino acid residues; and</div>
    <div class="description-paragraph style-scope patent-text">c) has the carboxy-terminal sequence presented as SEQ ID NO:4; and, where the carboxy-terminal amino acid sequence of said peptide antigen is encoded by the polynucleotide sequence presented as SEQ ID NO:3.</div>
    <div class="description-paragraph style-scope patent-text">Other polynucleotides of the invention include any one of the following sequences: SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO: 5, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:11, SEQ ID NO:13, SEQ ID NO:15, SEQ ID NO:17, SEQ ID NO:19, SEQ ID NO:21, SEQ ID NO:23, and SEQ ID NO:25.</div>
    <div class="description-paragraph style-scope patent-text">These and other objects and features of the invention will become more fully apparent when the following detailed description is read in conjunction with the accompanying drawings.</div>
    
    
    <heading class="style-scope patent-text">5. BRIEF DESCRIPTION OF THE DRAWINGS</heading>
    <div class="description-paragraph style-scope patent-text">FIG. 1 illustrates the steps in producing overlapping linking fragments of a nucleic acid segment, in accordance with the methods of the present invention;</div>
    <div class="description-paragraph style-scope patent-text">FIG. 2 shows the positions of overlap primer regions and linking regions along a 7,300 basepair portion of the HCV genome.</div>
    <div class="description-paragraph style-scope patent-text">FIG. 3 shows the DNA coding sequence of the <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40 insert. The underlined sequences correspond to an R<sub class="style-scope patent-text">9</sub> primer region.</div>
    <div class="description-paragraph style-scope patent-text">FIG. 4 shows the DNA coding sequence of a clone 36 insert. The underlined sequences correspond, respectively, to the F<sub class="style-scope patent-text">7</sub>, F<sub class="style-scope patent-text">8</sub>, and R<sub class="style-scope patent-text">8</sub> primer regions.</div>
    <div class="description-paragraph style-scope patent-text">FIG. 5 shows the DNA and protein coding sequences for a 409-1-1(abc) clone insert. The "A" region of this sequence is delineated by boxes, the "B" region by a box and a triangle, and the "C" region by a triangle and an asterisk.</div>
    <div class="description-paragraph style-scope patent-text">FIGS. 6A and 6B show the DNA and protein coding sequences for a 409-1-1(c-a) clone insert.</div>
    <div class="description-paragraph style-scope patent-text">FIG. 7 illustrates the groups of clones which have been obtained from the HCV genome in the region corresponding to the 409-1-1(abc) clone insert.</div>
    <div class="description-paragraph style-scope patent-text">FIG. 8A shows the DNA and protein coding sequences for the pGEX-GG1 insert. The three G's above the first line indicate where substitutions were made to generate the clone pGEX-CapA. FIGS. 8B and 8C shows the DNA and protein sequences for the pGEX-CapA insert coding sequence. The primers used in polymerase chain reactions to generate carboxy and amino terminal deletions are indicated below the nucleotide line. The sequences of the primers are indicated in the sense (coding strand). The actual sequence of the NC (non-coding), primers is the reverse complement of the indicated sequence. Coding primers are underlined; reverse (noncoding) primers are double-under-lined. Sequences shown in capital letters are exact matches. Sequences in lowercase letters are "mismatched" sequences used to introduce the terminal restriction sites (NcoI at the 5' ends and BamHI at the 3' ends). The three nucleotides which have been altered to remove the "slippery codons" at <figure-callout id="30" label="positions" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">positions</a></figure-callout> 24, 27, and 30 are indicated by bold type with the wild type A residues shown above the sequence.</div>
    <div class="description-paragraph style-scope patent-text">FIG. 9 shows a hydropathicity plot of the HCV-core protein encoded by pGEX-CapA. The relative location of the primers, used to generate carboxy and amino terminal deletions, are indicated relative to the protein coding sequence by arrows.</div>
    <div class="description-paragraph style-scope patent-text">FIG. 10 shows an epitope map of the HCV capsid protein region.</div>
    
    
    <heading class="style-scope patent-text">6. DETAILED DESCRIPTION OF THE INVENTION</heading>
    <div class="description-paragraph style-scope patent-text">I. Definitions</div>
    <div class="description-paragraph style-scope patent-text">The terms defined below have the following meaning herein:</div>
    <div class="description-paragraph style-scope patent-text">1. "Parenterally transmitted non-A, non-B hepatitis viral agent (PT-NANBH)" means a virus, virus type, or virus class which (i) causes parenterally transmitted infectious hepatitis, (ii) is transmissible in chimpanzees, (iii) is serologically distinct from hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis E virus (HEV).</div>
    <div class="description-paragraph style-scope patent-text">2. "HCV (HCV)" means a PT-NANBH viral agent whose polynucleotide sequence includes the sequence of the 7,300 basepair region of HCV given in the Appendix, and variations of the sequence, such as degenerate codons, or variations which may be present in different isolates or strains of HCV.</div>
    <div class="description-paragraph style-scope patent-text">3. Two nucleic acid fragments are "homologous" if they are capable of hybridizing to one another under hybridization conditions described in Maniatis et al., op. cit., pp. 320-323, using the following wash conditions: 2×SCC, 0.1% SDS, room temperature twice, 30 minutes each; then 2×SCC, 0.1% SDS, 50° C. once, 30 minutes; then 2×SCC, room temperature twice, 10 minutes each, homologous sequences can be identified that contain at most about 25-30% basepair mismatches. More preferably, homologous nucleic acid strands contain 15-25% basepair mismatches, even more preferably 5-15% basepair mismatches. These degrees of homology can be selected by using more stringent wash or hybridization conditions for identification of clones from gene libraries (or other sources of genetic material), as is well known in the art.</div>
    <div class="description-paragraph style-scope patent-text">4. A DNA fragment is "derived from" HCV if it has substantially the same basepair sequence as a region of the HCV viral genome which was defined in (2) above.</div>
    <div class="description-paragraph style-scope patent-text">5. A protein is "derived from" a PT-NANBH or HCV viral agent if it is encoded by an open reading frame of a cDNA or RNA fragment derived from a PT-NANBH or HCV viral agent, respectively.</div>
    <div class="description-paragraph style-scope patent-text">II. Molecular Clone Selection by Immunoscreening</div>
    <div class="description-paragraph style-scope patent-text">As one approach toward identifying a molecular clone of a PT-NANBH agent, cDNA libraries are prepared from infected sera in the expression vector lambda gt11. cDNA sequences are then selected for expression of peptides which are immunoreactive with PT-NANBH-infected sera. Recombinant proteins identified by this approach provide candidates for peptides which can serve as substrates in diagnostic tests. Further, the nucleic acid coding sequences identified by this approach serve as useful hybridization probes for the identification of further PT-NANBH coding sequences.</div>
    <div class="description-paragraph style-scope patent-text">In order to make immunoscreening a useful approach for identifying clones originating from PT-NANBH coding sequences, a well-defined source of PT-NANBH virus is important. To generate such a source, a chimpanzee (#771; Example 1A) was infected with transmissible PT-NANBH agents using a Factor VIII concentrate as a source (Bradley). The Factor VIII concentrate was known to contain at least two forms of parenterally transmitted NANB hepatitis (PT-NANBH). In addition to a chloroform-sensitive agent, which has subsequently been called HCV (HCV), a chloroform-resistant form of PT-NANBH was also transmitted in the concentrate (Bradley, 1983):</div>
    <div class="description-paragraph style-scope patent-text">In the method illustrated in Example 1, infected serum was pelleted, without dilution, by centrifugation, and cDNA libraries were generated from the resulting pelleted virus (Example 1B and 1C). Sera from infected human sources were treated in the same fashion. cDNA libraries were generated, e.g., by a random primer method using the RNA extracted from pelleted sera as starting material (Example 1B and 1C). The resulting cDNA molecules were then cloned into a suitable vector, for example, lambda gt11, for expression and screening of peptide antigens, and lambda gt10, for hybridization screening (Example 1C(iv)). Lambda gt11 is a particularly useful expression vector which contains a unique EcoRI insertion site 53 base pairs upstream of the translation termination codon of the beta-galactosidase gene. Thus, an inserted sequence is expressed as a beta-galactosidase fusion protein which contains the N-terminal portion of the beta-galactosidase gene, the heterologous peptide, and optionally the C-terminal region of the beta-galactosidase peptide (the C-terminal portion being expressed when the heterologous peptide coding sequence does not contain a translation termination codon). This vector also produces a temperature-sensitive repressor (cI857) which causes viral lysogeny at permissive temperatures, e.g., 32° C., and leads to viral lysis at elevated temperatures, e.g., 42° C. Advantages of this vector include: (1) highly efficient recombinant clone generation, (2) ability to select lysogenized host cells on the basis of host-cell growth at permissive, but not non-permissive, temperatures, and (3) high levels of recombinant fusion protein production. Further, since phage containing a heterologous insert produces an inactive beta-galactosidase enzyme, phage with inserts are typically identified using a beta-galactosidase colored-substrate reaction.</div>
    <div class="description-paragraph style-scope patent-text">In the screening procedure reported in Examples 1-3, individual cDNA libraries were prepared from the serum of one PT-NANBH infected chimpanzee (#771) and four PT-NANBH infected humans (designated EGM, BV, WEH, and AG). These five libraries were immunoscreened using PT-NANBH positive human or chimpanzee sera (Example 2): 111 lambda gt11 clones were identified which were immunoreactive with at least one of the sera. Of these 111 clones, 93 were examined for insert hybridization with normal DNA. The inserts were radioactively labelled and used as probes against HindIlI/EcoRI doubly-digested human peripheral lymphocyte (PBL) DNA (Example 3). Approximately 46% (43/93) of the inserts hybridized with normal human PBL DNA and were therefore not pursued. Inserts from 11 PT-NANBH-immunopositive clones derived from chimpanzee #771 sera were characterized as exogenous to normal human PBL DNA (Example 3). Of these 11 clones 2 PT-NANBH clones were identified having the following characteristics. One clone (clone 40) was clearly exogenous by repeated hybridization tests against normal human PBL DNA, had a relatively small insert size (approximately 0.5 kilobases), and was quite unreactive with negative control serum. The second clone (clone 36) was shown to be reactive with multiple PT-NANBH antisera, had a relatively large insert size (approximately 1.5 kilobases), and was exogenous by hybridization testing against normal human PBL DNA. The immunoreactive characteristics of <figure-callout id="40" label="clones" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clones</a></figure-callout> 36 and 40 are summarized in Table 1 (Example 3). Clone 36 was immunoreactive with chimpanzee #771 sera and two HCV-positive human sera, AG and BV. The clone 36 antigen did not immunoreact with the negative control sera SKF. <figure-callout id="40" label="Clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Clone</a></figure-callout> 40 was immunoreactive with chimpanzee #771 sera and was cleanly nonreactive when the negative control sera was used for screening.</div>
    <div class="description-paragraph style-scope patent-text">The DNA sequence of clone 36 was determined in part and is shown in FIG. 4. This sequence corresponds to nucleotides 5010 to 6516 of the HCV sequence given in the Appendix. The DNA sequence was also determined for the <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40 insert (FIG. 3). This sequence is homologous to the HCV sequence (Appendix) in the region of approximately nucleotides 6515 to 7070. The inserts of two other chimpanzee #771 clones, <figure-callout id="45" label="clones" filenames="US5843636-drawings-page-7.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clones</a></figure-callout> 44 and 45, were found to be homologous to clone 40 by hybridization and sequence analysis (Example 4). The sequences for <figure-callout id="40" label="clones" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clones</a></figure-callout> 36 and 40 are contiguous sequences, with the clone 36 sequences being located 5' of the <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40 sequences as presented in the Appendix. Accordingly, these two clones represent isolation of a significant block of the HCV genome by the above-described immunoscreening methods.</div>
    <div class="description-paragraph style-scope patent-text">The four <figure-callout id="40" label="lambda gt11 clones" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="45" label="lambda gt11 clones" filenames="US5843636-drawings-page-7.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">lambda gt11 clones</a></figure-callout> </a></figure-callout> 36, 40, 44, and 45 were deposited in the Genelabs Culture Collection, Genelabs Incorporated, 505 Penobscot Drive, Redwood City, Calif. 94063. Further, the lambda gt11 clones of <figure-callout id="40" label="clones" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clones</a></figure-callout> 36 and 40 were deposited with the American Type Culture Collection, 12301 Parklawn Dr., Rockville Md., 20852, and given the deposit numbers ATCC No. 40901 and ATCC 40893.</div>
    <div class="description-paragraph style-scope patent-text">III. PT-NANBH Sequence Identification by Hybridization Methods</div>
    <div class="description-paragraph style-scope patent-text">The polynucleotides identified in Section II can be employed as probes in hybridization methods to identify further HCV sequences, and these can then be used as probes to identify additional sequences. The polynucleotides can be directly cloned or fragmented by partial digestion to generate random fragments. The resulting clones can be immunoscreened as described above to identify HCV antigen coding sequences.</div>
    <div class="description-paragraph style-scope patent-text">To illustrate how the inserts of <figure-callout id="40" label="clones" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clones</a></figure-callout> 36 and 40 can be used to identify clones carrying HCV sequences, the insert of <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40 was isolated and used as a hybridization probe against the individual cDNA libraries established in lambda gt10 (see above). Using the <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40 probe approximately 24 independent hybridization-positive clones were plaque purified (Example 5). The positive signals arose with different frequencies in cDNA libraries from the different serum sources, suggesting that the hybridization signals were from the serum sources, rather than resulting from some common contaminant introduced during the cDNA synthesis or cloning (Table 2). One of the clones, 108-2-5, which tested positive by hybridization with the <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40 insert, had an insert of approximately 3.7 kb (Example 6). Since it had such a large insert, clone 108-2-5 was chosen for further analysis. The serum source of this cDNA clone was EGM human PT-NANBH serum (Example 1).</div>
    <div class="description-paragraph style-scope patent-text">The insert of 108-2-5 was isolated by EcoRI digestion of the lambda gt10 clone, electrophoretic fractionation, and electroelution (Example 6). The isolated insert was treated with DNase I to generate random fragments (Example 6), and the resulting digest fragments were inserted into lambda gt11 phage vectors for immunoscreening. The lambda gt11 clones of the 108-2-5 fragments were immunoscreened (Example 6) using human (BV and normal) and chimpanzee #771 serum. Twelve positive clones were identified by first round immunoscreening with the human and chimp sera. Seven of the 12 clones were plaque purified and rescreened using chimpanzee #771 serum. Partial DNA sequences of the insert DNA were determined for two of the resulting clones, designated 328-16-1 and 328-16-2. These two clones contained sequences essentially identical to clone 40 (Example 6).</div>
    <div class="description-paragraph style-scope patent-text">The clone 36 insert can be used in a similar manner to probe the original cDNA library generated in lambda gt10. Specific subfragments of clone 36 may be isolated by Polymerase chain reaction or after cleavage with restriction endonucleases. These fragments can be radioactively labelled and used as probes against the cDNA libraries generated in lambda gt10 (Example 1C). In particular, the 5' terminal sequences of the clone 36 insert are useful as probes to identify clones overlapping this region.</div>
    <div class="description-paragraph style-scope patent-text">Further, the sequences provided by the terminal clone 36 insert sequences and the <figure-callout id="40" label="terminal clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">terminal clone</a></figure-callout> 40 insert sequences are useful as specific sequence primers in first-strand DNA synthesis reactions (Maniatis et al.; Scharf et al.) using, for example, chimpanzee #771 sera generated RNA as substrate. Synthesis of the second-strand of the cDNA is randomly primed. The above procedures identify or produce cDNA molecules corresponding to nucleic acid regions that are 5' adjacent to the known <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 36 and 40 insert sequences. These newly isolated sequences can in turn be used to identify further flanking sequences, and so on, to identify the sequences composing the HCV genome. As described above, after new HCV sequences are isolated, the polynucleotides can be cloned and immunoscreened to identify specific sequences encoding HCV antigens.</div>
    <div class="description-paragraph style-scope patent-text">IV. Generating Overlapping Cloned Linking Fragments</div>
    <div class="description-paragraph style-scope patent-text">This section describes a method for producing and identifying HCV peptides which may be useful as HCV-diagnostic antigens. The present method is used to generate a series of overlapping linking fragments which span a segment of nucleic acid. The application of the method to generating a series of overlapping linking fragments which span a 7,300 basepair segment of the HCV genome, whose sequence is given in the FIGS 11A to 11H, will be described with reference to FIGS. 1 and 2.</div>
    <div class="description-paragraph style-scope patent-text">As a first step in the method, and with reference to FIG. 1, the nucleic acid of interest is obtained in double-strand DNA form. Typically, this is done by isolating genomic DNA fragments or by producing cDNAs from RNA species present in a sample fluid. The latter method is used to generate double-strand DNA from NANBH viral RNA present in serum from chimpanzees or humans with known PT-NANBH infection. Here RNA in the sample is isolated, e.g., by guanidinium thiocyanate extraction of PEG precipitated virions, and reacted with a suitable primer for first strand cDNA synthesis.</div>
    <div class="description-paragraph style-scope patent-text">First-strand cDNA priming may be by random primers, oligo dT primers, or sequence-specific primer(s). The primer conditions are selected to (a) optimize generation of cDNA fragments which collectively will span the nucleic acid segment of interest, and (b) produce cDNA fragments which are preferably equal to or greater than about 1,000 basepairs in length. In one method applied to HCV RNA, the first-strand synthesis is carried out using sequence-specific primers which are complementary to spaced regions along the length of the known HCV genomic sequence. The primer position are indicated at A, B, C, and D in FIG. 2, which shows a map of the HCV genome segment. The basepair locations of the primers in the HCV genome are given in Example 7 below. Following first strand synthesis, the second cDNA strand is synthesized by standard methods.</div>
    <div class="description-paragraph style-scope patent-text">The linking fragments in the method are produced by sequence-specific amplification of the double-strand DNA obtained as above, using pairs of overlap-region primers to be described. According to an important advantage of the methods of the present invention, it is possible to generate linking fragments even when the amount of double-strand DNA is too low for direct sequence-specific amplification. This limitation was found, for example, with HCV cDNA's produced from NANBH-infected serum. Here the amount of double-stranded DNA available for amplification is first amplified nonspecifically by a technique known as Sequence-Independent Single-Primer Amplification (SISPA).</div>
    <div class="description-paragraph style-scope patent-text">The SISPA technique is detailed in co-owned U.S. Patent application for "RNA and DNA Amplification Techniques", Ser. No. 224,961, filed Jul. 26, 1988. The method as applied to amplification of HCV cDNA fragments is also described in Example 7. Briefly, known-sequence linker primers are attached to opposite ends of double-stranded DNA in a DNA sample. These linkers then provide the common end sequences for primer-initiated amplification, using primers complementary to the linker/primer sequences. Typically, the SISPA method is carried out for 20-30 cycles of amplification, using thermal cycling to achieve successive denaturation and primer-initiated polymerization of second strand DNA.</div>
    <div class="description-paragraph style-scope patent-text">FIG. 1 illustrates the SISPA amplification of duplex DNA, to form amplified fragments which have known-sequence regions P<sub class="style-scope patent-text">i</sub>. As seen, the fragment mixture includes at least some fragments which (a) overlap at regions P<sub class="style-scope patent-text">i</sub> with other fragments in the mixture and (b) contain complete linking regions between adjacent P<sub class="style-scope patent-text">i</sub> and P<sub class="style-scope patent-text">i+1</sub> regions. Collectively, each linking region bounded by the associated overlap regions making up the segment is present in at least one DNA fragment.</div>
    <div class="description-paragraph style-scope patent-text">The production of overlapping linking fragments, in accordance with the methods of the present invention, is carried out using the polymerase chain reaction (PCR) method described in U.S. Pat. No. 4,683,195. In practicing this step of the method, first the total segment of interest is divided into a series of overlapping intervals bounded by regions of known sequence, as just described. In FIG. 2, the 7,300 basepair segment of the HCV genome has been divided into 10 intervals, each about 500-1,000 basepairs in length. The intervals are designated according to the forward F<sub class="style-scope patent-text">i</sub> and reverse R<sub class="style-scope patent-text">j</sub> primers used in amplifying the sequence, as will be described. The selection of the intervals is guided by (a) the requirement that the basepair sequence at each end of the interval be known, and (b) a preferred interval length of between about 500 and 2,000 basepairs.</div>
    <div class="description-paragraph style-scope patent-text">In the method applied to the 7,300 basepair segment of the HCV genome, the regions of overlap between the ten intervals were additionally amplified, to verify that the SISPA-amplified cDNA sample contained sufficient HCV cDNA to observe PCR-amplification of HCV linking fragments, and that HCV regions along the entire length of the genome were available for amplification. Each overlap region in the segment can be defined by a pair of primers which includes a forward primer F<sub class="style-scope patent-text">i</sub> and a reverse primer R<sub class="style-scope patent-text">i</sub> which are complementary to opposite strands of opposite ends of the overlap region. The primers are typically about 20 basepairs in length and span an overlap region of about 200 basepairs. The eleven overlap regions in the HCV segment and the regions corresponding to the forward and reverse primers in each region are given in example 8.</div>
    <div class="description-paragraph style-scope patent-text">The primers F<sub class="style-scope patent-text">i</sub> /R<sub class="style-scope patent-text">i</sub> are added to the amplified DNA material in a PCR reaction mix, and the overlap region bounded by the primers is amplified by 20--30 thermal cycles. The reaction material is then fractionated, e.g., by agarose gel electrophoresis, and probed for the presence of the desired sequence, e.g., by Southern blotting (Southern), using a radiolabeled oligonucleotide probe which is specific for an internal portion of the overlap region. As described in Example 8, this method was successful in producing amplified fragments for each of the eleven F<sub class="style-scope patent-text">i</sub> /R<sub class="style-scope patent-text">i</sub> overlap regions in the HCV genome segment. The overlap-region fragments may be used as probes for the corresponding (two) linking fragments connected by the overlap region. It is emphasized, however, that this amplification step was employed to confirm the presence of amplifiable cDNA along the length of the HCV genome, and not as an essential step in producing the desired linking fragments. The step is omitted from FIG. 1.</div>
    <div class="description-paragraph style-scope patent-text">The linking fragments F<sub class="style-scope patent-text">i</sub> /R<sub class="style-scope patent-text">j</sub> are produced by a two-primer PCR procedure in which the SISPA-amplified DNA fragments are amplified by a primer pair consisting of the forward primer F<sub class="style-scope patent-text">i</sub> of one overlap region and the reverse primer R<sub class="style-scope patent-text">j</sub> of an adjacent overlap region. The ten overlap regions in the HCV segment and the regions corresponding to the forward and reverse primers in each region are given in Example 9. Typical amplification conditions are give in Example 9. The amplified fragments in each reaction mixture are isolated and purified, e.g., by gel electrophoresis, to confirm the expected fragment size. Southern blots may be probed with oligonucleotide probes complementary to internal regions located between the fragment ends, to confirm the expected sequence of the fragments. As shown at the bottom in FIG. 1, the method generates the complete set of linking fragments, where each fragment is bounded by an overlap region P<sub class="style-scope patent-text">i</sub> and P<sub class="style-scope patent-text">i+1</sub>.</div>
    <div class="description-paragraph style-scope patent-text">The method, as applied to generating ten overlapping linking fragments of the 7,300 basepair HCV genome, is described in Example 9. As demonstrated by size criteria on gel electrophoresis and by sequence criteria by Southern blotting, the method was successful in generating all ten of the overlapping fragments spanning the HCV genome.</div>
    <div class="description-paragraph style-scope patent-text">It will be appreciated that the above flanking sequence amplification method can be applied to the generation of DNA fragments corresponding to the insert sequences of <figure-callout id="40" label="clones" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clones</a></figure-callout> 36 and 40, which have also been obtained by immunoscreening. The linker primers flanking the inserts are easily used to generate sequences corresponding to the clone inserts. For example, two-primer amplification of the SISPA-amplified cDNA fragments (Example 7) using the F<sub class="style-scope patent-text">12</sub> /R<sub class="style-scope patent-text">9</sub> primer pair (the sequences of which are given in Example 8) is carried out under conditions similar to those described in Example 9. The amplified fragment mixture is fractionated by agarose electrophoresis on 1.0% agarose, and the expected band cut from the gel and eluted.</div>
    <div class="description-paragraph style-scope patent-text">The purified amplified fragment is treated with the Klenow fragment of DNA polymerase I to assure the molecules are blunt-ended. The fragment is then ligated to EcoRI linkers (Example 10). The mixture is digested with EcoRI and inserted into the lambda gt11 vector. The resulting clones contain the entire coding sequences of either the clone 36 or <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40 inserts.</div>
    <div class="description-paragraph style-scope patent-text">Alternatively, the original amplified 36/40 fragment (primers F<sub class="style-scope patent-text">12</sub> /R<sub class="style-scope patent-text">9</sub>) is briefly treated with Exonuclease III (Boehringer Mannheim, as per manufacturer's instructions) to generate a family of fragments with different 5' ends. The digestion products are treated as above and ligated into the lambda gt11 vector. The resulting plaques are then immunoscreened.</div>
    <div class="description-paragraph style-scope patent-text">Further, different sets of primers, other than the F<sub class="style-scope patent-text">12</sub> /R<sub class="style-scope patent-text">9</sub> primers described above, can be used to directly generate sequence encoding all, or portions, of <figure-callout id="40" label="clones" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clones</a></figure-callout> 36 and 40. For example, primers F<sub class="style-scope patent-text">8</sub> /R<sub class="style-scope patent-text">9</sub> can generate a fragment corresponding to a portion of the 3' sequences of the insert of clone 36 (FIG. 4) and all of the insert sequences of clone 40 (FIG. 3). Also, primers F<sub class="style-scope patent-text">7</sub> /R<sub class="style-scope patent-text">9</sub> can be used to directly generate a fragment corresponding to a portion of the 5' sequences present in the insert of clone 36 (FIG. 4).</div>
    <div class="description-paragraph style-scope patent-text">V. PT-MANBH Immunoreactive Peptide Fragments</div>
    <div class="description-paragraph style-scope patent-text">Several novel peptide antigens which are immunoreactive with sera from human and chimpanzee NANBH-infected sera have been generated from the NANBH linking fragments produced above, in accordance with the methods of the present invention. Further, this method has confirmed antigenic regions previously identified by cDNA library immunoscreening (Section II above). The antigen peptides derived from linking fragments are preferably produced in a method which involves first digesting each of the above linking fragments with DNaseI under partial digestion conditions, yielding DNA digest fragments predominantly in the 100-300 basepair size range, as illustrated in Example 10. The digest fragments may be size fractionated, for example by gel electrophoresis, to select those in the desired size range.</div>
    <div class="description-paragraph style-scope patent-text">The digest fragments from each linking fragment are then inserted into a suitable expression vector. One exemplary expression vector is lambda gt11, the advantages of which have been described above.</div>
    <div class="description-paragraph style-scope patent-text">For insertion into the expression vector, the digest fragments may be modified, if needed, to contain selected restriction-site linkers, such as EcoRI linkers, according to conventional procedures. Typically, the digest fragments are blunt-ended, ligated with EcoRI linkers, and introduced into EcoRI-cut lambda gt11. Such recombinant techniques are well known in the art (e.g., Maniatis et al.).</div>
    <div class="description-paragraph style-scope patent-text">The resulting viral genomic library may be checked to confirm that a relatively large (representative) library has been produced for each linking fragment. This can be done, in the case of the lambda gt11 vector, by infecting a suitable bacterial host, plating the bacteria, and examining the plaques for loss of beta-galactosidase activity, as evidenced by clear plaques.</div>
    <div class="description-paragraph style-scope patent-text">The presence of a digest-fragment insert in the clear plaques can be confirmed by amplifying the phage DNA, using primers specific for the regions of the gt11 phage flanking the EcoRI insert site, as described in Example 10B. The results in Table 3 show that a large percentage of the plaques tested in each linking fragment library contained a digest-fragment insert.</div>
    <div class="description-paragraph style-scope patent-text">The linking-fragment libraries may also be screened for peptide antigens which are immunoreactive with human or chimpanzee sera identified with PT-NANBH chronic, convalescent, or acute infection. One preferred immunoscreening method is described in Example 10B. Here recombinant protein produced by the phage-infected bacteria is transferred from the plaques to the filter. After washing, the filter is incubated with test serum, and then reacted with reporter-labeled anti-human IgG antibody. The presence of the peptide antigen on the filter is then assayed for the presence of the reporter. As seen from Table 3, several of the linking-fragment libraries were positive for immunoreactive peptides in the primary screen.</div>
    <div class="description-paragraph style-scope patent-text">The immunoscreening method just described can be used to identify library plaques from each of the linking libraries which are immunoreactive with sera from human or chimpanzee with known chronic, convalescent, or acute PT-NANBH infection. One exemplary screening procedure is given in Example 11, where the ten HCV linking-fragment libraries are screened with known PT-NANBH (a) human chronic serum, (b) chimpanzee acute pooled sera and (c) chimpanzee chronic pooled sera. Of the ten libraries examined, only the F<sub class="style-scope patent-text">1</sub> /R<sub class="style-scope patent-text">10</sub> library did not give positive immunoreaction with any of the three sera. Several of the fragment libraries, including F<sub class="style-scope patent-text">3</sub> /R4, F<sub class="style-scope patent-text">6</sub> /R<sub class="style-scope patent-text">12</sub>, F<sub class="style-scope patent-text">12</sub> /R<sub class="style-scope patent-text">7</sub>, and F<sub class="style-scope patent-text">7</sub> /R<sub class="style-scope patent-text">8</sub> showed five or more positive reactions with chimpanzee acute sera, indicating that these libraries each express one or more peptide antigens which are useful for detecting chimpanzee or human acute PT-NANBH infection.</div>
    <div class="description-paragraph style-scope patent-text">The fragment library F<sub class="style-scope patent-text">7</sub> /R<sub class="style-scope patent-text">8</sub> corresponds to an internal fragment of clone 36 insert (Section II; FIG. 4). Accordingly, the linking fragment method confirmed that this DNA region encodes a useful antigen. Further, the fragment library F<sub class="style-scope patent-text">8</sub> /R<sub class="style-scope patent-text">9</sub> contains the sequences present in the <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40 insert (Section II: FIGS. 3 and 4). The results in Table 4 indicate that at least one peptide antigen effective to detect the presence of chronic-infection serum was isolated from the F<sub class="style-scope patent-text">8</sub> /R<sub class="style-scope patent-text">9</sub> fragment library.</div>
    <div class="description-paragraph style-scope patent-text">VI. Immunoreactive 409-1-1 Peptides</div>
    <div class="description-paragraph style-scope patent-text">A. Immunoreactive Screening</div>
    <div class="description-paragraph style-scope patent-text">Two of the immunoreactive plaques identified by immunoreactive screening, designated 409-1-1(abc) and 409-1-1(c-a), were tested for immunoreactivity against well-documented PT-NANBH chronic sera which showed strong immunoreactivity to the 5-1-1 HCV peptide antigen (Kuo). The 5-1-1 HCV peptide antigen has previously been identified as immunoreactive against a high percentage of human PT-NANBH chronic sera. The 5-1-1 antigen is encoded by the sequence between basepairs 3731 and 3857 in the HCV genome (Appendix) and is itself contained in a larger peptide antigen C-100 encoded by the sequence between basepairs 3531 and 4442. The latter peptide is employed in a commercial diagnostic kit for detection of human HCV infection (Ortho/Chiron). The kit is reported to react positively with about 80% of human chronic PT-NANBH samples, and about 15% of human acute PT-NANBH sera, as noted above.</div>
    <div class="description-paragraph style-scope patent-text">The 409-1-1 (c-a) phage was identified by immunoscreening and plaque purified, as outlined above. A related clone, designated 409-1-1(abc), was described in the parent to the present application (U.S. application Ser. No. 07/505,611, herein incorporated by reference). Clone 409-1-1(abc) was designated 409-1-1 in the parent application. The a, b and c designations refer to three regions of the 409-1-1(abc) sequence (see FIG. 5). The 5-1-1 coding sequence was isolated by polymerase chain reaction using oligonucleotide primers complementary to the ends of the 5-1-1 coding region, and cloned into lambda gt11 for expression under induction conditions of a fused beta-galactosidase protein which includes the 5-1-1 antigen peptide region. The 5-1-1 phage was identified and plaque purified by similar methods.</div>
    <div class="description-paragraph style-scope patent-text">The 409-1-1(c-a) arid 5-1-1 antigens were compared by plaque immunoscreening with a panel of 28 sera from normal (2 donors), human PT-NANBH-chronic (6 donors), chimpanzee normal (7 donors), chimpanzee PT-NANBH-acute (5 donors), and chimpanzee PT-NANBH-chronic (8 donors), with the results shown in Table 5 in Example 12. As can be seen in Table 5, the 5-1-1 and 409-1-1(c-a) peptides reacted with most of the human and chimpanzee chronic sera, although the 409-1-1(c-a) peptide detected a higher percentage of human chronic sera samples (83% vs 66%). The chronic human serum which was detected by the 409-1-1(c-a) peptide, but not by 5-1-1 was from a patient (BV) who died of fulminant NANBH infection. Because the 5-1-1 antigen is contained within the C-100 antigen in the commercially available kit format (Ortho/Chiron), it was of interest to determine whether the C-100 antigen gave a broader range of reactivity with the test sera. The results are shown at the right in Table 5 below. The only human NANBH serum that was tested was the above BV serum which was not detected by 5-1-1. This serum was also not immunoreactive with the C-100 antigen (0/1). Nor was the C-100 antigen reactive with any of the five acute chimp sera which were tested (0/5). It is also noted that the 409-1-1(c-a) antigen is immunoreactive with 3 of the 5 acute chimpanzee sera tested, compared with only 1 out of 5 for the 5-1-1 antigen. The results indicate that the 409-1-1(c-a) antigen has broader immunospecificity with PT-NANBH sera, and thus would provide a superior diagnostic agent. The results obtained with 409-1-1(c-a) are comparable to the results obtained using 409-1-1(abc).</div>
    <div class="description-paragraph style-scope patent-text">It is noted here that the 409-1-1(abc) coding sequence is contained in the F<sub class="style-scope patent-text">4</sub> /R<sub class="style-scope patent-text">5</sub> linking fragment and does not overlap the sequence of the C-100 (and 5-1-1) coding region which is in the F<sub class="style-scope patent-text">4</sub> /R<sub class="style-scope patent-text">5</sub> and F<sub class="style-scope patent-text">5</sub> /R<sub class="style-scope patent-text">6</sub> linking fragments. The relatively long coding sequence of the 409-1-1(abc) peptide illustrates that larger size digest fragments (substantially greater than 300 basepairs) are generated in the partial digest step used in producing digest fragments for antigen expression.</div>
    <div class="description-paragraph style-scope patent-text">The 409-1-1(abc) peptide, which forms one aspect of the invention, has the amino acid sequence which is presented as SEQ ID NO:10. The DNA coding sequence corresponding to the insert in the 409-1-1 clone is given in FIG. 5 and is presented as SEQ ID NO:9.</div>
    <div class="description-paragraph style-scope patent-text">The 409-1-1(c-a) peptide, which forms another aspect of the invention, has the amino acid sequence presented as SEQ ID NO:8. The DNA coding sequence corresponding to the insert in the 409-1-1(c-a) clone is given in FIG. 6 and is presented as SEQ ID NO:7. The relationship between the coding sequence of 409-1-1(c-a) and 409-1-1(abc) is outlined in Example 12. Briefly, 409-1-1(c-a) consists of a carboxy terminal region of 409-1-1(abc) moved to the amino terminus of the 409-1-1 coding sequence, with a truncation of the remaining 3' 409-1-1(abc) coding sequence.</div>
    <div class="description-paragraph style-scope patent-text">More generally, the invention includes a peptide antigen which is immunoreactive with sera from humans with HCV infection. Such peptide antigens are readily identifiable by the methods of the present invention.</div>
    <div class="description-paragraph style-scope patent-text">Antigens obtained from the region corresponding to the HCV sequences encoding the 409-1-1 antigens were further characterized as follows. The primers shown in Table 7 were used to generate a family of overlapping amplified fragments derived from this region. Several templates were used for the DNA amplification reactions (Table 8). The relationships of the coding sequences of the resulting clones to each other are graphically illustrated in FIG. 7. The amplified fragments were then cloned into lambda gt11 vectors (Example 13).</div>
    <div class="description-paragraph style-scope patent-text">These cloned fragments were then immunoscreened (Example 13). Seven of the nine clones tested positive by preliminary immunoscreening (Table 9). These seven clones were then tested against a more extensive battery of PT-NANBH serum samples, including numerous human clinical samples. The sensitivity of the antigens, in decreasing order, for reactivity with the serum used for screening was as follows: 33cu &gt;33c&gt;409-1-1(c-a)&gt;409-1-1-F1R2&gt;409-1-1(abc)≈409-1-1a&gt;5-1-1&gt;409-1-1(c+270). As can be seen from these results all of the alternative clones, with the exception of 409-1-1(c+270), provided a more sensitive antigen than 5-1-1. However, although 33cu and 33c were very sensitive antigens, in this assay they reacted slightly with serum which was known to be negative for HCV and may therefore be less specific. Accordingly, the 409-1-1 series appears preferable for use as diagnostic antigens since they are more specific to HCV-induced antibodies.</div>
    <div class="description-paragraph style-scope patent-text">The immunoscreening was extended to include the <figure-callout id="45" label="clone" filenames="US5843636-drawings-page-7.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 36 and 45 encoded epitopes: the insert of <figure-callout id="45" label="clone" filenames="US5843636-drawings-page-7.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 45 is essentially the same as the insert of clone 40 (Example 4). As can be seen from the results presented in Table 11, the antigens produced by <figure-callout id="40" label="clones" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clones</a></figure-callout> 36 and 40, while not as sensitive as 409-1-1(c-a), do yield HCV-specific immunopositive signals with selected samples. Accordingly, the two methods presented in the present invention, (i) immuno-screening of cDNA libraries generated directly from sera-derived RNA, and (ii) immunoscreening of amplified-fragment libraries, can both be seen to be effective methods of identifying cDNA sequences encoding viral antigens. Further, confirmation of the <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 36 and 40 encoded antigens by identification of antigens corresponding to these HCV regions using the amplified-fragment library method validates the usefulness of the amplified-fragment method.</div>
    <div class="description-paragraph style-scope patent-text">B. Peptide Purification</div>
    <div class="description-paragraph style-scope patent-text">The recombinant peptides of the present invention can be purified by standard protein purification procedures which may include differential precipitation, molecular sieve chromatography, ion-exchange chromatography, isoelectric focusing, gel electrophoresis and affinity chromatography. In the case of a fused protein, such as the beta-galactosidase fused proteins prepared as above, the fused protein can be isolated readily by affinity chromatography, by passing cell lysis material over a solid support having surface-bound anti-beta-galactosidase antibody. For example, purification of a beta-galactosidase/fusion protein, derived from 409-1-1(c-a) coding sequences, by affinity chromatography is described in Example 14.</div>
    <div class="description-paragraph style-scope patent-text">A fused protein containing the 409-1-1(a) peptide fused with glutathione-S-transferase (Sj26) protein has also been expressed using the pGEX vector system in E. Coli KM392 cells (Smith). This expression system has the advantage that the fused protein is generally soluble and therefore can be isolated under non-denaturing conditions. The fused Sj26 protein can be isolated readily by glutathione substrate affinity chromatography (Smith). This method of expressing this fusion protein is given in Example 15 and is applicable to any of the other antigen coding sequences described by the present invention.</div>
    <div class="description-paragraph style-scope patent-text">Also included in the invention is an expression vector, such as the lambda gt11 or pGEX vectors described above, containing the 409-1-1(a) coding sequence and expression control elements which allow expression of the coding region in a suitable host. The coding sequence is contained in the sequence given above corresponding to basepairs 2755-3331 of the HCV genome. The control elements generally include a promoter, translation initiation codon, and translation and transcription termination sequences, and an insertion site for introducing the insert into the vector. In the case of the two vectors illustrated in Example 15, the control elements control the synthesis of the protein which is fused with the heterologous peptide antigen. Such expression vectors can be readily constructed for the other antigen coding sequences described by the present invention.</div>
    <div class="description-paragraph style-scope patent-text">The lambda gt11 vectors containing the following coding regions have been deposited with The American Type Culture Collection, 12301 Parklawn Dr., Rockville Md., 20852: the 409-1-1(abc) coding region, designated gt11/-409-1-1(abc), ATCC No. 40876; the 409-1-1(c-a) coding region, designated gt11/409-1-1(c-a) ATCC No. 40792; clone 36, designated gt11/36, ATCC No. 40901; and, clone 40, designated gt11/40, ATCC No. 40893. Lambda gt11 clone 409-1-1 (ATCC Designation No. 40792) was accepted by the International Depository authority on Apr. 18, 1990; lambda gt11 clone 409-1-1abc (ATCC Designation No. 40876) was accepted for deposit by the International Depository Authority on Aug. 28, 1990.</div>
    <div class="description-paragraph style-scope patent-text">VII. Immunoreactive Clones of the HCV-Capsid Antigen</div>
    <div class="description-paragraph style-scope patent-text">At the 1990 Congress of Hepatology a region of the full-length HCV nucleic acid sequence was presented, nucleotide residues 325-970, containing the HCV non-coding, structural core protein and envelope protein coding sequences as capsid parts of a polyprotein sequence. During the course of experiments performed in support of the present invention, the coding region that corresponds to the capsid protein was more clearly defined.</div>
    <div class="description-paragraph style-scope patent-text">Polymerase Chain Reaction primers were constructed from selected HCV sequence which would generate amplification products of nucleotides 325-970 of the full length HCV genome (see FIGS. 11A to 11H). These primers, SF2(C) and SR1(C), are presented in Example 16. The primers contained non-complementary sequences which encoded restriction enzyme cleavage sites to facilitate subsequent cloning manipulations. The primers were used in amplification reactions containing SISPA-amplified HCV cDNA molecules (Example 7) as substrate. The resulting amplification products were cloned into the pGEX and pET vectors (Example 16). The pGEX vector allows expression of inserted coding sequences as fusion proteins to the Sj26 protein, glutathione-S-transferase. Insertion into the pET vector allows expression of the inserted coding sequences independent of fusion sequences.</div>
    <div class="description-paragraph style-scope patent-text">These clones were then immunologically screened using sera known to be reactive with HCV-antigens (Example 17). Several clones in both vectors were identified which were immunoreactive with the anti-HCV sera (in pGEX, <figure-callout id="60" label="clones" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-15.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clones</a></figure-callout> 14, 15, 56, 60, and 65, Example 17, Table 13). It was observed that the fusion proteins which were produced from the clones in pGEX were smaller than expected.</div>
    <div class="description-paragraph style-scope patent-text">Clone 15 was selected for scaled up production of the Sj26/HCV-antigen fusion protein. The fusion protein product (approximately 29 kd) was smaller than the expected fusion product (approximately 50 kd, Example 17). Further, the yield of the fusion protein from this preparation was unexpectedly low.</div>
    <div class="description-paragraph style-scope patent-text">Clones 15 and 56 were chosen for nucleic acid sequencing of the HCV-antigen containing inserts (Example 18). The sequences of the two clones were very similar with the exception that clone 15 had a termination codon starting at nucleotide position 126. This result suggested that the amino terminal 42 amino acids encoded by the HCV insert were immunogenic in regard to the anti-HCV sera used for immunoscreening.</div>
    <div class="description-paragraph style-scope patent-text">To test the suggestion that the amino terminus of the HCV polyprotein was antigenic, a synthetic oligopeptide was constructed essentially corresponding to amino acid residues 6-24 of FIG. 8A: this peptide had very strong immunoreactivity with anti-HCV sera as tested by ELISA. PCR primers (FIG. 8, C1 and NC105) were designed to generate a clone corresponding to this region (FIG. 10, C1NC 105, SEQ ID NO:25). Three other synthetic peptides were tested, one of which was strongly immunoreactive with anti-HCV sera (amino acid residues 47-74, FIG. 8A) and two which were weakly immunoreactive (amino acid residues 39-60 and 101-121, FIG. 8A). These synthetic peptides confirm the presence of a strong antigenic region at the amino-terminal end of the HCV polyprotein in the capsid protein region.</div>
    <div class="description-paragraph style-scope patent-text">The sequence of clone 56, designated pGEX-GG1-56, is shown in FIG. 8A and is presented in the sequence listing as SEQ ID NO:11. The sequence shows that the cone has a long open reading frame. When production of the fusion protein was induced, a fusion protein smaller than the expected product was produced, similar in size to the clone 15 product. The nucleotide sequence of the clones revealed a region which is prone to translational frameshifting, AAAAAAAAAA (Atkins et al., Wilson et al.). Such a nucleotide sequence may contribute to the low protein yields when these clones are expressed in E. coli. In an effort to improve the level of fusion protein expression the third nucleotide position of several codons through this region was changed to a G resulting in the sequence AGAAGAAGAA (Example 20): the changes had no effect on the protein coding sequence (amino acid residues 8-10, FIG. 8A). This modified insert was cloned into the pGEX vector and the resulting plasmid named pGEX-CapA.</div>
    <div class="description-paragraph style-scope patent-text">A hydropathicity plot was generated for the protein coding sequences of the insert of pGEX-GG1 (Example 19, FIG. 9). The results of this analysis indicated that the carboxy-terminal region of the encoded protein, approximately amino acid residues 168-182, had the potential for being a membrane spanning segment. Since it was unlikely that the membrane spanning segment would provide a strong antigen and since overproduction of proteins with these regions can adversely affect the growth of bacterial cells, a series of carboxy terminal deletions were generated from pGEX-CapA (Example 20).</div>
    <div class="description-paragraph style-scope patent-text">To generate the carboxy terminal deletions PCR primers were designed to be complementary to various regions of the pGEX-CapA insert encoded protein. The primers used to generate the carboxy terminal deletions are given in Table 14 and the location of the primers relative to the insert coding sequence is presented in FIG. 8B and FIG 8C. The carboxy terminal deletion fragments were cloned into the pGEX vector and Sj26/HCV-insert fusion proteins were produced. These fusion proteins were then screened with anti-HCV sera and an epitope map generated for the immunoreactive polypeptides (see FIG. 10). <figure-callout id="270" label="Clones C1NC" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Clones C1NC</a></figure-callout> 270, <figure-callout id="360" label="C1NC" filenames="US5843636-drawings-page-12.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C1NC</a></figure-callout> 360, and <figure-callout id="450" label="C1NC" filenames="US5843636-drawings-page-12.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C1NC</a></figure-callout> 450 all expressed high levels of the Sj26/HCV fusion proteins. Further, these fusion proteins all corresponded to the size predicted from their nucleic acid coding sequences. <figure-callout id="520" label="Clones C1NC" filenames="US5843636-drawings-page-12.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Clones C1NC</a></figure-callout> 520 and <figure-callout id="580" label="C1NC" filenames="US5843636-drawings-page-12.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C1NC</a></figure-callout> 580 gave poor yields of fusion proteins suggesting that when the hydrophobic region of amino acid residues 168-182 is present it may in part be responsible for the poor protein yields previously obtained.</div>
    <div class="description-paragraph style-scope patent-text">The deletion analysis was continued to further dissect the antigenic regions of the pGEX-CapA encoded HCV antigen. A series of amino terminal deletions (primers in Table 15) combined with carboxy terminal deletions were generated using PCR primers: the locations of all the primers are illustrated in FIG. 8B.</div>
    <div class="description-paragraph style-scope patent-text">The results of the deletion analysis are presented in Table 16 and in FIG. 10. These results, combined with the synthetic peptide data presented above, suggest that the capsid protein (which comprises the N-terminus of the HCV polyprotein) has two dominant immunoreactive regions. Both of these immunoreactive regions are useful use as diagnostic antigens. The region comprising the first 35 amino acids spans one of the epitopes and the region spanning residues 34-90 encompasses the other strongly immunoreactive domain.</div>
    <div class="description-paragraph style-scope patent-text">In summary, all of the pGEX clones containing the N-terminus of the HCV polyprotein and either 34, 90, 120 or 150 residues produced large quantities of fusion protein which was shown to be efficiently recognized by HCV positive sera. Expression of the PCR inserts containing amino acid residues 34-90 was also strongly immunoreactive, whereas inserts encoding residues 90-120 or 90-150 were not immunoreactive, demonstrating that these regions were not recognized by human sera. This result suggests that the regions important for the production of recombinant antigens is contained between <figure-callout id="1" label="residues" filenames="US5843636-drawings-page-10.png,US5843636-drawings-page-11.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">residues</a></figure-callout> 1 through 90.</div>
    <div class="description-paragraph style-scope patent-text">Analyses of the <figure-callout id="450" label="pGEXC1NC" filenames="US5843636-drawings-page-12.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">pGEXC1NC</a></figure-callout> 450 protein and the pET360 protein showed that the inclusion of these antigens in Western and ELISA formats permitted the identification of HCV positive sera which had been previously identified as either HCV negative or HCV indeterminate. Accordingly, the inclusion of these epitopes permits the generation of an improved screening system (Example 21).</div>
    <div class="description-paragraph style-scope patent-text">VIII. Anti-HCV Antigen Antibodies</div>
    <div class="description-paragraph style-scope patent-text">In another aspect, the invention includes antibodies specific against the recombinant antigens of the present invention. Typically, to prepare antibodies, a host animal, such as a rabbit, is immunized with the purified antigen or fused protein antigen. The host serum or plasma is collected following an appropriate time interval, and this serum is tested for antibodies specific against the antigen. Example 15 describes the production of rabbit serum antibodies which are specific against the 409-1-1 antigens in the Sj26/409-1-1(a) and beta-galactosidase/409-1-1(c-a) fusion protein. These techniques are equally applicable to the other antigens of the present invention.</div>
    <div class="description-paragraph style-scope patent-text">The gamma globulin fraction or the IgG antibodies of immunized animals can be obtained, for example, by use of saturated ammonium sulfate or DEAE Sephadex, or other techniques known to those skilled in the art for producing polyclonal antibodies.</div>
    <div class="description-paragraph style-scope patent-text">Alternatively, the purified antigen or fused antigen protein may be used for producing monoclonal antibodies. Here the spleen or lymphocytes from an immunized animal are removed and immortalized or used to prepare hybridomas by methods known to those skilled in the art. To produce a human-human hybridoma, a human lymphocyte donor is selected. A donor known to be infected with an HCV virus (where infection has been shown for example by the presence of anti-virus antibodies in the blood) may serve as a suitable lymphocyte donor. Lymphocytes can be isolated from a peripheral blood sample or spleen cells may be used if the donor is subject to splenectomy. Epstein-Barr virus (EBV) can be used to immortalize human lymphocytes or a human fusion partner can be used to produce human-human hybridomas. Primary In vitro immunization with peptides can also be used in the generation of human monoclonal antibodies.</div>
    <div class="description-paragraph style-scope patent-text">Antibodies secreted by the immortalized cells are screened to determine the clones that secrete antibodies of the desired specificity, for example, using the Western blot method described in Example 15.</div>
    <div class="description-paragraph style-scope patent-text">IX. Utility</div>
    <div class="description-paragraph style-scope patent-text">A. Diagnostic Method and Kit</div>
    <div class="description-paragraph style-scope patent-text">The antigens obtained by the methods of the present invention are advantageous for use as diagnostic agents for anti-HCV antibodies present in HCV-infected sera; particularly, the 409-1-1 antigens (409-1-1(abc), 409-1-1(c-a), and related antigens (see Table 9); the clone 36 antigen; and, the <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40 antigen and the capsid antigen. As noted above, many of the antigens provide the advantage over known HCV antigen reagents 5-1-1 and C-100 in that they are immunoreactive with a wider range of PT-NANBH infected sera, particularly acute-infection sera. This is particularly true of combinations of the 409-1-1 antigens with the HCV-core protein antigens as described in Section VII above. The antigens 409-1-1(c-a) and Cap450 have been combined in an ELISA test kit and tested against HCV test kits produced by Abbott and Ortho. The antigens of the present invention consistently identify more HCV+ samples with a high degree of specificity which is comparable to or better than the Abbott and Ortho test kits.</div>
    <div class="description-paragraph style-scope patent-text">In one preferred diagnostic configuration, test serum is reacted with a solid phase reagent having a surface-bound HCV antigen (or antigens) obtained by the methods of the present invention, e.g., the 409-1-1(c-a) antigen and the Cap450 antigen. After binding anti-HCV antibody to the reagent and removing unbound serum components by washing, the reagent is reacted with reporter-labeled anti-human antibody to bind reporter to the reagent in proportion to the amount of bound anti-PT-NANBH antibody on the solid support. The reagent is again washed to remove unbound labeled antibody, and the amount of reporter associated with the reagent is determined. Typically, the reporter is an enzyme which is detected by incubating the solid phase in the presence of a suitable fluorometric or calorimetric substrate.</div>
    <div class="description-paragraph style-scope patent-text">The solid surface reagent in the above assay is prepared by known techniques for attaching protein material to solid support material, such as polymeric beads, dip sticks, 96-well plate or filter material. These attachment methods generally include non-specific adsorption of the protein to the support or covalent attachment of the protein, typically through a free amine group, to a chemically reactive group on the solid support, such as an activated carboxyl, hydroxyl, or aldehyde group.</div>
    <div class="description-paragraph style-scope patent-text">In a second diagnostic configuration, known as a homogeneous assay, antibody binding to a solid support produces some change in the reaction medium which can be directly detected in the medium. Known general types of homogeneous assays proposed heretofore include (a) spin-labeled reporters, where antibody binding to the antigen is detected by a change in reported mobility (broadening of the spin splitting peaks), (b) fluorescent reporters, where binding is detected by a change in fluorescence efficiency, (c) enzyme reporters, where antibody binding effects enzyme/substrate interactions, and (d) liposome-bound reporters, where binding leads to liposome lysis and release of encapsulated reporter. The adaptation of these methods to the protein antigens of the present invention follows conventional methods for preparing homogeneous assay reagents.</div>
    <div class="description-paragraph style-scope patent-text">In each of the assays described above, the assay method involves reacting the serum from a test individual with the protein antigen and examining the antigen for the presence of bound antibody. The examination may involve attaching a labeled anti-human antibody to the antibody being examined, either IgM (acute phase) or IgG (convalescent or chronic phase), and measuring the amount of reporter bound to the solid support, as in the first method, or may involve observing the effect of antibody binding on a homogeneous assay reagent, as in the second method.</div>
    <div class="description-paragraph style-scope patent-text">Also forming part of the invention is an assay system or kit for carrying out the assay method just described. The kit generally includes a support with surface-bound recombinant HCV antigen (e.g., the 409-1-1 antigens, etc., as above), and a reporter-labeled anti-human antibody for detecting surface-bound anti-PT-NANBH-antigen antibody.</div>
    <div class="description-paragraph style-scope patent-text">As discussed in Section III above, peptide antigens associated with several of the linking-fragment libraries are immunoreactive with acute NANBH sera from chimpanzees, indicating that the peptides would be useful for detecting acute NANBH infection in human serum. In particular, one or more peptide antigens produced by the linking fragment libraries, F<sub class="style-scope patent-text">8</sub> /R<sub class="style-scope patent-text">9</sub> (reactive with chronic sera), F<sub class="style-scope patent-text">3</sub> R<sub class="style-scope patent-text">4</sub>, F<sub class="style-scope patent-text">6</sub> B<sub class="style-scope patent-text">12</sub>, F<sub class="style-scope patent-text">12</sub> R<sub class="style-scope patent-text">7</sub>, F<sub class="style-scope patent-text">7</sub> R<sub class="style-scope patent-text">8</sub>, or F<sub class="style-scope patent-text">7</sub> R<sub class="style-scope patent-text">8</sub> (which are shown in Example 11 to produce one or more peptide antigens which are immunoreactive with acute chimpanzee sera) can be combined with the 409-1-1 antigens to provide a diagnostic composition capable of immunoreacting with a high percentage of both chronic and acute human NANBH serum samples. Further, as discussed in Section VII above inclusion of the HCV-capsid protein antigens of the present invention add an extra level of sensitivity.</div>
    <div class="description-paragraph style-scope patent-text">A third diagnostic configuration involves use of the anti-HCV antibodies, described in Section VI above, capable of detecting HCV specific antigens. The HCV antigens may be detected, for example, using an antigen capture assay where HCV antigens present in candidate serum samples are reacted with an HCV specific monoclonal antibody. The monoclonal antibody is bound to a solid substrate and the antigen is then detected by a second, different labelled anti-HCV antibody: the monoclonal antibodies of the present invention which are directed against HCV specific antigens are particularly suited to this diagnostic method.</div>
    <div class="description-paragraph style-scope patent-text">B. Peptide Vaccine</div>
    <div class="description-paragraph style-scope patent-text">The HCV antigens identified by the methods of the present invention, e.g. 409-1-1(c-a) and HCV-core protein antigens, can be formulated for use in a HCV vaccine. The vaccine can be formulated by standard methods, for example, in a suitable diluent such as water, saline, buffered salines, complete or incomplete adjuvants, and the like. The immunogen is administered using standard techniques for antibody induction, such as by subcutaneous administration of physiologically compatible, sterile solutions containing inactivated or attenuated virus particles or antigens. An immune response producing amount of virus particles is typically administered per vaccinizing injection, typically in a volume of one milliliter or less.</div>
    <div class="description-paragraph style-scope patent-text">A specific example of a vaccine composition includes, in a pharmacologically acceptable adjuvant, a recombinant 409-1-1(c-a) peptide. The vaccine is administered at periodic intervals until a significant titer of anti-HCV antibody is detected in the serum. Such vaccines can also comprise combinations of the HCV antigens of the present invention.</div>
    <div class="description-paragraph style-scope patent-text">C. Passive Immunoprophylaxis</div>
    <div class="description-paragraph style-scope patent-text">The anti-HCV antibodies of the invention can be used as a means of enhancing an anti-HCV immune response since antibody-virus complexes are recognized by macrophages and other effector cells. The antibodies can be administered in amounts similar to those used for other therapeutic administrations of antibody. For example, pooled gamma globulin is administered at 0.02-0.1 ml/lb body weight during the early incubation of other viral diseases such as rabies, measles and hepatitis B to interfere with viral entry into cells. Thus, antibodies reactive with, for example, the 409-1-1(c-a) antigen can be passively administered alone in a "cocktail" with other anti-viral antibodies or in conjunction with another anti-viral agent to a host infected with a PT-NANBH virus to enhance the immune response and/or the effectiveness of an antiviral drug.</div>
    <div class="description-paragraph style-scope patent-text">The following examples illustrate various aspects of the invention, but are in no way intended to limit the scope thereof.</div>
    <heading class="style-scope patent-text">Materials</heading>
    <div class="description-paragraph style-scope patent-text">E. coli DNA polymerase I (Klenow fragment) was obtained from Boehringer Mannheim Biochemicals (Indianapolis, Ind.). T4 DNA ligase and T4 DNA polymerase were obtained from New England Biolabs (Beverly, Mass.); Nitrocellulose filters were obtained from Schleicher and Schuell (Keene, N.H.).</div>
    <div class="description-paragraph style-scope patent-text">Synthetic oligonucleotide linkers and primers were prepared using commercially available automated oligonucleotide synthesizers. Alternatively, custom designed synthetic oligonucleotides may be purchased, for example, from Synthetic Genetics (San Diego, Calif.). cDNA synthesis kit and random priming labeling kits were obtained from Boehringer-Mannheim Biochemical (BMB, Indianapolis, Ind.).</div>
    <heading class="style-scope patent-text">EXAMPLE 1</heading>
    <heading class="style-scope patent-text">Construction of NANB-containing cDNA libraries</heading>
    <div class="description-paragraph style-scope patent-text">A. Infection of a Chimpanzee with HCV</div>
    <div class="description-paragraph style-scope patent-text">A chimpanzee (#771) was inoculated with a Factor VIII preparation which was known to cause parenterally transmitted non-A non-B hepatitis (PT-NANBH) in human patients treated with the Factor VIII concentrate (Bradley). Post-infection ultrastructural changes in liver tissue were observed by electron microscopy and ALT (alanine amino transferase) elevation was observed in the infected chimpanzee. These observations are consistent with PT-NANBH infection.</div>
    <div class="description-paragraph style-scope patent-text">B. Isolation of RNA from Sera</div>
    <div class="description-paragraph style-scope patent-text">Serum was collected from the above described infected chimpanzee (#771) and four human PT-NANBH clinical sources (EGM, BV, CC and WEH). Ten milliliters of each undiluted serum was pelleted by centrifugation at 30K, for 3 hours in an SW40 rotor, at 4° C. RNA was extracted from each resulting serum pellet using the following modifications of the hot phenol method of Feramisco et al. Briefly, for each individual serum sample, the pellet was resuspended in 0.5 ml of 50 mM NaOAc, pH=4.8, containing 1% SDS. An equal volume of 60° C. phenol was added and incubated for 15 minutes at 60° C. with occasional vortexing. This mixture was transferred to a 1.5 ml microfuge tube and spun for two minutes at room temperature in a table top microfuge. The aqueous phase was transferred to a new microfuge tube. To the aqueous phase, 50 μl of 3M NaOAc, pH=5.2, and two volumes of 100% ethanol were added. This solution was held at -70° C. for approximately 10 minutes and then spun in a microfuge at 4° C. for 10 minutes. The resulting pellet was resuspended in 100 μl of sterile glass distilled water. To this <figure-callout id="10" label="solution" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">solution</a></figure-callout> 10 μl of NaOAc, pH=5.2, and two volumes of 100% ethanol were added. The solution was held at -70° C. for at least 10 minutes. The RNA pellet was recovered by centrifugation in a microfuge at 12,000×g for 15 minutes at 5° C. The pellet was washed in 70% ethanol and dried under vacuum.</div>
    <div class="description-paragraph style-scope patent-text">C. Synthesis of cDNA</div>
    <div class="description-paragraph style-scope patent-text">(i) First Strand Synthesis</div>
    <div class="description-paragraph style-scope patent-text">The synthesis of cDNA molecules was accomplished as follows. The above described RNA preparations were each resuspended in 26 μl of sterile glass distilled water (treated with diethyl pyrocarbonate, Maniatis et al.), 5 μl of 10×reaction buffer (0.5M Tris HCl, pH=8.5; 0.4M KCl; 0.1M MgCl<sub class="style-scope patent-text">2</sub> ; 4 mM DTT), 10 μl of a nucleotide solution (dGTP, dATP, dTTP, and dCTP, each at a concentration of 5 mM), 5 μl random primer, 0.25 μl of <sup class="style-scope patent-text">32</sup> P-dCTP, 2 μl AMV reverse transcriptase, and 2 μl of RNASIN (Promega), in a total reaction volume of 50 μl. This mixture was incubated for one hour at 42° C.</div>
    <div class="description-paragraph style-scope patent-text">(ii) Second Strand cDNA Synthesis</div>
    <div class="description-paragraph style-scope patent-text">To the first strand synthesis reaction mixture the following components were added: 55 μl of 2×second strand synthesis buffer (50 mM Tris HCl, pH=7.0; 60 mM KCl); 2 μl RNase H; 5 μl DNA polymerase I, and 2 μl of the above described nucleotide solution. The reaction was incubated for one hour at 12° C., followed by a one hour incubation at room temperature. The reaction mixture was extracted with an equal volume of 1:1 phenol/chloroform, followed by an extraction using 24:1 chloroform/isoamyl alcohol. To each <figure-callout id="1" label="reaction mixture" filenames="US5843636-drawings-page-10.png,US5843636-drawings-page-11.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">reaction mixture</a></figure-callout> 1 μl of 10 mg/ml tRNA was added as carrier. The cDNA was precipitated by the addition of two volumes of 100% ethanol and chilling at -70° C. for 15 minutes. The cDNA was collected by centrifugation, the pellet washed with 70% ethanol and dried under vacuum.</div>
    <div class="description-paragraph style-scope patent-text">(iii) Preparation of the Double Stranded cDNA for cloning</div>
    <div class="description-paragraph style-scope patent-text">To provide vector compatible ends each of the double stranded cDNA preparations was tailed with EcoRI linkers in the following manner.</div>
    <div class="description-paragraph style-scope patent-text">The cDNA was treated with EcoRI methylase under the following conditions: The cDNA pellet was resuspended in 20 <figure-callout id="1" label="μl" filenames="US5843636-drawings-page-10.png,US5843636-drawings-page-11.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">μl</a></figure-callout> 1×methylase buffer (50 mM Tris HCl, pH=7.5; 1 mM EDTA; 5 mM DTT), 2 <figure-callout id="1" label="μl" filenames="US5843636-drawings-page-10.png,US5843636-drawings-page-11.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">μl</a></figure-callout> 1 0.1 mM S-adenosyl-methionine (SAM) and 2 μl EcoRI methylase (New England Biolabs). The reaction was incubated for 30 minutes at 37° C. TE buffer (10 mM Tris-HCl, pH=7.5; 1 mM EDTA, pH=8.0) was added to achieve a final volume of 80 μl. The reaction mixture was extracted with an equal volume of phenol/chloroform (1:1) and then with an equal volume of chloroform/isoamyl alcohol (24:1). The cDNA was precipitated with two volumes of ethanol.</div>
    <div class="description-paragraph style-scope patent-text">To maximize the number of blunt ends for the addition of linkers (Maniatis et al, 1982) the cDNA was then treated with the Klenow fragment of DNA polymerase I. The pelleted cDNA was resuspended in 11.5 μl of distilled water. The following components were added to the resuspended cDNA: 4 μl of 5×NTB (10×NTB stock solution: 0.5M Tric.Cl pH=7.2; 0.1M MgSO<sub class="style-scope patent-text">4</sub> ; 1 mM dithiothreitol (DTT); 500 μg/ml bovine serum albumin (BSA)); 3 μl 0.1M MgCl<sub class="style-scope patent-text">2</sub>, 1.5 μl 10GATC (a solution containing 10 mM of each nucleotide G, A, T, and C), and 1 μl Klenow (Boehringer Mannheim Biochemicals). The reaction mixture was incubated at room temperature for 30 minutes. The reaction mixture was extracted with phenol/chloroform and chloroform isoamyl alcohol as described above, and then precipitated with two volumes of ethanol.</div>
    <div class="description-paragraph style-scope patent-text">The cDNA pellet was resuspended in 12 μl distilled water. To the resuspended linkers the following components were added: 5 μl EcoRI phosphorylated linkers (New England Biolabs), 2 <figure-callout id="10" label="μl" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">μl</a></figure-callout> 10×ligation buffer (0.66M Tris.Cl pH=7.6, 50 mM MgCl<sub class="style-scope patent-text">2</sub>, 50 mM DTT, 10 mM ATP) and 1 μl T4 DNA ligase. The reaction was incubated at 14° C. overnight. The following morning the reaction was incubated at 67° C. for three minutes to inactivate the ligase, then momentarily chilled. To the ligation reaction mixture 2.5 μl of 10×high salt restriction digest buffer (Maniatis et al.) and 2.5 μl of EcoRI enzyme were added and the mixture incubated at 37° C. for at least 6 hours to overnight. To remove excess linkers the digestion mixture was loaded onto a 1.2% agarose gel and the reaction components size fractionated by electrophoresis. Size fractions of the 0.3-1.3 Kb and 1.3-7 Kb ranges were electroeluted onto NA45 paper (Schleicher and Schuell). The NA45 paper, with the eluted cDNA bound to it, was placed in a 1.5 ml microfuge tube containing 0.5 ml of elution solution (50 mM arginine, 1M NaCl, pH=9.0). The tube was then placed at 67° C. for approximately one hour to allow the cDNA to be eluted from the paper into the solution. The solution was then phenol/chloroform, chloroform/isoamyl alcohol extracted and precipitated with two volumes of ethanol. The resulting cDNA pellets were resuspended in 20 μl TE (pH=7.5).</div>
    <div class="description-paragraph style-scope patent-text">(iv) Cloning of the cDNA into Lambda Vectors</div>
    <div class="description-paragraph style-scope patent-text">The linkers used in the construction of the cDNAs contained an EcoRI site which allowed for direct insertion of the amplified cDNAs into lambda gt10 and gt11 vectors (Promega, Madison Wis.). Lambda vectors were purchased from the manufacturer (Promega) which were already digested with EcoRI and treated with bacterial alkaline phosphatase, to remove the 5' phosphate and prevent self-ligation of the vector.</div>
    <div class="description-paragraph style-scope patent-text">The EcoRI-linkered cDNA preparations were ligated into both lambda gt10 and gt11 (Promega). The conditions of the ligation reactions were as follows: 1 μl vector DNA (Promega, 0.5 mg/ml); 0.5 or 3 μl of insert cDNA; 0.5 μl 10×ligation buffer (0.5M Tris-HCl, pH=7.8; 0.1M MgCl<sub class="style-scope patent-text">2</sub> ; 0.2M DTT; 10 mM ATP; 0.5 g/ml BSA), 0.5 μl T4 DNA ligase (New England Biolabs) and distilled Water to a final reaction volume of 5 μl.</div>
    <div class="description-paragraph style-scope patent-text">The ligation reaction tubes were placed at 14° C. overnight (12-18 hours). The ligated cDNA was packaged the following morning by standard procedures using a lambda DNA packaging system (GIGAPAK, Stratagene, LaJolla, Calif.), and then plated at various dilutions to determine the titer and recombinant frequency of the libraries. A standard X-gal blue/white assay was used to screen the lambda gt11 libraries (Miller; Maniatis et al.). E. coli HG415 (from Howard Gersenfeld, Dept. of Pathology, Stanford School of Medicine) plating bacteria, which allows only plaque formation by recombinant clones, was used for plating the lambda gt10 libraries. The standard strain, E. coli C600 hF<sup class="style-scope patent-text">-</sup>, may be used as an alternative to E. coli HG415.</div>
    <heading class="style-scope patent-text">EXAMPLE 2</heading>
    <heading class="style-scope patent-text">Screening the cDNA library for production of PT-NANBH antigens</heading>
    <div class="description-paragraph style-scope patent-text">The five lambda gt11 libraries generated in Example 1 were screened for specific HCV encoded viral antigens by immunoscreening. The phage were plated for plaque formation using the Escherichia coil bacterial plating strain E. coli KM392 (Kevin Moore, DNax, Palo Alto, Calif.). Alternatively, E. coli Y1088 may be used. The fusion proteins expressed by the lambda gt11 clones were screened with serum antibodies (Young et al.) from the following sources: chimpanzee #771 and various human PT-NANBH sera (including EGM, BV, WEH and AG).</div>
    <div class="description-paragraph style-scope patent-text">From the lambda gt11 libraries (Example 1) approximately 111 independent clones gave a positive immunological reaction with at least one of the chimp or human PT-NANBH sera. These phage clones were plaque purified and the recombinant phage grown for DNA purification (Maniatis et al.).</div>
    <heading class="style-scope patent-text">EXAMPLE 3</heading>
    <heading class="style-scope patent-text">Genomic Hybridization Screening of Immunopositive Clones</heading>
    <div class="description-paragraph style-scope patent-text">Out of the 111 plaque purified recombinant phage, obtained as in Example 2, 93 were isolated (Maniatis et al.) and digested with EcoRI as per the manufacturer's instructions (Bethesda Research Laboratories, Gaithersburg, Md.). Approximately 1.0 microgram of each digested phage DNA sample was loaded into sample wells of 1.0% agarose gels prepared using TAE (0.04 m Tris Acetate, 0.001M EDTA). The DNA samples were then electrophoretically separated. DNA bands were visualized by ethidium bromide staining (Maniatis et al.). Inserts were clearly identified for each of the 93 clones, purified by electroelution using NA45, and then radioactively labelled by nick translation (Maniatis et al.).</div>
    <div class="description-paragraph style-scope patent-text">Human peripheral blood lymphocyte (PBL) DNA was restriction digested with HindlIl and EcoRI, loaded on a 0.7% agarose gel (as above, except 10 μg of DNA was loaded per lane) and the fragments separated electrophoretically. The DNA fragments in the agarose gels were transferred to nitrocellulose filters (Southern) and the genomic DNA probed with the nick-translated lambda gt11 inserts which were prepared above.</div>
    <div class="description-paragraph style-scope patent-text">The filters were washed (Southern; Maniatis et al.) and exposed to X-ray film. Forty-three of the 93 lambda clone inserts displayed a positive hybridization reaction with the human PBL DNA. Among the remaining inserts which clearly did not hybridize with the PBL DNA, were 11 inserts derived from chimp #771 clones which were also clearly immunopositive from Example 2. Of these 11 clones, two of the clones had the immunoreactive characteristics summarized in Table 1. Chimpanzee #771 and humans Ag, BV and WEH were chronimc PT-NANBH sera samples and SKF was a normal human serum sample.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">              TABLE 1                                                     
______________________________________                                    
                 Clone Designation                                        
Sera             36    40                                                 
______________________________________                                    
#771             +     +                                                  
AG               +     -                                                  
BV               +     -                                                  
WEH              -     -                                                  
SKF              -     -                                                  
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">Clone 40 (original clone screening designation 304-12-1) was clearly exogenous, i.e., not derived from normal human DNA, as evidenced by repeated hybridization tests against normal human PBL DNA, and a second clone, designated clone 36 (original clone screening designation 303-1-4), was not only exogenous but also reactive with multiple PT-NANBH antisera.</div>
    <heading class="style-scope patent-text">EXAMPLE 4</heading>
    <heading class="style-scope patent-text">Sequencing of Clones</heading>
    <div class="description-paragraph style-scope patent-text">DNA sequencing was performed on <figure-callout id="40" label="clones" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clones</a></figure-callout> 36 and 40 as described in Example 3. Commercially available sequencing primers (New England Biolabs) homologous to flanking lambda sequences at the 5' and 3' ends of the inserts were initially used for sequencing. As sequencing progressed primers were constructed to correspond to newly discovered sequences. Synthetic oligonucleotide primers were prepared using commercially available automated oligonucleotide synthesizers. Alternatively, custom designed synthetic oligonucleotides may be purchased, for example, from Synthetic Genetics (San Diego, Calif.).</div>
    <div class="description-paragraph style-scope patent-text">DNA sequences were determined for the complete insert of clone 40 (presented as SEQ ID NO:1 and also shown in FIG. 3); this sequence corresponds to nucleotides 6516 to 7070 of the HCV genome (FIGS. 11A to 11H). Subsequently, the inserts present in clones 44 and 45 (2 other clones of the 11 clones identified in Example 3) were found to cross-hybridize to the <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40 insert. Partial sequencing of <figure-callout id="45" label="clones" filenames="US5843636-drawings-page-7.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clones</a></figure-callout> 44 and 45 showed that the sequences obtained from these two clones matched the sequence of <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40. A partial sequence of the clone 36 insert was determined and is presented as SEQ ID NO: 3; the complete sequence is presented as SEQ ID NO:5 and is also shown in FIG. 4. The sequence of clone 36 corresponds to nucleotides 5010 to 6515 given in the Appendix.</div>
    <heading class="style-scope patent-text">EXAMPLE 5</heading>
    <heading class="style-scope patent-text">Screening of the cDNA library in lambda gt10</heading>
    <div class="description-paragraph style-scope patent-text">The cDNA libraries in lambda gt10, generated in Example 1, were screened for the presence of sequences homologous to the <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40 insert.</div>
    <div class="description-paragraph style-scope patent-text">The lambda gt10 libraries were plated at a density of approximately 10<sup class="style-scope patent-text">4</sup> plaques/plate and plaques lifts were prepared according to Maniatis et al. Filters were indexed using india ink to allow alignment of the filters with the parent plate from which the plaque lift was performed. The bacteria and phage particles were lysed, and the nitrocellulose filters were processed and baked as previously described (Maniatis et al.). The prehybridization solution, per filter, consisted of the following: 5.4 ml prehybridization buffer (50 ml of 1M Tris HCl, pH=7.5; 2 ml of 0.5M EDTA, pH=8.0; 50 ml of 10% SDS; 150 ml of 20×SSC (Maniatis et al.); and, 238 ml of glass distilled water); 6.0 ml formamide; 0.4 <figure-callout id="50" label="ml" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ml</a></figure-callout> 50×Denhardt solution (5 g FICOLL; 5 g polyvinylpyrrolidone; 5 g bovine serum albumin; brought to a total volume of 500 ml with glass distilled water); and 0.2 ml of single-stranded salmon sperm DNA (10 mg/ml). Each filter was placed in a plastic bag and the prehybridization solution was added. The bag was sealed and incubated at 37° C. overnight with intermittent mixing of contents.</div>
    <div class="description-paragraph style-scope patent-text">The <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40 lambda DNA was isolated (Maniatis et al.) and digested with EcoRI. The resulting fragments were fractionated on an agarose gel and visualized by ethidium bromide staining (Maniatis et al.). The DNA fragment corresponding to the <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40 insert, approximately 500 base pairs, was isolated from the agarose by electroelution onto NA45. The aqueous suspension of the purified fragment was extracted once with a 1:1 phenol/chloroform solution, and once with a 24:1 chloroform/isoamylalcohol solution. The DNA was then precipitated with ethanol and resuspended in sterile water.</div>
    <div class="description-paragraph style-scope patent-text">The <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40 insert was radioactively labelled by nick translation and used to probe the lambda gt10 plaque lift filters. The prehybridization solution was removed from the filters. Each filter was hybridized with probe under the following conditions: 5.0 ml of hybridization buffer (5 ml of 1M Tris HCl, pH=7.5; 0.2 ml of 0.5M EDTA, pH=8.0; 5.0 ml of 10% SDS; 14.9 ml of 20×SSC (Maniatis et al.); 10 g of dextran sulfate; and, glass distilled water to a total volume of 50 ml); 5.0 ml formamide; 0.4 <figure-callout id="50" label="ml" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ml</a></figure-callout> 50×Denhardt's solution (5 g FICOLL; 5 g polyvinylpyrrolidone; 5 g bovine serum albumin; brought to a total volume of 500 ml with glass distilled water); and 0.2 ml of single-stranded salmon sperm DNA (10 mg/ml). To this hybridization mix was added 50-250 μl of denatured probe (boiled 5-10 minutes and quick-chilled on ice), resulting in approximately 10<sup class="style-scope patent-text">6</sup> cpm of labelled probe per filter. The hybridization mix containing the labelled probe was then added to the plastic bag containing the filters. The bag was resealed and placed under a glass plate in a 37° C. water bath overnight with intermittent mixing of contents.</div>
    <div class="description-paragraph style-scope patent-text">The next day the hybridization solution was removed and the filters washed three times, for 5 minutes each, in 2×SSC (Maniatis et al.) containing 0.5% SDS, at room temperature. The filters were then washed for one hour in 2×SSC, containing 0.5% SDS, at 50° C. The filters were then washed for 15-60 minutes in 0.1×SSC, containing 0.1% SDS, at 50° C. and finally 2×SSC, 15 minutes, 2-3×at room temperature. The washed filters were dried and then exposed to X-ray film for detection of positive plaques.</div>
    <div class="description-paragraph style-scope patent-text">Approximately 24 plaques from the lambda gt10 libraries were plaque purified from the approximately 200 plaques which tested positive by the hybridization screen (Table 2).</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">              TABLE 2                                                     
______________________________________                                    
          cDNA              Positives/                                    
Library   Source            Plate                                         
______________________________________                                    
EGM       Human             ≅ 50                                
BV        Human             ≅ 100                               
WEH       Human             ≅ 25                                
#771      Chimp             ≅ 10-15                             
______________________________________                                    
</pre>
    
    <heading class="style-scope patent-text">EXAMPLE 6</heading>
    <heading class="style-scope patent-text">Analysis of lambda gt10 cDNA Library Clones Homologous to the <figure-callout id="40" label="Clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Clone</a></figure-callout> 40 insert</heading>
    <div class="description-paragraph style-scope patent-text">The clones identified in Example 5 which have homology to the <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40 insert were analyzed by standard restriction analysis and the insert sizes were determined. The original frequencies of positive hybridization signals per plate using the <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40 insert as probe against the different cDNA sources are shown in the last column of Table 2. That these positive signals arose with different frequencies for the different cDNA sources in the lambda gt10 library suggests that the hybridization signals originated from the sera source rather than common contamination introduced during cDNA synthesis or cloning.</div>
    <div class="description-paragraph style-scope patent-text">One of the clones (108-2-5) from the EGM-generated cDNA library identified by hybridization with the <figure-callout id="40" label="clone" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clone</a></figure-callout> 40 insert, had an insert of approximately 3.7 kb and was chosen for further analysis. The insert was isolated by EcoRI digestion of the clone, electrophoretic fractionation, and electroelution (Example 5). The insert was treated with DNase I under conditions resulting in partial digestion (Maniatis et al.) to generate random fragments. The resulting fragments were inserted into lambda gt11 vectors for expression. The lambda gt11 clones were then immunoscreened (Example 2) using human (BV and normal) and chimpanzee #771 sera. Twelve positive clones were identified by first round immunoscreening with the human and chimp sera. Seven of the 12 clones were plaque purified and rescreened using chimp serum (#771). Partial DNA sequences of the insert DNA were determined for two of the resulting clones that had the largest sequences, designated 328-16-1 and 328-16-2. The 2 clones had sequences essentially identical to clone 40.</div>
    <heading class="style-scope patent-text">EXAMPLE 7</heading>
    <heading class="style-scope patent-text">Preparing Amplified HCV cDNA Fragments</heading>
    <div class="description-paragraph style-scope patent-text">A. Preparing cDNA fragments</div>
    <div class="description-paragraph style-scope patent-text">A plasma pool obtained from a chimpanzee with chronic PT-NANBH was obtained from the Centers for Disease Control (CDC) (Atlanta, Ga.). After direct pelleting or PEG precipitation, RNA was extracted from the virions by guanidinium thiocyanate-phenol-chloroform extraction, according to published methods (Chomczynski). The pelleted RNA was used for cDNA synthesis using oligo dT or random primers, or HCV sequence-specific primers and a commercial cDNA kit (Boehringer-Mannheim).</div>
    <div class="description-paragraph style-scope patent-text">In one method, synthesis of first strand cDNA was achieved by addition of four primers, designated A, B, C, and D, having the sequences shown below. These sequences are complementary to the HCV genomic regions indicated: ##STR1##</div>
    <div class="description-paragraph style-scope patent-text">Second strand cDNA synthesis was performed by the method of Gubler and Hoffman. The reactions were carried out under standard cDNA synthesis methods given in the commercial kit.</div>
    <div class="description-paragraph style-scope patent-text">B. Amplifying the cDNA Fragments</div>
    <div class="description-paragraph style-scope patent-text">The cDNA from above was blunt ended and ligated to the linker/primer having the following sequence: ##STR2##</div>
    <div class="description-paragraph style-scope patent-text">The cDNA and linker were mixed at a 1:100 molar ratio in the presence of 0.3 to 0.6 Weiss units of T4 DNA ligase. To 100 μl of 10 mM Tris-Cl buffer, pH 8.3, containing 1.5 mM MgCl<sub class="style-scope patent-text">2</sub> and 50 mM KCl (Buffer A) was added about 1×10-3 μg of the linker-ended cDNA, 2 μM of linker/primer A (A-strand) having the sequence d(5'-GGAATTCGCGGCCGCTCG-3'), 200 μM each of dATP, dCTP, dGTP, and dTTP, and 2.5 units of Thermus aquaticus DNA polymerase (Taq polymerase). The reaction mixture was heated to 94° C. for 30 sec for denaturation, allowed to cool to 50° C. for 30 sec for primer annealing, and then heated to 72° C. for 0.5-3 minutes to allow for primer extension by Taq polymerase. The replication reaction, involved successive heating, cooling, and polymerase reaction, was repeated an additional 25 times with the aid of a Perkin-Elmer Cetus DNA thermal cycler. This results in a pool of SISPA (sequence-independent single primer amplification)-amplified DNA fragments.</div>
    <heading class="style-scope patent-text">EXAMPLE 8</heading>
    <heading class="style-scope patent-text">Preparing Primer-Pair Fragments</heading>
    <div class="description-paragraph style-scope patent-text">Amplified cDNA fragments from Example 7 were mixed with 100 μl Buffer A, 1 μM of equal molar amounts of one of the primer pairs given below, 200 μM each of dATP, dCTP, dGTP, and dTTP, and 2.5 units of Thermus aquaticus DNA polymerase (Taq polymerase). Each primer pair includes a forward (upstream) primer F<sub class="style-scope patent-text">i</sub> which is identical to the coding strand at the upstream end of an overlap region P<sub class="style-scope patent-text">i</sub> of duplex genomic DNA and a reverse primer R<sub class="style-scope patent-text">i</sub> which is complementary to the coding at the downstream end of the region P<sub class="style-scope patent-text">i</sub>. The sets of primers each define an overlap region of about 200 basepairs, and the spacing between adjacent overlapping primer regions (i.e., between adjacent pairs of F<sub class="style-scope patent-text">i</sub> /R<sub class="style-scope patent-text">i</sub> pairs) is about 0.5-1 kilobase. The regions of HCV which are complementary to the primers are given below:</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">1</sub>, basepairs 183-201; R<sub class="style-scope patent-text">1</sub>, basepairs 361-380</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">10</sub>, basepairs 576-595; R<sub class="style-scope patent-text">10</sub>, basepairs 841-860</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">2</sub>, basepairs 1080-1100; R<sub class="style-scope patent-text">2</sub>, basepairs 1254-1273</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">3</sub>, basepairs 1929-1948; R<sub class="style-scope patent-text">3</sub>, basepairs 2067-2086</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">4</sub>, basepairs 2754-2733; R<sub class="style-scope patent-text">4</sub>, basepairs 2920-2940</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">5</sub>, basepairs 3601-3620; R<sub class="style-scope patent-text">5</sub>, basepairs 3745-3764</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">6</sub>, basepairs 4301-4320; R<sub class="style-scope patent-text">6</sub>, basepairs 4423-4442</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">12</sub>, basepairs 4847-4865; R<sub class="style-scope patent-text">12</sub>, basepairs 4715-4734</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">7</sub>, basepairs 5047-5066; R<sub class="style-scope patent-text">7</sub>, basepairs 5200-5216</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">8</sub>, basepairs 5885-5904; R<sub class="style-scope patent-text">8</sub>, basepairs 6028-6047</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">9</sub>, basepairs 6902-6921; R<sub class="style-scope patent-text">9</sub>, basepairs 7051-7070</div>
    <div class="description-paragraph style-scope patent-text">Polymerase Chain Reaction (PCR) amplification of the SISPA-amplified cDNA fragments with each F<sub class="style-scope patent-text">i</sub> /R<sub class="style-scope patent-text">i</sub> primer pair was carried out under conditions similar to those used above, with about 25 cycles.</div>
    <div class="description-paragraph style-scope patent-text">The amplified fragment mixtures from above were each fractionated by electrophoresis on 1.5% agarose and transferred to nitrocellulose filters (Southern). Hybridization of the nitrocellulose-bound fragments, each with an internal-sequence oligonucleotide probe confirmed that each fragment contained the expected sequences. Hybridization was carried out with an internal oligonucleotide radiolabeled by polynucleotide kinase, according to standard methods.</div>
    <heading class="style-scope patent-text">EXAMPLE 9</heading>
    <heading class="style-scope patent-text">Preparing Linking Fragments</heading>
    <div class="description-paragraph style-scope patent-text">This example describes preparing large overlapping linking fragments of the HCV sequence. SISPA-amplified cDNA fragments from Example 7 were mixed with 100 μl Buffer A, 1 μM of equal molar amounts of forward and reverse primers in each of the primer pairs given below, 200 μM each of dATP, dCTP, dGTP, and dTTP, and 2.5 units of Thermus aquaticus DNA polymerase (Taq polymerase), as in Example 8. Each primer pair includes a forward primer Fi and a reverse primer<sub class="style-scope patent-text">j</sub>, where F<sub class="style-scope patent-text">i</sub> is the forward primer for one overlap region P<sub class="style-scope patent-text">i</sub>, and R<sub class="style-scope patent-text">j</sub> is the reverse primer of the adjacent overlap region. Thus each linking fragment spans two adjacent overlap regions. The sets of primers each define a linking fragment of about 0.5-1 kilobases. The sequences of the primer pairs are given in Example 8. The overlapping linking fragments of the HCV sequence (FIGS. 11A to 11H) spanned by each primer pair is given below:</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">1</sub> /R<sub class="style-scope patent-text">10</sub>, basepairs 183-860</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">10</sub> /R<sub class="style-scope patent-text">2</sub>, basepairs 576-1273</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">2</sub> /R<sub class="style-scope patent-text">3</sub>, basepairs 1080-2086</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">3</sub> /R<sub class="style-scope patent-text">4</sub>, basepairs 1929-2940</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">4</sub> /R<sub class="style-scope patent-text">5</sub>, basepairs 2754-3762</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">5</sub> /R<sub class="style-scope patent-text">6</sub>, basepairs 3601-4442</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">6</sub> /R<sub class="style-scope patent-text">12</sub>, basepairs 4301-4865</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">12</sub> /R<sub class="style-scope patent-text">7</sub>, basepairs 4715-5216</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">7</sub> /R<sub class="style-scope patent-text">8</sub>, basepairs 5047-6047</div>
    <div class="description-paragraph style-scope patent-text">F<sub class="style-scope patent-text">8</sub> /R<sub class="style-scope patent-text">9</sub>, basepairs 5885-7070</div>
    <div class="description-paragraph style-scope patent-text">Two-primer amplification of the SISPA-amplified cDNA fragments with each F<sub class="style-scope patent-text">i</sub> /R<sub class="style-scope patent-text">j</sub> primer pair was carried out under conditions similar to those described above, with about 25 cycles.</div>
    <div class="description-paragraph style-scope patent-text">The amplified fragment mixtures from above were each fractionated by agarose electrophoresis on 1.2 % agarose, and transferred to nitrocellulose filters (Southern) for hybridization with radiolabeled internal oligonucleotide probes as above. The analysis confirmed that each linking fragment contained the two end-primer sequences from adjacent overlap regions. The sequences contained in each of the linking fragments are indicated in FIGS. 11A to 11H.</div>
    <heading class="style-scope patent-text">EXAMPLE 10</heading>
    <heading class="style-scope patent-text">Preparing Cloned Peptide Fragments</heading>
    <div class="description-paragraph style-scope patent-text">A. DNA Fragment Digestion</div>
    <div class="description-paragraph style-scope patent-text">Each of the ten linking fragments from Example 9 was suspended in a standard digest buffer (0.5M Tris HCl, pH 7.5; 1 mg/ml BSA; 10 mM MnC12) to a concentration of about 1 mg/ml and digested with DNAse I at room temperature for various times (1-5 minutes). These reaction conditions were determined from a prior calibration study, in which the incubation time required to produce predominantly 100-300 basepair fragments was determined. The material was extracted with phenol/chloroform before ethanol precipitation.</div>
    <div class="description-paragraph style-scope patent-text">The fragments in the digest mixture were blunt-ended and ligated with EcoRI linkers. The resultant fragments were analyzed by electrophoresis (5-1 OV/cm) on 1.2% agarose gels, using PhiX174/HaeIII and lambda/HindIII size markers. The 100-300 bp fraction was eluted onto NA45 strips (Schleicher and Schuell), which were then placed into 1.5 ml microtubes with eluting solution (1M NaCl, 50 mM arginine, pH 9.0), and incubated at 67° C. for 30-60 minutes. The eluted DNA was phenol/chloroform extracted and then precipitated with two volumes of ethanol. The pellet was resuspended in 20 μl TE buffer (0.01M Tris HCl, pH 7.5, 0.001M EDTA).</div>
    <div class="description-paragraph style-scope patent-text">B. Cloning the Digest Fragments</div>
    <div class="description-paragraph style-scope patent-text">Lambda gt11 phage vector (Young et al.) was obtained from Promega Biotec (Madison, Wis.). This cloning vector has a unique EcoRI cloning site 53 base pairs upstream from the beta-galactosidase translation termination codon. The partial digest fragments from each linking fragment in Part A were introduced into the EcoRI site by mixing 0.5-1.0 μg EcoRI-cleaved lambda gt11, 0.3-3 μl of the above sized fragments, 0.5 μl 10×ligation buffer (above), 0.5 μl DNA ligase (200 units), and distilled water to 5 μl. The mixture was incubated overnight at 14° C, followed by in vitro packaging, according to standard methods (Maniatis, pp. 256-268).</div>
    <div class="description-paragraph style-scope patent-text">The packaged phage were used to infect E. coli strain KM392, obtained from Dr. Kevin Moore, DNAX (Palo Alto, Calif.). Alternatively, E. coli strain Y1090, available from the American Type Culture Collection (ATCC No. 37197), could be used. A lawn of KM392 cells infected with about 10<sup class="style-scope patent-text">3</sup> -10<sup class="style-scope patent-text">4</sup> pfu of the phage stock from above was prepared on a 150 mm plate and incubated, inverted, for 5-16 hours at 37° C. The infected bacteria were checked for loss of beta-galactosidase activity (clear plaques) in the presence of X-gal using a standard X-gal substrate plaque assay method (Maniatis).</div>
    <div class="description-paragraph style-scope patent-text">Identification of single plaques containing a digest-fragment insert was confirmed as follows. Clear single plaques (containing the progeny of a single phage) were removed from the plate and suspended in extraction buffer (Maniatis) to release the phage DNA. The phage extract was added to the above DNA amplification mixture in the presence of primers which are about 70 basepairs away in either direction from the EcoRI site of lambda gt11. Thus phage containing a digest-fragment insert will yield an amplified digest fragment of about 140 basepairs plus insert. Phage DNA amplification was carried out as described above, with 25 cycles of amplification. The reaction material from each plaque tested was fractionated on 1.5% agarose, and examined for the size of amplified digest fragments. Non-recombinant phage gave a 140 basepair band, and recombinant phage, a band which is 140 basepair plus the insert sequence in size. The results are shown in column 2 (REC Freq) of Table 3 below, for the six linking-fragment libraries indicated in the first column in Table 3 below. The denominator in the column-2 entries is the total number of plaques assayed by primer amplification. The numerator is the number of clear plaques containing fragment inserts. Thus, 3/15 means that 3 plaques tested positive by PCR out of a total of 15 clear plaques assayed.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">              TABLE 3                                                     
______________________________________                                    
Library.sup.1                                                             
         REC Freq.sup.2                                                   
                       1° Screen.sup.3                             
                                PA/REC.sup.4                              
______________________________________                                    
F2R3 #2  3/15          2        0.33                                      
<figure-callout id="1" label="F3R4 #" filenames="US5843636-drawings-page-10.png,US5843636-drawings-page-11.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">F3R4 #</a></figure-callout>1  7/12          0        --                                        
<figure-callout id="3" label="F4R5 #" filenames="US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">F4R5 #</a></figure-callout>3  9/10          10       0.37                                      
F5R6 #5  11/12         37       1.35                                      
F7R8 #7  0/12          1        --                                        
<figure-callout id="10" label="F8R9 #" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">F8R9 #</a></figure-callout>10 3/12          58       7.73                                      
______________________________________                                    
 .sup.1 Libraries constructed by partial DNasel Digestion of indicated    
 linking clone                                                            
 .sup.2 Recombinant frequency determined by PCR with insert flanking lambd
 gt11 primers                                                             
 .sup.3 Primary screening with chronic human PTNANBH serum (1:100) on 1.5 
 × 10 phage                                                         
 .sup.4 PA/REC indicates the number of positive areas detected per actual 
 number of recombinant plated                                             
</pre>
    
    <div class="description-paragraph style-scope patent-text">The library of digest fragments constructed for each linking fragment was screened for expression of peptides which are immunoreactive with a human PT-NANBH serum. The lawn of phage-infected bacteria was overlaid with a nitro- cellulose sheet, transferring PT-NANBH recombinant peptides from the plaques to filter paper. The plate and filter were indexed for matching corresponding plate and filter positions.</div>
    <div class="description-paragraph style-scope patent-text">The filter was removed after 6-12 hours, washed three times in TBS buffer (10 mM Tris, pH 8.0, 150 mM NaCl), blocked with AIB (TBS buffer with 1% gelatin), washed again in TBS, and incubated overnight with of antiserum (diluted to 1:100 in AIB, 12-15 ml/plate). The sheet was washed twice in TBS and then incubated with alkaline-phosphatase-conjugated anti-human IgG to attach the labeled antibody at filter sites containing antigen recognized by the antiserum. After a final washing, the filter was developed in a substrate medium containing 33 μl NBT (50 mg/ml stock solution maintained at 4° C.) mixed with 16 μl BCIP (50 mg/ml stock solution maintained at 4° C.) in 5 ml of alkaline phosphatase buffer (100 mM Tris, 9.5, 100 mM NaCl, 5 mM MgC12). Reacted substrate precipitated at points of antigen production, as recognized by the antiserum.</div>
    <div class="description-paragraph style-scope patent-text">The total number of plaques which showed antigen-positive reaction (positive areas PA) in the primary screen are given in the third column in Table 3. The fourth column in the table is the frequency of positive areas per total number of recombinant phage screened (×10<sup class="style-scope patent-text">3</sup>). This last column is therefore a measure of the relative immunogenicity of antigen expressed from a particular linking fragment using this particular serum sample.</div>
    <heading class="style-scope patent-text">EXAMPLE 11</heading>
    <heading class="style-scope patent-text">Screening Digest Fragments</heading>
    <div class="description-paragraph style-scope patent-text">The digest-fragment libraries of each of the ten linking fragments from Example 9 were screened with sera from a human patient with chronic PT-NANBH and with pooled sera from chimpanzees with acute PT-NANBH infection and chronic PT-NANBH infection. Individual chronic and acute chimpanzee sera from 5 chimpanzees were obtained from the Centers for Disease Control.</div>
    <div class="description-paragraph style-scope patent-text">The digest-fragment libraries from the linking fragments indicated in Table 4 below were screened with each of the three sera, using the screening procedure described in Example 10. The total number of positive areas observed in each plate (making up one fragment library) is given in the table. The entries in the table which are not in parentheses represent the number of positive areas which were confirmed by plaque purification, i.e., by replating plaques from the positive areas at low dilution and confirming a positive area (secondary screen). Typically about 90-95 percent of the positive areas in the primary screen tested positive by secondary screening. The entries in parentheses indicate positive areas which have not been confirmed in a secondary screen.</div>
    <div class="description-paragraph style-scope patent-text">As seen from Table 4, all but one of the linking fragment libraries contained sequences encoding peptide antigens which are immunoreactive with either chronic human or chimpanzee infected sera. Five of the libraries contain sequences encoding antigens which are immunoreactive with acute sera, indicating that one or more of the antigens in this group are effective to detect acute-infection serum. Three of these latter libraries--F<sub class="style-scope patent-text">3</sub> /R<sub class="style-scope patent-text">4</sub>, F<sub class="style-scope patent-text">12</sub> /R<sub class="style-scope patent-text">7</sub>, and F<sub class="style-scope patent-text">7</sub> /R<sub class="style-scope patent-text">8</sub> --gave over 10 positives in each library. These data are not corrected for the recombinant frequency in a particular library and therefore do not reflect the comparative immunogenicity of the various linking fragments.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">              TABLE 4                                                     
______________________________________                                    
Human     Acute Pool       Chronic Pool                                   
P.P. Clones                                                               
          P.P. Clones      P.P. Clones                                    
______________________________________                                    
F1R10     0              0       0                                        
F10R2     4              2       4                                        
F2R3      4              0       1                                        
F3R4      0              10      10                                       
F4R5      5              0       7                                        
F5R6      34             0         (42)                                   
F6R12     (400)          5       10(200)                                  
F12R7     2              17(200)  9(200)                                  
F7R8      0              20      10(130)                                  
F8R9      60             0       1                                        
______________________________________                                    
 () = not plaque purified                                                 
 P.P. = Plaque Pure                                                       
 Acute Pool = CDC Panel of Chimps                                         
 Chronic Pool = CDC Panel of Chimps                                       
</pre>
    
    <heading class="style-scope patent-text">EXAMPLE 12</heading>
    <heading class="style-scope patent-text">Immunoscreening for 409-1-1-Antigen</heading>
    <div class="description-paragraph style-scope patent-text">A. Plaque Immunoscreening</div>
    <div class="description-paragraph style-scope patent-text">Several clear plaques identified in the primary screen of the F<sub class="style-scope patent-text">4</sub> /R<sub class="style-scope patent-text">5</sub> linking fragment were replated and plaque purified. One of the purified plaques was designated gt11/ 409-1-1(c-a). The digest fragment contained in clone 409-1-1(c-a) corresponds to two sets of base pairs present in the HCV genome and present in clone 409-1-1(abc). For ease of reference three regions (a, b, and c,) have been designated in the 409-1-1(abc) clone (see below and FIG. 5). The longest homology of base pairs corresponds approximately to <figure-callout id="2754" label="nucleotides" filenames="US5843636-drawings-page-9.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">nucleotides</a></figure-callout> 2754 to 3129 of FIGS. 11A to 11H (the "a" region, see FIG. 5, region delineated by boxes) and the shorter homology corresponds approximately to nucleotides 3242 to 3311 of FIGS. 11A to 11H (the "c" region, see FIG. 5): normally the "c" region is located approximately 112 nucleotides distal the 3' end of the "a" region (see FIG. 5). The complete sequence of the gt11/409-1-1(c-a) insert is given in FIG. 6 and presented as SEQ ID NO:7. This clone arose through a ligation event between two independent DNaseI fragments generated from the F<sub class="style-scope patent-text">4</sub> /R<sub class="style-scope patent-text">5</sub> linking clone and has ATCC No. 40792. A related clone, designated 409-1-1(abc), has been described in co-owned patent application Ser. No. 505,611 and has ATCC No. 40876.</div>
    <div class="description-paragraph style-scope patent-text">A lambda gt11 clone corresponding to the immunoreactive sequence reported in the EPO application 88310922.5, and designated 5-1-1, was prepared by primer-specific amplification of the amplified cDNA fragments generated in Example 7. The 5-1-1 sequence corresponds to basepairs 3730-3858 of the HCV sequence (FIGS. 11A to 11H), in the linking fragment F<sub class="style-scope patent-text">5</sub> /R<sub class="style-scope patent-text">6</sub>. The primers used for fragment amplification are 20 basepair oligomers complementary to the forward and reverse sequences of the 3732-3857 basepair 5-1-1 sequence. Both oligomers have EcoRI sites incorporated into their ends and the forward oligomer is designed to ensure a contiguous open reading frame with the beta-galactosidase gene. The amplified 5-1-1 sequence was purified by agarose gel electrophoresis, and cloned into lambda gt11 phage. Amplification and cloning methods were as described above. Phage containing the 5-1-1 sequence were identified and purified by primary and secondary screening, respectively, with human PT-NANBH serum, also as described above.</div>
    <div class="description-paragraph style-scope patent-text">The purified gt11/409-1-1(c-a) and gt11/5-1-1 clones were each mixed with negative lambda gt11 phage, plated and immunoscreened with a number of different donor sera from normal and NANBH-infected humans and chimpanzees, as indicated in Table 5 below. Each plate was divided into several equal-area sections, and the corresponding sections on the nitrocellulose transfer filter were separately screened with the donor sera indicated, using the immunoscreening method described in Example 11. The number of positives detected for each group of sera by the 5-1-1 and 409-1-1 (c-a) peptides are shown, as well as a comparison with the C-100 test in the ELISA format, in Table 5.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">              TABLE 5                                                     
______________________________________                                    
                # Positive                                                
Source Diagnosis # Donors 5-1-1 409-1-1 (c-a)                             
                                        C-100                             
______________________________________                                    
Human  Normal    2        0     0       NT                                
Human  ANAB      6        4     5        0/1*                             
Chimp  Normal    7        0     0       0/5                               
Chimp  Acute     5        1     3       0/5                               
Chimp  Chronic   8        7     7       5/5                               
______________________________________                                    
 NT, not tested; * only BV serum was tested; N/5 means N positives out of 
 five sera tested.                                                        
</pre>
    
    <div class="description-paragraph style-scope patent-text">B. Western Blot Screening</div>
    <div class="description-paragraph style-scope patent-text">For Western blot screening, gt11/409-1-1(c-a) phage from Example 11 was used to infect E. coli BNN103 temperature-sensitive bacteria. These bacteria were obtained from the American Type Culture Collection. The bacterial host allows expression of a beta-galactosidase/peptide antigen fused protein encoded by the vector under temperature induction conditions (Hunyh).</div>
    <div class="description-paragraph style-scope patent-text">Infected bacteria were streaked, grown at 32° C. overnight or until colonies were apparent, and individual colonies were replica plated and examined for growth at 32° C. and 42° C. Bacterial colonies which grew at 32° C., but not 42° C., indicating integration of the phage genome, were used to inoculate 1 ml of NZYDT (Maniatis) broth A saturated overnight bacterial culture was used to inoculate a 10 ml culture, which was incubated with aeration to an O.D. of about 0.2 to 0.4, typically requiring 1 hour incubation. The culture was then brought to 43° C. quickly in a 43° C. water bath and shaken for 15 minutes to induce lambda gt11 peptide synthesis, and incubated further at 37° C. for 1 hour.</div>
    <div class="description-paragraph style-scope patent-text">The cells were pelleted by centrifugation, and 1 ml of the pelleted material was resuspended in 100 μl of lysis buffer (62 mM Tris, pH 7.5 containing 5% mercaptoethanol, 2.4% SDS and 10% glycerol). Aliquots (about 15 μl) were loaded directly onto gels and fractionated by SDS-PAGE. After electrophoresis, the fractionated bands were transferred by electroelution to nitrocellulose filters, according to known methods (Ausubel et al.).</div>
    <div class="description-paragraph style-scope patent-text">The lysate was treated with DNaseI to digest bacterial DNA, as evidenced by a gradual loss of viscosity in the lysate. An aliquot of the material was diluted with Triton X-100™ and sodium dodecyl sulfate (SDS) to a final concentration of 2% Triton X-100™ and 0.5% SDS. Non-solubilized material was removed by centrifugation and the supernatant was fractionated by SDS polyacrylamide electrophoresis (SDS-PAGE).PAGE, A portion of the gel was stained, to identify the peptide antigen of interest, and the corresponding unstained band was transferred onto a nitrocellulose filter.</div>
    <div class="description-paragraph style-scope patent-text">The 5-1-1 antigen coding sequence (Example 11) was also expressed as a glutathione-S-transferase fusion protein using the pGEX vector system, according to published methods (Smith). The fusion protein obtained from bacterial lysate and fractionated by SDS-PAGE were transferred to a nitrocellulose filter for Western blotting, as above.</div>
    <div class="description-paragraph style-scope patent-text">Western blotting was carried out substantially as described in Example 10. Briefly, the filters were blocked with AIB, then reacted with the serum samples identified in Table 5, including human and chimpanzee normal, chronic NANBH, and hepatitis B (HBV) sera sample. The presence of specific antibody binding to the nitrocellulose filters was assayed by further immunobinding of alkaline-phosphatase labelled anti-human IgG. The results of the Western blot analysis with the Sj26/5-1-1 fusion protein and /409-1-1(c-a) fusion proteins are shown in Table 6. The data confirm that 409-1-1(c-a) and 5-1-1 peptide antigens are specifically immunoreactive with human and chimpanzee NANBH antisera.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">              TABLE 6                                                     
______________________________________                                    
                    # Positive                                            
                              Sj26 β-gal                             
Source    Diagnosis                                                       
                   # Donors   5-1-1                                       
                                   409-1-1 (c-a)                          
______________________________________                                    
Human     Normal   2          0    0                                      
Human     NANB     7          5    5                                      
<figure-callout id="1" label="Human HBV" filenames="US5843636-drawings-page-10.png,US5843636-drawings-page-11.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Human     HBV</a></figure-callout>      1          0    0                                      
Chimp     Normal   5          0    0                                      
Chimp     NANB     6          5    5                                      
<figure-callout id="1" label="Chimp HBV" filenames="US5843636-drawings-page-10.png,US5843636-drawings-page-11.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Chimp     HBV</a></figure-callout>      1          0    0                                      
______________________________________                                    
</pre>
    
    <heading class="style-scope patent-text">EXAMPLE 13</heading>
    <heading class="style-scope patent-text">Generation of Alternative Clones</heading>
    <div class="description-paragraph style-scope patent-text">Alternative clones were generated from the region identified in Example 12 as encoding antigen specifically immunoreactive with human and chimpanzee NANBH antisera. The primers shown in Table 7 were selected from the HCV or 409-1-1(abc) coding sequences to generate a variety of overlapping clones.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">              TABLE 7                                                     
______________________________________                                    
Primer    Sequence                                                        
______________________________________                                    
33C-<figure-callout id="33C" label="F1 CCGAATTCGCGGTGGACTTTATCCCTGT" filenames="US5843636-drawings-page-9.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">F1    CCGAATTCGCGGTGGACTTTATCCCTGT</a></figure-callout>                                    
33C-R1    CCGAATTCCAGAGCAACCTCCTCGATG                                     
409-1-1(c-a)F                                                             
          CCGAATTCCGCACGCCCGCCGAGACTAC                                    
409-1-1-F1                                                                
          CCGAATTCTCCACCACCGGAGAGATCCC                                    
409-1-1-R2                                                                
          CCGAATTCCACACGTATTGCAGTCTATC                                    
409-1-1-F3                                                                
          CCGAATTCGTCACCCAGACAGTCGAT                                      
409-1-1-R5                                                                
          CCGAATTCCCCTCCCAAAATTCAAGATGG                                   
409-1-1(c-a)R                                                             
          CCGAATTCGCCAGTCCTGCCCCGACGTT                                    
409-1-1CR CCGAATTCGTCCTGGCACACGGGAAG                                      
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">The primers shown in Table 7 were used in DNA amplification reactions as described in Examples 7B and 8: the primers and templates used in each reaction are shown in Table 8. The amplified fragments were then treated with the Klenow fragment of DNA polymerase I, under standard conditions (Maniatis et al.), to fill in the ends of the molecules. The blunt-end amplified fragments were digested with EcoRI under standard conditions and cloned into lambda gt11 expression vectors essentially as described in Example 10B. The resulting inserts are aligned for comparison in FIG. 7.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">              TABLE 8                                                     
______________________________________                                    
Generated Fragment                                                        
            Template     Primers                                          
______________________________________                                    
33C         cDNA*        33-C-F1 and 409-1-1-R2                           
33CU        cDNA*        33-C-F1 and 33-C-R1                              
4O9-1-1(F1R2)                                                             
            gt11 409-1-1(c-a)                                             
                         409-1-1-F1 and 409-1-1-R2                        
409-1-1(a)  gt11 409-1-1(c-a)                                             
                         409-1-1-F1 and 409-1-1caR                        
4O9-1-1(c)  gt11 409-1-1(c-a)                                             
                         409-1-1caF and 409-1-1CR                         
409-1-1(c + 270)                                                          
            gt11 409-1-1(c-a)                                             
                         409-1-1caF and 409-1-1-R2                        
409-1-1u    gt11 409-1-1(c-a)                                             
                         409-1-1-F3 and 409-1-1caR                        
______________________________________                                    
 *Amplified cDNA fragments from Example 7                                 
</pre>
    
    <heading class="style-scope patent-text">EXAMPLE 13</heading>
    <heading class="style-scope patent-text">Immunoscreening of the Alternative Clones</heading>
    <div class="description-paragraph style-scope patent-text">The alternative clones generated in Example 12 were immunoscreened essentially as described in Example 10B. Clones 409-1-1(abc) and 409-1-1(c-a), generated in Example 12, were also included in the following immunoscreenings. The results of the preliminary immunoscreening are shown in Table 9.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">              TABLE 9                                                     
______________________________________                                    
                  GLI-1   FEC                                             
______________________________________                                    
33C               +        ND*                                            
33cu              +       ND                                              
409-1-1 (abc)     +       ND                                              
409-1-1 (F1R2)    +       ND                                              
409-1-1 (a)       +       ND                                              
409-1-1 (ca)      +       ND                                              
409-1-1 (C)       -       --                                              
409-1-1 (c + 270) +       ND                                              
409-1-1 u         -       --                                              
______________________________________                                    
 *Not Done                                                                
</pre>
    
    <div class="description-paragraph style-scope patent-text">The GLI-1 sera was a human chronic PT-NANBH sera. If a clone tested negative with GLI-1 it was further examined by screening with FEC, a human chronic PT-NANBH sera.</div>
    <div class="description-paragraph style-scope patent-text">The seven of the 9 alternative clones which tested positive by the above preliminary immunoscreening were more extensively screened against a battery of sera. In addition, clone C100 (see Background) was included in the screening. The results of this more exhaustive screening are presented in Table 10.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">                                  TABLE 10                                
__________________________________________________________________________
             ANTIGEN                                                      
             409-1-1                                                      
                   409-1-1                                                
                       409-1-1                                            
                           409-1-1                                        
                               409-1-1                                    
Serum                                                                     
    C100                                                                  
       33C                                                                
          33Cu                                                            
             abc   FIR2                                                   
                       a   c + 270                                        
                               ca  5-1-1                                  
__________________________________________________________________________
SKF(-) -  -  -     -   -   -   -   -                                      
FEC(+) +  +3 +3    +1  +2  +2  -   +2+2                                   
BV  -  +2 +3 |                                                   
                   +1  +1  -   +1  -                                      
Bar -  +2 +2 |                                                   
                   -   -   -   -   -                                      
PP(-)                                                                     
    -  -  -  -     -   -   -   -   -                                      
AP  -  +1 +2 -     |                                             
                       -   -   |                                 
                                   -                                      
CP  +  +2 +3 +2    +3  +3  |                                     
                               +3  +2                                     
1   -  -  -  -     -   -   -   -   -                                      
2   -  -  -  -     -   -   -   -   -                                      
3   -  -  -  -     -   -   -   -   |                             
4   -  -  -  |                                                   
                   |                                             
                       -   -   -   |                             
5   -  -  +1 -     -   -   -   -   -                                      
6   -  +1 +3 +1    +1  +1  -   +1  +1                                     
7   -  +2 +3 +1    +2  +2  -   +2  +1                                     
38  -  -  |                                                      
             +1    |                                             
                       |                                         
                           -   -   |                             
39  -  -  +1 |                                                   
                   +1  -   -   |                                 
                                   |                             
40  +  +1 +2 +1    +1  -   |                                     
                               +1  +1                                     
41  +  +2 +3 +1    +1  +1  -   +2  +1                                     
42  +  +2 +3 +1    +1  +1  -   +2  +1                                     
43  -  -  -  -     -   -   -   -   -                                      
44  -  |                                                         
          |                                                      
             -     -   -   -   -   -                                      
45  -  |                                                         
          +1 |                                                   
                   |                                             
                       -   -   |                                 
                                   |                             
46  +  +1 +2 +1    +2  +1  -   +1  |                             
47  +  +1 +2 +2    +2  +3  ≈                                      
                               +3  +1                                     
B18 -  +3 +3 +1    +3  +3  -   +3  -                                      
A7  -  +3 +3 +1    +1  +3  -   +3  +3                                     
C7  -  +2 +3 -     -   -   -   -   -                                      
A3  -  +3 +3 +1    +2  +1  -   +2  -                                      
B7  -  +2 +3 I     +3  +3  -   +3  I                                      
C12 +  +2 +3 -     -   -   -   -   -                                      
__________________________________________________________________________
</pre>
    
    <div class="description-paragraph style-scope patent-text">The serum samples used for screening were identified as follows: SKF, PT-NANBH negative; FEC, PT-NANBH positive; BV, community acquired NANBH; Bar, PT-NANBH positive; PP (pre-inoculation pooled chimpanzee serum), PT-NANBH negative; AP (acute HCV pooled chimpanzee serum), PT-NANBH positive; and, CP (chronic HCV pooled chimpanzee serum) PT-NANBH positive. The numbered serum samples correspond to human clinical serum samples which were PT-NANBH positive. The PP, CP, and AP sera were pooled sera samples from 5 different chimpanzees: the chimpanzee serum samples were obtained from the Centers for Disease Control. The scoring system presented in Table 10 is a qualitative scoring system defined as follows: (-), a clear negative; (+), (1+), (2+), (3+), increasing strength of positive signal, with (3+) being the strongest signal; and (I) stands for Indeterminate, where two readings were different and not repeated.</div>
    <div class="description-paragraph style-scope patent-text">In view of the data presented in Table 10 the sensitivity of the antigens in terms of immunoscreening is 33cu&gt;33c&gt;409-1-1(c-a)&gt;409-1-1-F1R2&gt;409-1-1(abc)≧409-1-1a&gt;5-1-1&gt;409-1-1-(c+270). Although 33cu and 33c were sensitive antigens, they reacted with high background against all sera. Accordingly, the 409-1-1 series are more useful as diagnostic antigens since they are more specific to HCV induced antibodies.</div>
    <div class="description-paragraph style-scope patent-text">The immunoscreening was further extended to include the clone 36 and 45 (corresponds to clone 40) encoded epitopes which were identified above. Table 11 shows the results of the immunoscreening.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">              TABLE 11                                                    
______________________________________                                    
PANEL I: SEROCONVERSION SPECIMENS                                         
                             ANTI-                                        
                             GEN                                          
                             409-1-1                                      
SERUM    C-100   33C    5.1.1                                             
                             (c-a)  36   45   gt11                        
______________________________________                                    
GLI-1    +       4+     2+   4+     -    3+   -                           
FEC      +       4+     3+   4+     3+   -    -                           
BV       -       3+     -    3+     -    -    -                           
SKF(norm)                                                                 
         -       -      -    -      -    -    -                           
1-NO1/D69                                                                 
         -       I      -    -      -    -    -                           
2-NO1/D124                                                                
         -       +      -    -      -    -    -                           
3-NO1/D146                                                                
         -       I      -    -      -    -    -                           
4-NO1/D211                                                                
         -       +      -    -      -    -    -                           
5-N00/D22                                                                 
         -       +      I    I      -    -    -                           
6-N00/D29                                                                 
         -       2+     +    2+     -    -    -                           
7-N00/D41                                                                 
         -       3+     2+   3+     -    -    -                           
8-N00/D60                                                                 
         -       4+     3+   4+     -    -    -                           
9-N00/D137                                                                
         +       4+     4+   4+     2+   -    -                           
10-N240/D0                                                                
         -       I      -    I      -    -    -                           
11-N240/D45                                                               
         -       -      -    -      -    -    -                           
12-N240/D71                                                               
         -       I      -    I      -    -    -                           
13-N240/D89                                                               
         -       I      -    -      -    -    -                           
14-N240/D106                                                              
         -       I      -    -      -    -    -                           
15-N240/D155                                                              
         -       I      -    -      -    -    -                           
16-N228/D0                                                                
         -       I      -    -      -    -    -                           
17-N228/D31                                                               
         -       I      -    -      -    -    -                           
18-N228/D41                                                               
         -       I      -    -      -    -    -                           
19-N228/D51                                                               
         -       I      -    -      -    -    -                           
20-N228/D73                                                               
         -       I      -    -      -    -    -                           
21-N228/D93                                                               
         -       -      -    -      -    -    -                           
22-N228/D127                                                              
         -       -      -    -      -    -    -                           
23-N192/D114                                                              
         -       -      I    -      -    -    -                           
24-N192/D184                                                              
         -       -      -    -      -    -    -                           
25-N192/D224                                                              
         -       -      -    -      -    -    -                           
26-N192/D280                                                              
         -       I      -    -      -    -    -                           
27-N176/D0                                                                
         -       I      -    -      -    -    -                           
28-N176/D66                                                               
         -       -      -    -      -    -    -                           
29-N176/D77                                                               
         -       -      -    -      -    -    -                           
30-N176/D94                                                               
         -       -      -    -      -    -    -                           
31-N176/D200                                                              
         -       -      -    -      -    -    -                           
32-N170/D0                                                                
         -       -      -    -      -    -    -                           
33-N170/D27                                                               
         -       I      -    -      -    -    -                           
34-N170/D49                                                               
         -       -      -    -      -    -    -                           
35-N170/D64                                                               
         -       -      -    -      -    -    -                           
36-N170/D183                                                              
         -       -      -    -      -    -    -                           
37-N170/D278                                                              
         -       -      -    -      -    -    -                           
38-N144/D63                                                               
         -       I      -    -      -    -    -                           
39-N144/D72                                                               
         -       I      -    -      -    -    -                           
40-N144/D91                                                               
         +       2+     +    2+     -    -    -                           
41-N144/D289                                                              
         +       4+     +    3+     2+   -    -                           
42-N144/D233                                                              
         +       4+     3+   4+     2+   -    -                           
43-N122/D0                                                                
         -       I      -    -      -    -    -                           
44-N122/D51                                                               
         -       I      I    I      -    -    -                           
45-N122/D57                                                               
         -       2+     I    +      -    -    -                           
46-N122/D72                                                               
         +       2+     -    3+     I    -    -                           
47-N122/D94                                                               
         +       3+     +    4+     +    -    -                           
48-N122/D199                                                              
         +       4+     2+   4+     +    -    -                           
49-N31/D0                                                                 
         -       I      -    -      -    -    -                           
50-N31/D140                                                               
         -       -      -    -      -    -    -                           
51-N31/D154                                                               
         -       -      -    -      -    -                                
52-N31/D170                                                               
         -       -      -    -      -    -    -                           
53-N31/D210                                                               
         -       -      -    -      -    -    -                           
54-N31/D266                                                               
         -       -      -    -      -    -    -                           
55-N31/D336                                                               
         -       -      -    -      -    -    -                           
56-N31/D394                                                               
         -       -      -    -      -    -    -                           
57-N16/D0                                                                 
         -       -      -    -      -    -    -                           
58-N16/D47                                                                
         -       -      -    -      -    -    -                           
59-N16/D62                                                                
         -       -      -    -      -    -    -                           
60-N16/D83                                                                
         -       -      -    -      -    -    -                           
61-N16/D137                                                               
         -       -      -    -      -    -    -                           
61-N16/D167                                                               
         -       -      -    -      -    -    -                           
63-N16/D197                                                               
         -       -      -    -      -    -    -                           
64-N16/D370                                                               
         -       -      -    -      -    -    -                           
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">The screening sera GLI-1, FEC, BV, and SKF have been defined above. The numbered sera samples correspond to human clinical serum samples which were PT-NANBH positive: these samples were obtained from Dr. Francoise Fabiani-Lunel, Hospital La Pitie Salpetriere, Paris, France. As can be seen from the results presented in Table 11, the antigens produced by <figure-callout id="40" label="clones" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clones</a></figure-callout> 36 and 40, while not as sensitive as 409-1-1(c-a), do yield HCV-specific immunopositive signals.</div>
    <heading class="style-scope patent-text">EXAMPLE 14</heading>
    <heading class="style-scope patent-text">Isolation of 409-1-1 Fusion Protein</heading>
    <div class="description-paragraph style-scope patent-text">Sepharose 4B beads conjugated with anti-beta galactosidase were purchased from Promega. The beads were packed in 2 ml column and washed successively with phosphate-buffered saline with 0.02% sodium azide and 10 ml TX buffer (10 mM Tris buffer, pH 7.4, 1% aprotinin).</div>
    <div class="description-paragraph style-scope patent-text">BNN103 lysogens infected with gt11/409-1-1(c-a) from Example 12 were used to inoculate 500 ml of NZYDT broth. The culture was incubated at 32° C. with aeration to an O.D. of about 0.2 to 0.4, then brought to 43° C. quickly in a 43° C. water bath for 15 minutes to induce gt11 peptide synthesis, and incubated further at 37° C. for 1 hour. The cells were pelleted by centrifugation, suspended in 10 ml of lysis buffer (10 mM Tris, pH 7.4 containing 2% Triton X-100™ and 1% aprotinin added just before use. The resuspended cells were frozen in liquid nitrogen, then thawed, resulting in substantially complete cell lysis. The lysate was treated with DNaseI to digest bacterial and phage DNA, as evidenced by a gradual loss of viscosity in the lysate. Non-solubilized material was removed by centrifugation.</div>
    <div class="description-paragraph style-scope patent-text">The clarified lysate material was loaded on the Sepharose column, the ends of the column were closed, and the column was placed on a rotary shaker for 2 hrs. at room temperature and 16 hours at 4° C. After the column settled, it was washed with 10 ml of TX buffer. The fused protein was eluted with 0.1M carbonate/bicarbonate buffer, pH10. A total of 14 ml of the elution buffer was passed through the column, and the fusion protein eluted in the first 4-6 ml of eluate.</div>
    <div class="description-paragraph style-scope patent-text">The first 6 ml of eluate from the affinity column were concentrated in Centricon™-30 cartridges (Amicon, Danvers, Mass.). The final protein concentrate was resuspended in 400 μl PBS buffer. Protein purity was analyzed by SDS-PAGE. A single prominent band was observed.</div>
    <heading class="style-scope patent-text">EXAMPLE 15</heading>
    <heading class="style-scope patent-text">Preparation of Anti-409-1-1(c-a) Antibody</heading>
    <div class="description-paragraph style-scope patent-text">The 409-1-1(c-a) digest fragments from lambda gt11 were released by EcoRI digestion of the phage, and the "A" region purified by gel electrophoresis. The purified fragment was introduced into the pGEX expression vector (Smith). Expression of glutathione S-transferase fused protein (Sj26 fused protein) containing the 409-1-1(a) peptide antigen was achieved in E. coli strain KM392 (above). The fusion protein was isolated from lysed bacteria, and isolated by affinity chromatography on a column packed with glutathione-conjugated beads, according to published methods (Smith).</div>
    <div class="description-paragraph style-scope patent-text">The purified Sj26/409-1-1(a) fused protein was injected subcutaneously in Freund's adjuvant in a rabbit. Approximately 1 mg of fused protein was injected at days 0 and 21, and rabbit serum was collected on days 42 and 56.</div>
    <div class="description-paragraph style-scope patent-text">A purified Sj26/5-1-1 fused protein was similarly prepared using the an amplified HCV fragment encoding the 5-1-1 fragment. The fused Sj26/5-1-1 protein was used to immunize a second rabbit, following the same immunization schedule. A third rabbit was similarly immunized with purified Sj26 protein obtained from control bacterial lysate.</div>
    <div class="description-paragraph style-scope patent-text">Minilysates from the following bacterial cultures were prepared as described in Example 12: (1) KM392 cells infected with pGEX, pGEX containing the 5-1-1 insert, and pGEX containing the 409-1-1(a) insert; and (2) BNN103 infected with lambda gt11 containing the 5-1-1 insert and gt11 containing the 409-1-1(c-a) insert. The minilysates were fractionated by SDS-PAGE, and the bands transferred to nitrocellulose filters for Western blotting as described in Example 12. Table 12 shows the pattern of immunoreaction which was observed when the five lysate preparations (containing the antigens shown at the left in the table) were screened with each of the three rabbit immune sera. Summarizing the results, serum from control (Sj26) rabbits was immunoreactive with each of the Sj26 and Sj26 fused protein antigens. Serum from the animal immunized with Sj26/5-1-1 fused protein was reactive with all three Sj-26 antigens and with the beta-gal/5-1-1 fusion protein, indicating the presence of specific immunoreaction with the 5-1-1 antigen. Serum from the animal immunized with Sj26/409-1-1(a) fused protein was reactive with all three Sj-26 antigens and with the beta-gal/409-1-1(c-a) fusion protein, indicating the presence of specific immunoreaction with the 409-1-1(a) antigen. None of the sera were immunoreactive with beta-galactosidase (obtained from a commercial source).</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">              TABLE 12                                                    
______________________________________                                    
Antigens              Antibody                                            
Sj26      Sj26        5-1-1/Sj26                                          
                               409-1-1(a)/-                               
______________________________________                                    
Sj26      +           +        +                                          
5-1-1/    +           +        +                                          
(Sj26)                                                                    
5-1-1/    -           +        -                                          
(β-bal)                                                              
409-1-1(a)                                                                
          +           +        +                                          
(Sj26)                                                                    
409-1-1(c-a)                                                              
          -           -        +                                          
(β-gal)                                                              
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">Anti-409-1-1(a) antibody present in the sera from the animal immunized with the Sj26/409-1-1(a) is purified by affinity chromatography, following the general procedures described in Example 12, but where the ligand derivatized to the Sepharose beads is the purified beta-gal/409-1-1(c-a) fusion protein, rather than the anti-beta-galactosidase antibody.</div>
    <heading class="style-scope patent-text">EXAMPLE 16</heading>
    <heading class="style-scope patent-text">Cloning the HCV Capsid Protein Coding Sequences</heading>
    <div class="description-paragraph style-scope patent-text">The example describes the cloning of HCV coding sequences which encodes the N-terminal region of the HCV capsid protein.</div>
    <div class="description-paragraph style-scope patent-text">The protein sequence of the HCV-capsid associated antigen corresponds to the nucleotide residues 325-970 of the full length HCV sequence (see FIGS. 11A to 11H). The following sequences were used as PCR primers to clone this region: SF2(C), 5' end starting at nucleotide 325 of the full length HCV sequence (Appendix), 5'-GCGCCCATGGGCACGATTCCCAAACCTCA; and SR1(C), 3' end starting at nucleotide 969 of the full length HCV sequence (Appendix), 5'-GCCGGATCCCTATTACTC(G/A)TACACAAT(A/G)CT(C/T)GAGTT(A/G)G. The anticipated size of the fragment generated using the SF2(C)/SR1(C) primer pair was 644 base pairs.</div>
    <div class="description-paragraph style-scope patent-text">SISPA-amplified cDNA fragments from Example 7 were mixed with 100 μl Buffer A, 1 μM of equal molar amounts of each SR2 and SF1 primer given above, 200 μM each of dATP, dCTP, dGTP, and dTTP, and 2.5 units of Thermus aquaticus DNA polymerase (Taq polymerase), as in Example 8.</div>
    <div class="description-paragraph style-scope patent-text">Specific amplification of the SISPA-amplified cDNA fragments with the capsid primer pair given above was carried out under conditions similar to those described in Example 7, with 1 minute at 72° C. and about 30 cycles.</div>
    <div class="description-paragraph style-scope patent-text">The amplified fragment mixtures from above were each fractionated by agarose gel electrophoresis on duplicate 1.2% agarose gels, and one of the gels transferred to nitrocellulose filters (Southern) for hybridization with with a radioactively labelled oligonucleotide (Southern) having the following sequence: SF3(M/E), 5' end starting at nucleotide 792 of the full length HCV sequence (Appendix), 5'-GCGCCCATGGTTCTGGAAGACGGCGTG. This oligonucleotide corresponds to a sequence internal to the amplification product generated by using the SF2(C) and SR1(C) primers. Eight out of 15 PCR products were identified which gave a positive hybridization signal with the internal probe.</div>
    <div class="description-paragraph style-scope patent-text">The vectors pGEX (Example 15) and pET (NOVAGEN, 565 Science Drive, Madison, Wis. 53711) were chosen for bacterial expression of protein sequences encoded by the inserts. The pGEX vector provided expression of the inserted coding sequences as fusion proteins to Sj26 (see Examples 12 and 15) and the pET vector provided expression of the cloned sequences alone. To clone the capsid sequences, the amplification product bands were excised from the duplicate gel. The DNA was extracted from the agarose and doubly-digested with NcoI and BamHI. A pGEX vector containing the BamHI/NcoI cloning sites was also doubly digested with BamHI and NcoI. The vector and extracted DNA were then ligated under standard conditions and the ligation mixture transformed into bacterial cells.</div>
    <div class="description-paragraph style-scope patent-text">The bacterial transformants were cultured under ampicillin selection, and the plasmid DNA isolated by alkaline lysis (Maniatis et al.). The isolated plasmid DNA was digested with NcoI and BamHI. The digestion products were then electrophoretically separated on an agarose gel. The gel was transferred to nitrocellulose and probed with radioactively labelled SF3 as above. Twelve clones were confirmed to have the insert of interest by the Southern blot analysis.</div>
    <div class="description-paragraph style-scope patent-text">Clones were generated in the pET vector in essentially the same manner.</div>
    <heading class="style-scope patent-text">EXAMPLE 17</heading>
    <heading class="style-scope patent-text">Immunological Screening of the Putative HCV Capsid Protein Clones</heading>
    <div class="description-paragraph style-scope patent-text">This example describes the immunological screening of the putative HCV capsid protein clones which were obtained in Example 18.</div>
    <div class="description-paragraph style-scope patent-text">Of the twelve clones obtained in Example 16, protein mini-lysates of 7 clones (<figure-callout id="60" label="clones #" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-15.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">clones #</a></figure-callout> 8, 14, 15, 56, 60, 65, and 66) were prepared as described in Example 12. These mini-lysates were fractionated as described and transferred to nitrocellulose for Western Blot analysis. Table 13 shows the pattern of immunoreaction which was observed when the 7 lysate preparations were screened with the indicated sera.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">              TABLE 13                                                    
______________________________________                                    
Sera                                                                      
Clone   SKF       FEL    A6       B9   BV                                 
______________________________________                                    
8       -         -      -        -    -                                  
14      -         +      +        +    +                                  
15      -         +      +        +    +                                  
56      -         +      +        +    +                                  
60      -         +      +        +    +                                  
65      -         +      +        +    +                                  
SJ26    -         -      -        -    -                                  
5-1-1   -         +      +        +    -                                  
409-1-1 -         -      +        +    -                                  
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">The serum samples used for screening were identified as follows: SKF, HCV negative; FEC, HCV positive; BV, community acquired HCV; A6 and B9 correspond to human clinical serum samples which were HCV positive.</div>
    <div class="description-paragraph style-scope patent-text">Immunoreactive bands identified on the Western blot were all smaller than the expected size of 50 kd (based on the predicted coding sequence of the cloned inserts, see below).</div>
    <div class="description-paragraph style-scope patent-text">Clone 15 was chosen for scale-up production of the Sj26 fusion protein (Smith et al.). A one liter preparation of clone 15 yielded about 200 μg of purified immunoreactive material. The bulk of the immunoreactive material appeared in a major doublet band which ran at approximately 29 kd. The yield from this preparation was unexpectedly low: typically with the pGEX system a one liter protein preparation yields in the range of 50-100 mg fusion protein.</div>
    <heading class="style-scope patent-text">EXAMPLE 18</heading>
    <heading class="style-scope patent-text">Nucleic Acid Sequences of Clones 15 and 56</heading>
    <div class="description-paragraph style-scope patent-text">The inserts of clones 15 and 56 (discussed in Example 17) were sequenced as per the manufacturer's instructions (US Biochemical Corporation, Cleveland Ohio) using the dideoxy chain termination technique (Sanger, 1979). Each of the clones had an open reading frame contiguous with the Sj26 reading frame of the pGEX vector. The sequences of the clone inserts were near identical with only a few minor sequence variations: the sequence of clone 15 had a termination codon starting at nucleotide position 126. The sequence data for clone 56 is presented as SEQ ID NO:11 and in FIG. 8A.</div>
    <div class="description-paragraph style-scope patent-text">The sequencing of the inserts revealed the unusual feature of a run of adenine residues from nucleotide position 25 to position 34 (FIG. 8A): such sequences are similar to sequences known to promote translation frame-shifting (Wilson et al., Atkins et al.). The open reading frame contiguous with the Sj26 coding sequence predicts a protein of approximately 23.5 kd. Accordingly, given the approximately 26 kd size of the Sj26 protein fragment in this construct (Smith et al.), the complete fusion protein would be predicted to be approximately 50 kd.</div>
    <heading class="style-scope patent-text">EXAMPLE 19</heading>
    <heading class="style-scope patent-text">Hydropathicity Plot of the Protein Encoded by Clone 56</heading>
    <div class="description-paragraph style-scope patent-text">The SOAP program from IntelliGenetics PC/GENE™ software package was used to generate the hydropathicity plot of FIG. 9. The SOAP program uses the method of Kyte et al. to plot the hydropathicity of the protein along its sequence. The interval used for the computation was 11 amino acids. In FIG. 9, the hydrophobic side of the plot corresponds to the positive values range and the hydrophilic side to the negative values range.</div>
    <div class="description-paragraph style-scope patent-text">The hydropathicity plot indicates (i) the hydrophilic nature of the amino terminus of the capsid protein, (ii) the relatively hydrophobic nature of the region of amino acid residues approximately 122 to 162, and (iii) the hydrophobic nature of amino acid residues approximately 168-182.</div>
    <div class="description-paragraph style-scope patent-text">Further, the region of amino acid residues 168-182 demonstrates potential for being a membrane spanning segment (Klein et al.).</div>
    <heading class="style-scope patent-text">EXAMPLE 20</heading>
    <heading class="style-scope patent-text">Deletion Analysis of the Clone 56 Protein Coding Region</heading>
    <div class="description-paragraph style-scope patent-text">This example describes the generation of a series of carboxy and amino terminal deletions of the HCV capsid protein and the effect of these deletions on the immunoreactivity of the resulting proteins.</div>
    <div class="description-paragraph style-scope patent-text">A. Carboxy Terminal Deletions of Clone 56.</div>
    <div class="description-paragraph style-scope patent-text">As one step to improve the expression of the HCV capsid protein, the putative region of translational frameshifting was modified to reduce the probability of a frameshift occurring in this region. In each AAA codon, encoding lysine, (nucleotide positions 25 to 33, FIG. 8A) the third nucleotide in each codon (<figure-callout id="30" label="positions" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">positions</a></figure-callout> 27, 30 and 33, FIG. 8A) was changed from A to G using standard PCR mismatch techniques (Ausubel et al., Mullis, Mullis et al.). The sites of these substitutions are indicated in FIG. 8A by the three G's placed over the corresponding A's. The sequence of the modified pGEX clone was confirmed as in Example 19 and the clone was named pGEX-CapA. The insert sequence of clone pGEX-CapA is shown in FIG. 8B and presented as SEQ ID NO: 13.</div>
    <div class="description-paragraph style-scope patent-text">The deletion clones were generated using the PCR primers given in Table 14. In Table 14 the BamHI site is italicized and the termination codon is underlined.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">                                  TABLE 14                                
__________________________________________________________________________
CARBOXY TERMINAL DELETION PRIMERS                                         
__________________________________________________________________________
  C1  5'-CGA TCC ATG GGC ACG AAT CCT AAA CC                               
  NC580                                                                   
      5'-G                                                                
         GCC                                                              
            GGA                                                           
               TCC                                                        
                  TTA                                                     
                     GGC                                                  
                        CGA                                               
                           AGC                                            
                              GGG                                         
                                 CAC                                      
                                    AG                                    
  NC520                                                                   
      5'-G                                                                
         GCC                                                              
            GGA                                                           
               TCC                                                        
                  TTA                                                     
                     ACC                                                  
                        AGG                                               
                           AAG                                            
                              GTT                                         
                                 CCC                                      
                                    TGT                                   
                                       TGC                                
  NC450                                                                   
      5'-G                                                                
         GCC                                                              
            GGA                                                           
               TCC                                                        
                  TTA                                                     
                     GGC                                                  
                        CCT                                               
                           GGC                                            
                              ACG                                         
                                 GCC                                      
                                    TCC                                   
  NC360                                                                   
      5'-G                                                                
         GCC                                                              
            GGA                                                           
               TCC                                                        
                  TTA                                                     
                     CAA                                                  
                        ATT                                               
                           GCG                                            
                              CGA                                         
                                 CCT                                      
                                    ACG                                   
                                       CC                                 
  NC270                                                                   
      5'-G                                                                
         GCC                                                              
            GGA                                                           
               TCC                                                        
                  TTA                                                     
                     GCC                                                  
                        CTC                                               
                           ATT                                            
                              GCC                                         
                                 ATA                                      
                                    GAG                                   
__________________________________________________________________________
</pre>
    
    <div class="description-paragraph style-scope patent-text">Amplification reactions were carried out essentially as described in Example 16 using primer C1 paired with each of the NC primers and purified plasmid pGEX-CapA as template: the amplification reaction was 1 minute at 95°, annealed 2 minutes at 50° and 3 minutes at 72° for 20 cycles.</div>
    <div class="description-paragraph style-scope patent-text">The following sequence comparisons are given relative to the nucleic acid sequence presented in FIG. 8B. The C1 primer corresponds to the common 5' end of the pGEX-CapA insert which contains an NcoI site near the initiating methionine. The sequence of the NC primers each start at the nucleotide position indicated, for example, the homologous sequence of the NC580 primer ends at <figure-callout id="580" label="nucleotide position" filenames="US5843636-drawings-page-12.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">nucleotide position</a></figure-callout> 580. A termination codon is inserted at that position, following a BamHI site. The positions of the primers given in Table 14 are indicated in FIG. 8B. The approximate locations of the primers relative to the protein sequence are indicated in FIG. 9.</div>
    <div class="description-paragraph style-scope patent-text">The resulting amplification products were electrophoretically size fractionated on a polyacrylamide gel and the DNA products of the appropriate sizes electroeluted from the gel. The amplification products were cloned into both the pGEX and the pET vectors for expression. The sequences of the inserts were confirmed as described in Example 18.</div>
    <div class="description-paragraph style-scope patent-text">The pGEX vectors containing the carboxy-terminal deletions were transformed into E. coli and the fusion proteins purified essentially as follows. Expression of the fusion protein was induced with IPTG for 3-4 hours. The cells were then harvested at 6,000 rpm for 10 minutes. The E. coli were then lysed in MTPBS buffer (150 mM NaCl; 16 mM Na<sub class="style-scope patent-text">2</sub> HPO<sub class="style-scope patent-text">4</sub> ; 4 mM NaH<sub class="style-scope patent-text">2</sub> PO<sub class="style-scope patent-text">4</sub>, pH=8.0 ) after which 1% "TRITON X-100, " 3 μg/ml DNase I, and 1 mM PMSF were added. The lysates were centrifuged at 15,000 rpm for 20 minutes. The supernatants were discarded and the pellets resuspended in 8M urea. The components of the resuspenion were separated by HPLC using a "BIO-GEL SP-5-PW" column. Typically, the fusion protein was the predominant peak: the location of the fusion protein was confirmed by Western Blot analysis. Clones C1NC270, C1NC360, and C1NC450 all expressed Sj26 fusion proteins at high levels: the fusion proteins all corresponded to the size predicted from the insert coding sequence fused to the Sj26 protein and were immunoreactive with HCV-positive sera (Western Blots were performed as described in Example 17). Although the supernatants were discarded substantial amounts of the fusion proteins were also present in the supernatants. Clones C1NC520 and <figure-callout id="580" label="C1NC" filenames="US5843636-drawings-page-12.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C1NC</a></figure-callout> 580 gave poor yields of fusion proteins.</div>
    <div class="description-paragraph style-scope patent-text">An epitope map of the HCV capsid region is presented in FIG. 10: the location of the immunoreactive protein coding sequences corresponding to <figure-callout id="450" label="inserts C1NC" filenames="US5843636-drawings-page-12.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">inserts C1NC</a></figure-callout> 450, <figure-callout id="360" label="C1NC" filenames="US5843636-drawings-page-12.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C1NC</a></figure-callout> 360, and <figure-callout id="270" label="C1NC" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C1NC</a></figure-callout> 270 are indicated. The sequences of <figure-callout id="450" label="C1NC" filenames="US5843636-drawings-page-12.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C1NC</a></figure-callout> 450, <figure-callout id="360" label="C1NC" filenames="US5843636-drawings-page-12.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C1NC</a></figure-callout> 360, and <figure-callout id="270" label="C1NC" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C1NC</a></figure-callout> 270 are presented in the Sequence Listing as SEQ ID NO:15, SEQ ID NO:17, and SEQ ID NO:19, respectively.</div>
    <div class="description-paragraph style-scope patent-text">B. Amino Terminal Deletions of Clone 56</div>
    <div class="description-paragraph style-scope patent-text">Amino terminal deletion clones were generated using the PCR primers given in Table 15.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">              TABLE 15                                                    
______________________________________                                    
AMINO TERMINAL DELETION PRIMERS                                           
______________________________________                                    
1.    C100 GAG CCC ATG GGT GGA GTT TAC TTG TTG CC                         
2.    C270 GAG CCC ATG GGC TGC GGG <figure-callout id="3" label="TGG GCG GG" filenames="US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TGG GCG GG</a></figure-callout>                             
3.    C360 GAG CCC ATG GGT AAG GTC ATC GAT ACC                            
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">Amplification reactions were carried out essentially as described above using the primer pairs presented in Table 16 and purified plasmid pGEX-CapA as template: the amplification reaction included was 1 minute at 95°, annealed 2 minutes at 50°, and 3 minutes at 72° for 20 cycles.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">              TABLE 16                                                    
______________________________________                                    
NH.sub.2 Primer                                                           
         COOH Primer                                                      
                    Protein Produced?                                     
                                 Immunoreactive?                          
______________________________________                                    
C100     NC450      LOW          YES                                      
         NC360      YES          YES                                      
         NC270      YES          YES                                      
C270     NC450      YES          NO                                       
         NC360      YES          NO                                       
C360     NC450      YES          NO                                       
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">The following sequence comparison are given relative to the nucleic acid sequence presented in FIG. 8B where the above described A to G substitutions have been made for the sequence of pGEX-CapA. The NC660 primer corresponds to the common 3' end of the pGEX-CapA insert which contains a BamHI site near the end of the insert. The sequence of the C primers each start at the nucleotide position indicated, for example, the sequence of the NC100 primer begins at <figure-callout id="100" label="nucleotide position" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-3.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">nucleotide position</a></figure-callout> 100. Each of the C primers introduces an in-frame initiation codon in the resulting amplification product. The positions of the primers given in Table 15 are indicated in FIG. 8C.</div>
    <div class="description-paragraph style-scope patent-text">The resulting amplification products were cloned into the pGEX and pET vector for expression as described above. The sequences of the inserts were confirmed.</div>
    <div class="description-paragraph style-scope patent-text">The pGEX vectors containing the carboxy-terminal deletions were transformed into E. coli, protein minilysates prepared, and the immunoreactivity of the proteins analyzed by Western Blots as described above. The results of the analysis are presented in Table 16. Clones C100NC270 and C100NC360 expressed Sj26 fusion proteins at high levels: the fusion proteins corresponded to the size predicted from the insert coding sequence fused to the Sj26 protein.</div>
    <div class="description-paragraph style-scope patent-text">An epitope map of the HCV capsid region is presented in FIG. 10: the location of the protein coding sequences corresponding to <figure-callout id="270" label="inserts C100NC" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">inserts C100NC</a></figure-callout> 270, <figure-callout id="360" label="C100NC" filenames="US5843636-drawings-page-12.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C100NC</a></figure-callout> 360, C270NC360, and C270NC450 are indicated. The sequences for <figure-callout id="270" label="C100NC" filenames="US5843636-drawings-page-11.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C100NC</a></figure-callout> 270 and <figure-callout id="360" label="C100NC" filenames="US5843636-drawings-page-12.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C100NC</a></figure-callout> 360 are presented in the Sequence Listing as SEQ ID NO:21 and SEQ ID NO:23, respectively.</div>
    <heading class="style-scope patent-text">EXAMPLE 21</heading>
    <heading class="style-scope patent-text">Expanded Immunoscreening Using the Capsid Antigen</heading>
    <div class="description-paragraph style-scope patent-text">This example describes three different comparisons of the immunoreactivity of the various HCV antigens of the present invention to several battery of sera.</div>
    <div class="description-paragraph style-scope patent-text">A. Effectiveness of Cap450 Antigen</div>
    <div class="description-paragraph style-scope patent-text">Table 17 shows the results of 50 human sera samples from patients suspected of NANB hepatitis infection. The ELISA assays were performed essentially as described by Tijssen using the following 3 antigens: C100, 409-1-1(c-a), C33u, Cap450 (the protein product of the pGEX-<figure-callout id="450" label="C1NC" filenames="US5843636-drawings-page-12.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C1NC</a></figure-callout> 450 clone), and with 409-1-1(c-a) and cap4150 in one well which was optimized to give the most sensitive results. These ELISA data were compared with the Abbott C100 test.</div>
    <div class="description-paragraph style-scope patent-text">Patient serum was scored positive for Sj26 fusion proteins (409-1-1 ca, 33u, 5-1-1, and Cap450) if the absorbance was three times the absorbance of that serum on Sj26 native protein. A sample was scored positive on pET antigens (cap360) if the absorbance was three times the mean of the absorbance of negative control sera. A patient serum was scored positive on the combined 409-1-1 ca/cap450 assay if the absorbance was equivalent or greater than that of control positive sera. Samples within 10% of the control positive sera were scored weak positives.</div>
    <div class="description-paragraph style-scope patent-text"> Samples 1-19: Chronic active hepatitis proven by biopsy. HBS Ag(-).</div>
    <div class="description-paragraph style-scope patent-text">Samples 20-44: Acute viral hepititis HBsAg(1), ISM Anti-HBC(-), IgM anti-HAV(-).</div>
    <div class="description-paragraph style-scope patent-text">Samples 45-50: Chronic active hepatitis proven by biopsy. HBsAg(-).</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">              TABLE 17                                                    
______________________________________                                    
Korean Panel II                                                           
                                      Combined                            
Sample            409-1-1        Cap  409-1-1 (c-a) +                     
#         C100    (c-a)    C33u  450  CAP450                              
______________________________________                                    
1             +       +      +     +    +                                 
2             +       +      +     +    +                                 
3             +       +      +     +    +                                 
4             +       +      +     +    +                                 
5             +       +      +     +    +                                 
6             +       +      +     +    +                                 
7             +       +      +     +    +                                 
8             +       +      +     +    +                                 
9             +       -      +     +    +                                 
10            +       -      +     *    +                                 
11            +       +      +     *    +                                 
12            +       +      +     +    +                                 
13            +       +      +     +    +                                 
14            +       +      +     +    +                                 
15            +       +      +     +    +                                 
16            +       +      +     *    +                                 
17            +       +      +     +    +                                 
18            +       +      +     +    +                                 
19            +       -      -     -    -                                 
20   945      -       -      -     -    -                                 
21   988      +       +      +     *    +                                 
22   3383     +       -      -     -    -                                 
23   4072     -       -      -     -    -                                 
24   4242     -       -      -     -    -                                 
25   4490     -       -      -     -    -                                 
26   4816     -       -      -     -    -                                 
27   5322     -       -      -     -    -                                 
28   6603     -       -      -     -    -                                 
29   7923     -       -      -     -    -                                 
30   9033     -       -      -     -    -                                 
31   9768     -       -      -     -    -                                 
32   9775     -       -      -     -    -                                 
33   10197    +       -      -     +    w+*                               
34   10200    -       -      -     -    -                                 
35   10409    -       -      -     -    -                                 
36   10811    -       -      -     -    -                                 
37   11209    -       +      +     +    ND                                
38   12245    -       -      -     -    -                                 
39   12143    -       -      -     -    -                                 
40   12519    -       -      -     -    -                                 
41   13510    -       -      -     -    -                                 
42   14018    -       -      -     -    -                                 
43   14188    -       -      -     -    -                                 
44   13437    -       -      -     -    -                                 
45   863      -       -      -     -    -                                 
46   3354     -       -      -     -    -                                 
47   12640    -       +      +     +    +                                 
48   13095    -       *      +     -    w+                                
49   14501    -       -      -     -    -                                 
50   14345    +       +      +     +    +                                 
______________________________________                                    
 * = positive (low)                                                       
</pre>
    
    <div class="description-paragraph style-scope patent-text">The results demonstrate that the Cap450 protein has good sensitivity for detecting the presence of anti-HCV antibodies in sera samples. Three additional samples (6, 37, and 47) were detected. Further, these results indicate that the combination of Cap450 and 409-1-1(c-a) can be used to produce a kit which is very effective for detection of anti-HCV antibodies in human sera samples.</div>
    <div class="description-paragraph style-scope patent-text">B. Cap450 and Cap360</div>
    <div class="description-paragraph style-scope patent-text">The results in Table 18 demonstrate the effectiveness of the Cap450 and Cap360 antigen (the protein product encoded by of pET-C1NC 360) to detect HCV antibodies present in human sera. The samples were tested for the presence of HCV by ELISA using each individual antigen shown, or with 409-1-1 (c-a) and Cap450 antigens combined in one well.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">                                  TABLE 18                                
__________________________________________________________________________
                                  Combined                                
                    ELISA                                                 
                        409-1-1                                           
                               Cap                                        
                                  (409-1-1) +                             
SERUM                                                                     
     PATIENT DIAGNOSIS                                                    
                 C100                                                     
                    5-1-1                                                 
                        (c-a)                                             
                            <figure-callout id="360" label="C33u" filenames="US5843636-drawings-page-12.png,US5843636-drawings-page-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C33u</a></figure-callout>                                          
                               360                                        
                                  Cap450                                  
__________________________________________________________________________
G-131                                                                     
     Acute Hepatitis; Pt "C.O."                                           
                 -  -   -   -  -  -                                       
G-132                                                                     
     Acute Hepatitis; Pt "C.O."                                           
                 -  -   -   -  -  -                                       
G-143                                                                     
     Acute Hepatitis; Pt "C.O."                                           
                 -  -   -   -  -  -                                       
G-285                                                                     
     Acute Hepatitis; Pt "C.O."                                           
                 ND ND  ND  ND ND -                                       
G-150                                                                     
     Acute P.T. Hepatitis; Pt                                             
                 -  -   I   I  +  +                                       
     "G.L."                                                               
G-151                                                                     
     Acute P.T. Hepatitis; Pt                                             
                 -  -   I   -  +  +                                       
     "G.L."                                                               
G-152                                                                     
     Acute P.T. Hepatitis; Pt                                             
                 -  -   -   -  +  +                                       
     "G.L."                                                               
G-153                                                                     
     Acute P.T. Hepatitis; Pt                                             
                 -  -   I   -  +  +                                       
     "G.L."                                                               
G-286                                                                     
     Acute P.T. Hepatitis; Pt                                             
                 ND ND  ND  ND ND +                                       
     "G.L."                                                               
G-43 Fulminant Liver Disease                                              
                 -  -   -   -  -  -                                       
G-1  Community Acquired                                                   
                 ND I   +   +  +  +                                       
     Hepatitis                                                            
G-109                                                                     
     Community Acquired                                                   
                 +  -   +   +  +  +                                       
     Hepatitis                                                            
G-114                                                                     
     Community Acquired                                                   
                 ND -   -   -  -  -                                       
     Hepatitis                                                            
G-128                                                                     
     Community Acquired                                                   
                 +  -   I   +  +  +                                       
     Hepatitis                                                            
G-3  Community Acquired                                                   
                 -  -   -   -  -  -                                       
     Hepatitis                                                            
G-126                                                                     
     Community Acquired                                                   
                 -  -   -   -  -  +                                       
     Hepatitis                                                            
G-127                                                                     
     Community Acquired                                                   
                 +  I   +   +  -  +                                       
     Hepatitis                                                            
G-42 Idiopath. Comm. Ac.                                                  
                 -  -   -   -  -  -                                       
     Hepatitis                                                            
G-51 Community Acquired                                                   
                 -  -   +   +  +  +                                       
     Hepatitis B                                                          
G-27 Community Acquired                                                   
                 -  -   -   -  -  -                                       
     Hepatitis B                                                          
G-22 Community Acquired                                                   
                 -  -   -   -  -  -                                       
     Hepatitis B                                                          
G-40 Community Acquired                                                   
                 -  -   -   -  -  -                                       
     Hepatitis B                                                          
G-31 Community Acquired                                                   
                 +  -   +   +  +  +                                       
     Hepatitis B                                                          
G-45 Community Acquired                                                   
                 -  -   -   -  -  -                                       
     Hepatitis B                                                          
G-38 Fulminant Hepatitis B                                                
                 -  -   -   -  -  -                                       
G-41 Community Acquired                                                   
                 -  -   I   +  I  +                                       
     Hepatitis C                                                          
G-13 Hepatitis C +  I   +   +  +  +                                       
G-12 Hepatitis C +  -   +   +  +  +                                       
G-6  Hepatitis C -  -   -   -  -  -                                       
G-49 EtOH Cirrhosis                                                       
                 -  -   -   -  -  -                                       
G-25 EtOH Cirrhosis                                                       
                 -  -   -   -  -  -                                       
G-110                                                                     
     EtOH Cirrhosis                                                       
                 -  -   +   +  I  +                                       
G-46 EtOH Cirrhosis                                                       
                 -  -   -   -  -  -                                       
G-272                                                                     
     Infant Liver Transplant                                              
                 ND -   -   -  -  -                                       
G-274                                                                     
     Infant Liver Transplant                                              
                 ND -   +   +  -  -                                       
G-16 PBC         -  -   +   +  -  -                                       
G-123                                                                     
     INC LT      -  -   -   -  -  -                                       
G-122                                                                     
     INC LT      -  +   -   -  -  -                                       
G-125                                                                     
     No Diagnosis                                                         
                 -  I   +   +  I  +                                       
G-124                                                                     
     No Diagnosis                                                         
                 -  -   -   +  +  +                                       
__________________________________________________________________________
</pre>
    
    <div class="description-paragraph style-scope patent-text">These results indicate that the combination of antigen 409-1-1(c-a) and Cap360 or Cap450 result in a effective diagnostic tool for detection of HCV infection. Five additional samples (G150,G151, G110, G125, and G124) were detected with these ELISA's compared with C100 test alone.</div>
    <div class="description-paragraph style-scope patent-text">C. pET360</div>
    <div class="description-paragraph style-scope patent-text">The results in Table 19 demonstrate the effectiveness of the pET360 to detect HCV antibodies present in human sera. The samples were tested for the presence of HCV by ELISA using each individual antigen shown, or with 409-1-1 (c-a) and pET360 antigens combined in one well.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">              TABLE 19                                                    
______________________________________                                    
                                     Combined                             
                409-1-1              409-1-1 (c-a) +                      
C100     5-1-1  (c-a)    C33u pET360 pET360                               
______________________________________                                    
A    +       -      +      +    -      +                                  
B    +       +      +      +    -      +                                  
C    +       -      -      +    -      +                                  
D    +       +      +      -    +      +                                  
E    +       -      w+     +    +      +                                  
F    -       -      -      -    -      -                                  
G    +       -      w+     +    +      +                                  
H    -       -      +      +    +      +                                  
I    -       -      -      -    -      -                                  
J    -       -      -      -    -      -                                  
K    -       -      -      +    +      +                                  
L    -       -      -      -    -      -                                  
M    -       -      -      -    -      -                                  
N    -       w+     -      +    +      +                                  
O    +       w+     +      +    +      +                                  
P    +       w+     +      +    +      +                                  
Q    -       -      -      -    -      -                                  
R    -       -      -      -    -      -                                  
S    -       -      -      -    -      -                                  
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">These results indicate that the combination of antigen 409-1-1 (c-a) and pET360 result in a effective diagnostic tool for detection of HCV infection. Three additional samples were detected with these ELISA's compared with C100 test alone.</div>
    <div class="description-paragraph style-scope patent-text">Although the invention has been described with reference to particular embodiments, methods, construction and use, it will be apparent to those skilled in the art that various changes and modifications can be made without departing from the invention.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">__________________________________________________________________________
SEQUENCE LISTING                                                          
(1) GENERAL INFORMATION:                                                  
(iii) NUMBER OF SEQUENCES: 26                                             
(2) INFORMATION FOR SEQ ID NO:1:                                          
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 561 base pairs                                                
(B) TYPE: nucleic acid                                                    
(C) STRANDEDNESS: double                                                  
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: cDNA to mRNA                                          
(iii) HYPOTHETICAL: NO                                                    
(iv) ANTI-SENSE: NO                                                       
(vi) ORIGINAL SOURCE:                                                     
(A) ORGANISM: Hepatitis C Virus                                           
(B) STRAIN: CDC                                                           
(vii) IMMEDIATE SOURCE:                                                   
(B) CLONE: 304-12-1                                                       
(ix) FEATURE:                                                             
(A) NAME/KEY: CDS                                                         
(B) LOCATION: 1..561                                                      
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:                                   
GAATTCCTCGTGCAAGCGTGGAAGTCCAAGAAAACCCCAATGGGGTTC48                        
GluPheLeuValGlnAlaTrpLysSerLysLysThrProMetGlyPhe                          
151015                                                                    
TCGTATGATACCCGCTGCTTTGACTCCACAGTCACTGAGAGCGACATC96                        
SerTyrAspThrArgCysPheAspSerThrValThrGluSerAspIle                          
202530                                                                    
CGTACGGAGGAGGCAATCTACCAATGTTGTGACCTCGACCCCCAAGCC144                       
ArgThrGluGluAlaIleTyrGlnCysCysAspLeuAspProGlnAla                          
354045                                                                    
CGCGTGGCCATCAAGTCCCTCACCGAGAGGCTTTATGTTGGGGGCCCT192                       
ArgValAlaIleLysSerLeuThrGluArgLeuTyrValGlyGlyPro                          
505560                                                                    
CTTACCAATTCAAGGGGGGAGAACTGCGGCTATCGCAGGTGCCGCGCG240                       
LeuThrAsnSerArgGlyGluAsnCysGlyTyrArgArgCysArgAla                          
65707580                                                                  
AGCGGCGTACTGACAACTAGCTGTGGTAACACCCTCACTTGCTACATC288                       
SerGlyValLeuThrThrSerCysGlyAsnThrLeuThrCysTyrIle                          
859095                                                                    
AAGGCCCGGGCAGCCTGTCGAGCCGCAGGGCTCCAGGACTGCACCATG336                       
LysAlaArgAlaAlaCysArgAlaAlaGlyLeuGlnAspCysThrMet                          
100105110                                                                 
CTCGTGTGTGGCGACGACTTAGTCGTTATCTGTGAAAGCGCGGGGGTC384                       
LeuValCysGlyAspAspLeuValValIleCysGluSerAlaGlyVal                          
115120125                                                                 
CAGGAGGACGCGGCGAGCCTGAGAGCCTTCACGGAGGCTATGACCAGG432                       
GlnGluAspAlaAlaSerLeuArgAlaPheThrGluAlaMetThrArg                          
130135140                                                                 
TACTCCGCCCCCCCCGGGGACCCCCCACAACCAGAATACGACTTGGAG480                       
TyrSerAlaProProGlyAspProProGlnProGluTyrAspLeuGlu                          
145150155160                                                              
CTCATAACATCATGCTCCTCCAACGTGTCAGTCGCCCACGACGGCGCT528                       
LeuIleThrSerCysSerSerAsnValSerValAlaHisAspGlyAla                          
165170175                                                                 
GGAAAGAGGGTCTACTACCTCACCCGGGAATTC561                                      
GlyLysArgValTyrTyrLeuThrArgGluPhe                                         
180185                                                                    
(2) INFORMATION FOR SEQ ID NO:2:                                          
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 187 amino acids                                               
(B) TYPE: amino acid                                                      
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: protein                                               
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:                                   
GluPheLeuValGlnAlaTrpLysSerLysLysThrProMetGlyPhe                          
151015                                                                    
SerTyrAspThrArgCysPheAspSerThrValThrGluSerAspIle                          
202530                                                                    
ArgThrGluGluAlaIleTyrGlnCysCysAspLeuAspProGlnAla                          
354045                                                                    
ArgValAlaIleLysSerLeuThrGluArgLeuTyrValGlyGlyPro                          
505560                                                                    
LeuThrAsnSerArgGlyGluAsnCysGlyTyrArgArgCysArgAla                          
65707580                                                                  
SerGlyValLeuThrThrSerCysGlyAsnThrLeuThrCysTyrIle                          
859095                                                                    
LysAlaArgAlaAlaCysArgAlaAlaGlyLeuGlnAspCysThrMet                          
100105110                                                                 
LeuValCysGlyAspAspLeuValValIleCysGluSerAlaGlyVal                          
115120125                                                                 
GlnGluAspAlaAlaSerLeuArgAlaPheThrGluAlaMetThrArg                          
130135140                                                                 
TyrSerAlaProProGlyAspProProGlnProGluTyrAspLeuGlu                          
145150155160                                                              
LeuIleThrSerCysSerSerAsnValSerValAlaHisAspGlyAla                          
165170175                                                                 
GlyLysArgValTyrTyrLeuThrArgGluPhe                                         
180185                                                                    
(2) INFORMATION FOR SEQ ID NO:3:                                          
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 252 base pairs                                                
(B) TYPE: nucleic acid                                                    
(C) STRANDEDNESS: double                                                  
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: cDNA to mRNA                                          
(iii) HYPOTHETICAL: NO                                                    
(iv) ANTI-SENSE: NO                                                       
(vi) ORIGINAL SOURCE:                                                     
(A) ORGANISM: Hepatitis HCV Virus                                         
(B) STRAIN: CDC                                                           
(vii) IMMEDIATE SOURCE:                                                   
(B) CLONE: 303-1-4                                                        
(ix) FEATURE:                                                             
(A) NAME/KEY: CDS                                                         
(B) LOCATION: 1..252                                                      
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:                                   
AACTCCGTGTGGAAAGACCTTCTGGAAGACAATGTAACACCAATAGAC48                        
AsnSerValTrpLysAspLeuLeuGluAspAsnValThrProIleAsp                          
151015                                                                    
ACTACCATCATGGCTAAGAACGAGGTTTTCTGCGTTCAGCCTGAGAAG96                        
ThrThrIleMetAlaLysAsnGluValPheCysValGlnProGluLys                          
202530                                                                    
GGGGGTCGTAAGCCAGCTCGTCTCATCGTGTTCCCCGATCTGGGCGTG144                       
GlyGlyArgLysProAlaArgLeuIleValPheProAspLeuGlyVal                          
354045                                                                    
CGCGTGTGCGAAAAGATGGCTTTGTACGACGTGGTTACCAAGCTCCCC192                       
ArgValCysGluLysMetAlaLeuTyrAspValValThrLysLeuPro                          
505560                                                                    
TTGGCCGTGATGGGAAGCTCCTACGGATTCCAATACTCACCAGGACAG240                       
LeuAlaValMetGlySerSerTyrGlyPheGlnTyrSerProGlyGln                          
65707580                                                                  
CGGGTTGAATTC252                                                           
ArgValGluPhe                                                              
(2) INFORMATION FOR SEQ ID NO:4:                                          
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 84 amino acids                                                
(B) TYPE: amino acid                                                      
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: protein                                               
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:                                   
AsnSerValTrpLysAspLeuLeuGluAspAsnValThrProIleAsp                          
151015                                                                    
ThrThrIleMetAlaLysAsnGluValPheCysValGlnProGluLys                          
202530                                                                    
GlyGlyArgLysProAlaArgLeuIleValPheProAspLeuGlyVal                          
354045                                                                    
ArgValCysGluLysMetAlaLeuTyrAspValValThrLysLeuPro                          
505560                                                                    
LeuAlaValMetGlySerSerTyrGlyPheGlnTyrSerProGlyGln                          
65707580                                                                  
ArgValGluPhe                                                              
(2) INFORMATION FOR SEQ ID NO:5:                                          
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 1512 base pairs                                               
(B) TYPE: nucleic acid                                                    
(C) STRANDEDNESS: double                                                  
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: cDNA to mRNA                                          
(iii) HYPOTHETICAL: NO                                                    
(iv) ANTI-SENSE: NO                                                       
(vi) ORIGINAL SOURCE:                                                     
(A) ORGANISM: Hepatitis C Virus                                           
(vii) IMMEDIATE SOURCE:                                                   
(B) CLONE: 303-1-4                                                        
(ix) FEATURE:                                                             
(A) NAME/KEY: CDS                                                         
(B) LOCATION: 1..1512                                                     
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:                                   
GAATTCTTCACAGAATTGGACGGGGTGCGCCTACATAGGTTTGCGCCC48                        
GluPhePheThrGluLeuAspGlyValArgLeuHisArgPheAlaPro                          
151015                                                                    
CCCTGCAAGCCCTTGCTGCGGGAGGAGGTATCATTCAGAGTAGGACTC96                        
ProCysLysProLeuLeuArgGluGluValSerPheArgValGlyLeu                          
202530                                                                    
CACGAATACCCGGTAGGGTCGCAATTACCTTGCGAGCCCGAACCGGAT144                       
HisGluTyrProValGlySerGlnLeuProCysGluProGluProAsp                          
354045                                                                    
GTGGCCGTGTTGACGTCCATGCTCACTGATCCCTCCCATATAACAGCA192                       
ValAlaValLeuThrSerMetLeuThrAspProSerHisIleThrAla                          
505560                                                                    
GAGGCGGCCGGGCGAAGGTTGGCGAGGGGATCACCCCCCTCTGTGGCC240                       
GluAlaAlaGlyArgArgLeuAlaArgGlySerProProSerValAla                          
65707580                                                                  
AGCTCCTCGGCTAGCCAGCTATCCGCTCCATCTCTCAAGGCAACTTGC288                       
SerSerSerAlaSerGlnLeuSerAlaProSerLeuLysAlaThrCys                          
859095                                                                    
ACCGCTAACCATGACTCCCCTGATGCTGAGCTCATAGAGGCCAACCTC336                       
ThrAlaAsnHisAspSerProAspAlaGluLeuIleGluAlaAsnLeu                          
100105110                                                                 
CTATGGAGGCAGGAGATGGGCGGCAACATCACCAGGGTTGAGTCAGAA384                       
LeuTrpArgGlnGluMetGlyGlyAsnIleThrArgValGluSerGlu                          
115120125                                                                 
AACAAAGTGGTGATTCTGGACTCCTTCGATCCGCTTGTGGCGGAGGAG432                       
AsnLysValValIleLeuAspSerPheAspProLeuValAlaGluGlu                          
130135140                                                                 
GACGAGCGGGAGATCTCCGTACCCGCAGAAATCCTGCGGAAGTCTCGG480                       
AspGluArgGluIleSerValProAlaGluIleLeuArgLysSerArg                          
145150155160                                                              
AGATTCGCCCAGGCCCTGCCCGTTTGGGCGCGGCCGGACTATAACCCC528                       
ArgPheAlaGlnAlaLeuProValTrpAlaArgProAspTyrAsnPro                          
165170175                                                                 
CCGCTAGTGGAGACGTGGAAAAAGCCCGACTACGAACCACCTGTGGTC576                       
ProLeuValGluThrTrpLysLysProAspTyrGluProProValVal                          
180185190                                                                 
CATGGCTGTCCGCTTCCACCTCCAAAGTCCCCTCCTGTGCCTCCGCCT624                       
HisGlyCysProLeuProProProLysSerProProValProProPro                          
195200205                                                                 
CGGAAGAAGCGGACGGTGGTCCTCACTGAATCAACCCTATCTACTGCC672                       
ArgLysLysArgThrValValLeuThrGluSerThrLeuSerThrAla                          
210215220                                                                 
TTGGCCGAGCTCGCCACCAGAAGCTTTGGCAGCTCCTCAACTTCCGGC720                       
LeuAlaGluLeuAlaThrArgSerPheGlySerSerSerThrSerGly                          
225230235240                                                              
ATTACGGGCGACAATACGACAACATCCTCTGAGCCCGCCCCTTCTGGC768                       
IleThrGlyAspAsnThrThrThrSerSerGluProAlaProSerGly                          
245250255                                                                 
TGCCCCCCCGACTCCGACGCTGAGTCCTATTCCTCCATGCCCCCCCTG816                       
CysProProAspSerAspAlaGluSerTyrSerSerMetProProLeu                          
260265270                                                                 
GAGGGGGAGCCTGGGGATCCGGATCTTAGCGACGGGTCATGGTCAACG864                       
GluGlyGluProGlyAspProAspLeuSerAspGlySerTrpSerThr                          
275280285                                                                 
GTCAGTAGTGAGGCCAACGCGGAGGATGTCGTGTGCTGCTCAATGTCT912                       
ValSerSerGluAlaAsnAlaGluAspValValCysCysSerMetSer                          
290295300                                                                 
TACTCTTGGACAGGCGCACTCGTCACCCCGTGCGCCGCGGAAGAACAG960                       
TyrSerTrpThrGlyAlaLeuValThrProCysAlaAlaGluGluGln                          
305310315320                                                              
AAACTGCCCATCAATGCACTAAGCAACTCGTTGCTACGTCACCACAAT1008                      
LysLeuProIleAsnAlaLeuSerAsnSerLeuLeuArgHisHisAsn                          
325330335                                                                 
TTGGTGTATTCCACCACCTCACGCAGTGCTTGCCAAAGGCAGAAGAAA1056                      
LeuValTyrSerThrThrSerArgSerAlaCysGlnArgGlnLysLys                          
340345350                                                                 
GTCACATTTGACAGACTGCAAGTTCTGGACAGCCATTACCAGGACGTA1104                      
ValThrPheAspArgLeuGlnValLeuAspSerHisTyrGlnAspVal                          
355360365                                                                 
CTCAAGGAGGTTAAAGCAGCGGCGTCAAAAGTGAAGGCTAACTTGCTA1152                      
LeuLysGluValLysAlaAlaAlaSerLysValLysAlaAsnLeuLeu                          
370375380                                                                 
TCCGTAGAGGAAGCTTGCAGCCTGACGCCCCCACACTCAGCCAAATCC1200                      
SerValGluGluAlaCysSerLeuThrProProHisSerAlaLysSer                          
385390395400                                                              
AAGTTTGGTTATGGGGCAAAAGACGTCCGTTGCCATGCCAGAAAGGCC1248                      
LysPheGlyTyrGlyAlaLysAspValArgCysHisAlaArgLysAla                          
405410415                                                                 
GTAACCCACATCAACTCCGTGTGGAAAGACCTTCTGGAAGACAATGTA1296                      
ValThrHisIleAsnSerValTrpLysAspLeuLeuGluAspAsnVal                          
420425430                                                                 
ACACCAATAGACACTACCATCATGGCTAAGAACGAGGTTTTCTGCGTT1344                      
ThrProIleAspThrThrIleMetAlaLysAsnGluValPheCysVal                          
435440445                                                                 
CAGCCTGAGAAGGGGGGTCGTAAGCCAGCTCGTCTCATCGTGTTCCCC1392                      
GlnProGluLysGlyGlyArgLysProAlaArgLeuIleValPhePro                          
450455460                                                                 
GATCTGGGCGTGCGCGTGTGCGAAAAGATGGCTTTGTACGACGTGGTT1440                      
AspLeuGlyValArgValCysGluLysMetAlaLeuTyrAspValVal                          
465470475480                                                              
ACCAAGCTCCCCTTGGCCGTGATGGGAAGCTCCTACGGATTCCAATAC1488                      
ThrLysLeuProLeuAlaValMetGlySerSerTyrGlyPheGlnTyr                          
485490495                                                                 
TCACCAGGACAGCGGGTTGAATTC1512                                              
SerProGlyGlnArgValGluPhe                                                  
500                                                                       
(2) INFORMATION FOR SEQ ID NO:6:                                          
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 504 amino acids                                               
(B) TYPE: amino acid                                                      
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: protein                                               
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:6:                                   
GluPhePheThrGluLeuAspGlyValArgLeuHisArgPheAlaPro                          
151015                                                                    
ProCysLysProLeuLeuArgGluGluValSerPheArgValGlyLeu                          
202530                                                                    
HisGluTyrProValGlySerGlnLeuProCysGluProGluProAsp                          
354045                                                                    
ValAlaValLeuThrSerMetLeuThrAspProSerHisIleThrAla                          
505560                                                                    
GluAlaAlaGlyArgArgLeuAlaArgGlySerProProSerValAla                          
65707580                                                                  
SerSerSerAlaSerGlnLeuSerAlaProSerLeuLysAlaThrCys                          
859095                                                                    
ThrAlaAsnHisAspSerProAspAlaGluLeuIleGluAlaAsnLeu                          
100105110                                                                 
LeuTrpArgGlnGluMetGlyGlyAsnIleThrArgValGluSerGlu                          
115120125                                                                 
AsnLysValValIleLeuAspSerPheAspProLeuValAlaGluGlu                          
130135140                                                                 
AspGluArgGluIleSerValProAlaGluIleLeuArgLysSerArg                          
145150155160                                                              
ArgPheAlaGlnAlaLeuProValTrpAlaArgProAspTyrAsnPro                          
165170175                                                                 
ProLeuValGluThrTrpLysLysProAspTyrGluProProValVal                          
180185190                                                                 
HisGlyCysProLeuProProProLysSerProProValProProPro                          
195200205                                                                 
ArgLysLysArgThrValValLeuThrGluSerThrLeuSerThrAla                          
210215220                                                                 
LeuAlaGluLeuAlaThrArgSerPheGlySerSerSerThrSerGly                          
225230235240                                                              
IleThrGlyAspAsnThrThrThrSerSerGluProAlaProSerGly                          
245250255                                                                 
CysProProAspSerAspAlaGluSerTyrSerSerMetProProLeu                          
260265270                                                                 
GluGlyGluProGlyAspProAspLeuSerAspGlySerTrpSerThr                          
275280285                                                                 
ValSerSerGluAlaAsnAlaGluAspValValCysCysSerMetSer                          
290295300                                                                 
TyrSerTrpThrGlyAlaLeuValThrProCysAlaAlaGluGluGln                          
305310315320                                                              
LysLeuProIleAsnAlaLeuSerAsnSerLeuLeuArgHisHisAsn                          
325330335                                                                 
LeuValTyrSerThrThrSerArgSerAlaCysGlnArgGlnLysLys                          
340345350                                                                 
ValThrPheAspArgLeuGlnValLeuAspSerHisTyrGlnAspVal                          
355360365                                                                 
LeuLysGluValLysAlaAlaAlaSerLysValLysAlaAsnLeuLeu                          
370375380                                                                 
SerValGluGluAlaCysSerLeuThrProProHisSerAlaLysSer                          
385390395400                                                              
LysPheGlyTyrGlyAlaLysAspValArgCysHisAlaArgLysAla                          
405410415                                                                 
ValThrHisIleAsnSerValTrpLysAspLeuLeuGluAspAsnVal                          
420425430                                                                 
ThrProIleAspThrThrIleMetAlaLysAsnGluValPheCysVal                          
435440445                                                                 
GlnProGluLysGlyGlyArgLysProAlaArgLeuIleValPhePro                          
450455460                                                                 
AspLeuGlyValArgValCysGluLysMetAlaLeuTyrAspValVal                          
465470475480                                                              
ThrLysLeuProLeuAlaValMetGlySerSerTyrGlyPheGlnTyr                          
485490495                                                                 
SerProGlyGlnArgValGluPhe                                                  
500                                                                       
(2) INFORMATION FOR SEQ ID NO:7:                                          
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 477 base pairs                                                
(B) TYPE: nucleic acid                                                    
(C) STRANDEDNESS: double                                                  
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: cDNA to mRNA                                          
(iii) HYPOTHETICAL: NO                                                    
(iv) ANTI-SENSE: NO                                                       
(vi) ORIGINAL SOURCE:                                                     
(A) ORGANISM: Hepatitis C Virus                                           
(B) STRAIN: CDC                                                           
(C) INDIVIDUAL ISOLATE: Rodney                                            
(vii) IMMEDIATE SOURCE:                                                   
(B) CLONE: 409-1-1 (c-a)                                                  
(ix) FEATURE:                                                             
(A) NAME/KEY: CDS                                                         
(B) LOCATION: 1..477                                                      
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:                                   
GAATTCCGCACGCCCGCCGAGACTACAGTTAGGCTACGGGCGTACATG48                        
GluPheArgThrProAlaGluThrThrValArgLeuArgAlaTyrMet                          
151015                                                                    
AACACTCCGGGGCTTCCCGTGTGCCAGGACGGAATTCCGTCCCCGTCC96                        
AsnThrProGlyLeuProValCysGlnAspGlyIleProSerProSer                          
202530                                                                    
ACCACCGGAGAGATCCCTTTTTACGGCAAGGCTATCCCCCTCGAAGTA144                       
ThrThrGlyGluIleProPheTyrGlyLysAlaIleProLeuGluVal                          
354045                                                                    
ATCAAGGGGGGGAGACATCTCATCTTCTGTCATTCAAAGAAGAAGTGC192                       
IleLysGlyGlyArgHisLeuIlePheCysHisSerLysLysLysCys                          
505560                                                                    
GACGAACTCGCCGCAAAGCTGGTCGCATTGGGCATCAATGCCGTGGCC240                       
AspGluLeuAlaAlaLysLeuValAlaLeuGlyIleAsnAlaValAla                          
65707580                                                                  
TACTACCGCGGTCTTGACGTGTCCGTCATCCCGACCAGCGGCGATGTT288                       
TyrTyrArgGlyLeuAspValSerValIleProThrSerGlyAspVal                          
859095                                                                    
GTCGTCGTGGCAACCGATGCCCTCATGACCGGCTATACCGGCGACTTC336                       
ValValValAlaThrAspAlaLeuMetThrGlyTyrThrGlyAspPhe                          
100105110                                                                 
GACTCGGTGATAGACTGCAATACGTGTGTCACCCAGACAGTCGATTTC384                       
AspSerValIleAspCysAsnThrCysValThrGlnThrValAspPhe                          
115120125                                                                 
AGCCTTGACCCTACCTTCACCATTGAGACAATCACGCTCCCCCAGGAT432                       
SerLeuAspProThrPheThrIleGluThrIleThrLeuProGlnAsp                          
130135140                                                                 
GCTGTCTCCCGCACTCAACGTCGGGGCAGGACTGGCACGGAATTC477                          
AlaValSerArgThrGlnArgArgGlyArgThrGlyThrGluPhe                             
145150155                                                                 
(2) INFORMATION FOR SEQ ID NO:8:                                          
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 159 amino acids                                               
(B) TYPE: amino acid                                                      
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: protein                                               
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:8:                                   
GluPheArgThrProAlaGluThrThrValArgLeuArgAlaTyrMet                          
151015                                                                    
AsnThrProGlyLeuProValCysGlnAspGlyIleProSerProSer                          
202530                                                                    
ThrThrGlyGluIleProPheTyrGlyLysAlaIleProLeuGluVal                          
354045                                                                    
IleLysGlyGlyArgHisLeuIlePheCysHisSerLysLysLysCys                          
505560                                                                    
AspGluLeuAlaAlaLysLeuValAlaLeuGlyIleAsnAlaValAla                          
65707580                                                                  
TyrTyrArgGlyLeuAspValSerValIleProThrSerGlyAspVal                          
859095                                                                    
ValValValAlaThrAspAlaLeuMetThrGlyTyrThrGlyAspPhe                          
100105110                                                                 
AspSerValIleAspCysAsnThrCysValThrGlnThrValAspPhe                          
115120125                                                                 
SerLeuAspProThrPheThrIleGluThrIleThrLeuProGlnAsp                          
130135140                                                                 
AlaValSerArgThrGlnArgArgGlyArgThrGlyThrGluPhe                             
145150155                                                                 
(2) INFORMATION FOR SEQ ID NO:9:                                          
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 558 base pairs                                                
(B) TYPE: nucleic acid                                                    
(C) STRANDEDNESS: double                                                  
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: cDNA to mRNA                                          
(iii) HYPOTHETICAL: NO                                                    
(vi) ORIGINAL SOURCE:                                                     
(A) ORGANISM: Hepatitis C Virus                                           
(B) STRAIN: CDC                                                           
(vii) IMMEDIATE SOURCE:                                                   
(B) CLONE: 409-1-1 (abc)                                                  
(ix) FEATURE:                                                             
(A) NAME/KEY: CDS                                                         
(B) LOCATION: 1..558                                                      
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:9:                                   
TCCACCACCGGAGAGATCCCTTTTTACGGCAAGGCTATCCCCCTCGAA48                        
SerThrThrGlyGluIleProPheTyrGlyLysAlaIleProLeuGlu                          
151015                                                                    
GTAATCAAGGGGGGGAGACATCTCATCTTCTGTCATTCAAAGAAGAAG96                        
ValIleLysGlyGlyArgHisLeuIlePheCysHisSerLysLysLys                          
202530                                                                    
TGCGACGAACTCGCCGCAAAGCTGGTCGCATTGGGCATCAATGCCGTG144                       
CysAspGluLeuAlaAlaLysLeuValAlaLeuGlyIleAsnAlaVal                          
354045                                                                    
GCCTACTACCGCGGTCTTGACGTGTCCGTCATCCCGACCAGCGGCGAT192                       
AlaTyrTyrArgGlyLeuAspValSerValIleProThrSerGlyAsp                          
505560                                                                    
GTTGTCGTCGTGGCAACCGATGCCCTCATGACCGGCTATACCGGCGAC240                       
ValValValValAlaThrAspAlaLeuMetThrGlyTyrThrGlyAsp                          
65707580                                                                  
TTCGACTCGGTGATAGACTGCAATACGTGTGTCACCCAGACAGTCGAT288                       
PheAspSerValIleAspCysAsnThrCysValThrGlnThrValAsp                          
859095                                                                    
TTCAGCCTTGACCCTACCTTCACCATTGAGACAATCACGCTCCCCCAG336                       
PheSerLeuAspProThrPheThrIleGluThrIleThrLeuProGln                          
100105110                                                                 
GATGCTGTCTCCCGCACTCAACGTCGGGGCAGGACTGGCAGGGGGAAG384                       
AspAlaValSerArgThrGlnArgArgGlyArgThrGlyArgGlyLys                          
115120125                                                                 
CCAGGCATCTACAGATTTGTGGCACCGGGGGAGCGCCCCTCCGGCATG432                       
ProGlyIleTyrArgPheValAlaProGlyGluArgProSerGlyMet                          
130135140                                                                 
TTCGACTCGTCCGTCCTCTGTGAGTGCTATGACGCAGGCTGTGCTTGG480                       
PheAspSerSerValLeuCysGluCysTyrAspAlaGlyCysAlaTrp                          
145150155160                                                              
TATGAGCTCACGCCCGCCGAGACTACAGTTAGGCTACGAGCGTACATG528                       
TyrGluLeuThrProAlaGluThrThrValArgLeuArgAlaTyrMet                          
165170175                                                                 
AACACCCCGGGGCTTCCCGTGTGCCAGGAC558                                         
AsnThrProGlyLeuProValCysGlnAsp                                            
180185                                                                    
(2) INFORMATION FOR SEQ ID NO:10:                                         
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 186 amino acids                                               
(B) TYPE: amino acid                                                      
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: protein                                               
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:10:                                  
SerThrThrGlyGluIleProPheTyrGlyLysAlaIleProLeuGlu                          
151015                                                                    
ValIleLysGlyGlyArgHisLeuIlePheCysHisSerLysLysLys                          
202530                                                                    
CysAspGluLeuAlaAlaLysLeuValAlaLeuGlyIleAsnAlaVal                          
354045                                                                    
AlaTyrTyrArgGlyLeuAspValSerValIleProThrSerGlyAsp                          
505560                                                                    
ValValValValAlaThrAspAlaLeuMetThrGlyTyrThrGlyAsp                          
65707580                                                                  
PheAspSerValIleAspCysAsnThrCysValThrGlnThrValAsp                          
859095                                                                    
PheSerLeuAspProThrPheThrIleGluThrIleThrLeuProGln                          
100105110                                                                 
AspAlaValSerArgThrGlnArgArgGlyArgThrGlyArgGlyLys                          
115120125                                                                 
ProGlyIleTyrArgPheValAlaProGlyGluArgProSerGlyMet                          
130135140                                                                 
PheAspSerSerValLeuCysGluCysTyrAspAlaGlyCysAlaTrp                          
145150155160                                                              
TyrGluLeuThrProAlaGluThrThrValArgLeuArgAlaTyrMet                          
165170175                                                                 
AsnThrProGlyLeuProValCysGlnAsp                                            
180185                                                                    
(2) INFORMATION FOR SEQ ID NO:11:                                         
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 657 base pairs                                                
(B) TYPE: nucleic acid                                                    
(C) STRANDEDNESS: double                                                  
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: cDNA to mRNA                                          
(iii) HYPOTHETICAL: NO                                                    
(iv) ANTI-SENSE: NO                                                       
(vi) ORIGINAL SOURCE:                                                     
(A) ORGANISM: Hepatitis C Virus                                           
(B) STRAIN: CDC                                                           
(vii) IMMEDIATE SOURCE:                                                   
(B) CLONE: GG1                                                            
(ix) FEATURE:                                                             
(A) NAME/KEY: CDS                                                         
(B) LOCATION: 1..657                                                      
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:11:                                  
ATGGGCACGAATCCTAAACCTCAAAAAAAAAACAAACGTAACACCAAC48                        
MetGlyThrAsnProLysProGlnLysLysAsnLysArgAsnThrAsn                          
151015                                                                    
CGTCGCCCACAGGACGTCAAGTTCCCGGGTGGCGGTCAGATCGTTGGT96                        
ArgArgProGlnAspValLysPheProGlyGlyGlyGlnIleValGly                          
202530                                                                    
GGAGTTTACTTGTTGCCGCGCAGGGGCCCTAGATTGGGTGTGCGCGCG144                       
GlyValTyrLeuLeuProArgArgGlyProArgLeuGlyValArgAla                          
354045                                                                    
ACGAGAAAGACTTCCGAGCGGTCGCAACCTCGAGGTAGACGTCAGCCT192                       
ThrArgLysThrSerGluArgSerGlnProArgGlyArgArgGlnPro                          
505560                                                                    
ATCCCCAAGGCTCGTCGGCCCGAGGGCAGGACCTGGGCTCAGCCCGGG240                       
IleProLysAlaArgArgProGluGlyArgThrTrpAlaGlnProGly                          
65707580                                                                  
TACCCTTGGCCCCTCTATGGCAATGAGGGCTGCGGGTGGGCGGGATGG288                       
TyrProTrpProLeuTyrGlyAsnGluGlyCysGlyTrpAlaGlyTrp                          
859095                                                                    
CTCCTGTCTCCCCGTGGCTCTCGGCCTAGCTGGGGCCCCACAGACCCC336                       
LeuLeuSerProArgGlySerArgProSerTrpGlyProThrAspPro                          
100105110                                                                 
CGGCGTAGGTCGCGCAATTTGGGTAAGGTCATCGATACCCTTACGTGC384                       
ArgArgArgSerArgAsnLeuGlyLysValIleAspThrLeuThrCys                          
115120125                                                                 
GGCTTCGCCGACCTCATGGGGTACATACCGCTCGTCGGCGCCCCTCTT432                       
GlyPheAlaAspLeuMetGlyTyrIleProLeuValGlyAlaProLeu                          
130135140                                                                 
GGAGGCGCTGCCAGGGCCCTGGCGCATGGCGTCCGGGTTCTGGAAGAC480                       
GlyGlyAlaAlaArgAlaLeuAlaHisGlyValArgValLeuGluAsp                          
145150155160                                                              
GGCGTGAACTATGCAACAGGGAACCTTCCTGGTTGCTCTTTCTCTATC528                       
GlyValAsnTyrAlaThrGlyAsnLeuProGlyCysSerPheSerIle                          
165170175                                                                 
TTCCTTCTGGCCCTGCTCTCTTGCTTGACTGTGCCCGCTTCGGCCTAC576                       
PheLeuLeuAlaLeuLeuSerCysLeuThrValProAlaSerAlaTyr                          
180185190                                                                 
CAAGTGCGCAACTCCACGGGGCTTTACCACGTCACCAATGATTGCCCT624                       
GlnValArgAsnSerThrGlyLeuTyrHisValThrAsnAspCysPro                          
195200205                                                                 
AACTCGAGCATTGTGTACGAGTAATAGGGATCC657                                      
AsnSerSerIleValTyrGluGlySer                                               
210215                                                                    
(2) INFORMATION FOR SEQ ID NO:12:                                         
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 217 amino acids                                               
(B) TYPE: amino acid                                                      
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: protein                                               
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:12:                                  
MetGlyThrAsnProLysProGlnLysLysAsnLysArgAsnThrAsn                          
151015                                                                    
ArgArgProGlnAspValLysPheProGlyGlyGlyGlnIleValGly                          
202530                                                                    
GlyValTyrLeuLeuProArgArgGlyProArgLeuGlyValArgAla                          
354045                                                                    
ThrArgLysThrSerGluArgSerGlnProArgGlyArgArgGlnPro                          
505560                                                                    
IleProLysAlaArgArgProGluGlyArgThrTrpAlaGlnProGly                          
65707580                                                                  
TyrProTrpProLeuTyrGlyAsnGluGlyCysGlyTrpAlaGlyTrp                          
859095                                                                    
LeuLeuSerProArgGlySerArgProSerTrpGlyProThrAspPro                          
100105110                                                                 
ArgArgArgSerArgAsnLeuGlyLysValIleAspThrLeuThrCys                          
115120125                                                                 
GlyPheAlaAspLeuMetGlyTyrIleProLeuValGlyAlaProLeu                          
130135140                                                                 
GlyGlyAlaAlaArgAlaLeuAlaHisGlyValArgValLeuGluAsp                          
145150155160                                                              
GlyValAsnTyrAlaThrGlyAsnLeuProGlyCysSerPheSerIle                          
165170175                                                                 
PheLeuLeuAlaLeuLeuSerCysLeuThrValProAlaSerAlaTyr                          
180185190                                                                 
GlnValArgAsnSerThrGlyLeuTyrHisValThrAsnAspCysPro                          
195200205                                                                 
AsnSerSerIleValTyrGluGlySer                                               
210215                                                                    
(2) INFORMATION FOR SEQ ID NO:13:                                         
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 657 base pairs                                                
(B) TYPE: nucleic acid                                                    
(C) STRANDEDNESS: double                                                  
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: cDNA to mRNA                                          
(iii) HYPOTHETICAL: NO                                                    
(iv) ANTI-SENSE: NO                                                       
(vi) ORIGINAL SOURCE:                                                     
(A) ORGANISM: Hepatitis C Virus                                           
(B) STRAIN: CDC                                                           
(vii) IMMEDIATE SOURCE:                                                   
(B) CLONE: CapA                                                           
(ix) FEATURE:                                                             
(A) NAME/KEY: CDS                                                         
(B) LOCATION: 1..657                                                      
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:13:                                  
ATGGGCACGAATCCTAAACCTCAGAAGAAGAACAAACGTAACACCAAC48                        
MetGlyThrAsnProLysProGlnLysLysAsnLysArgAsnThrAsn                          
151015                                                                    
CGTCGCCCACAGGACGTCAAGTTCCCGGGTGGCGGTCAGATCGTTGGT96                        
ArgArgProGlnAspValLysPheProGlyGlyGlyGlnIleValGly                          
202530                                                                    
GGAGTTTACTTGTTGCCGCGCAGGGGCCCTAGATTGGGTGTGCGCGCG144                       
GlyValTyrLeuLeuProArgArgGlyProArgLeuGlyValArgAla                          
354045                                                                    
ACGAGAAAGACTTCCGAGCGGTCGCAACCTCGAGGTAGACGTCAGCCT192                       
ThrArgLysThrSerGluArgSerGlnProArgGlyArgArgGlnPro                          
505560                                                                    
ATCCCCAAGGCTCGTCGGCCCGAGGGCAGGACCTGGGCTCAGCCCGGG240                       
IleProLysAlaArgArgProGluGlyArgThrTrpAlaGlnProGly                          
65707580                                                                  
TACCCTTGGCCCCTCTATGGCAATGAGGGCTGCGGGTGGGCGGGATGG288                       
TyrProTrpProLeuTyrGlyAsnGluGlyCysGlyTrpAlaGlyTrp                          
859095                                                                    
CTCCTGTCTCCCCGTGGCTCTCGGCCTAGCTGGGGCCCCACAGACCCC336                       
LeuLeuSerProArgGlySerArgProSerTrpGlyProThrAspPro                          
100105110                                                                 
CGGCGTAGGTCGCGCAATTTGGGTAAGGTCATCGATACCCTTACGTGC384                       
ArgArgArgSerArgAsnLeuGlyLysValIleAspThrLeuThrCys                          
115120125                                                                 
GGCTTCGCCGACCTCATGGGGTACATACCGCTCGTCGGCGCCCCTCTT432                       
GlyPheAlaAspLeuMetGlyTyrIleProLeuValGlyAlaProLeu                          
130135140                                                                 
GGAGGCGCTGCCAGGGCCCTGGCGCATGGCGTCCGGGTTCTGGAAGAC480                       
GlyGlyAlaAlaArgAlaLeuAlaHisGlyValArgValLeuGluAsp                          
145150155160                                                              
GGCGTGAACTATGCAACAGGGAACCTTCCTGGTTGCTCTTTCTCTATC528                       
GlyValAsnTyrAlaThrGlyAsnLeuProGlyCysSerPheSerIle                          
165170175                                                                 
TTCCTTCTGGCCCTGCTCTCTTGCTTGACTGTGCCCGCTTCGGCCTAC576                       
PheLeuLeuAlaLeuLeuSerCysLeuThrValProAlaSerAlaTyr                          
180185190                                                                 
CAAGTGCGCAACTCCACGGGGCTTTACCACGTCACCAATGATTGCCCT624                       
GlnValArgAsnSerThrGlyLeuTyrHisValThrAsnAspCysPro                          
195200205                                                                 
AACTCGAGCATTGTGTACGAGTAATAGGGATCC657                                      
AsnSerSerIleValTyrGluGlySer                                               
210215                                                                    
(2) INFORMATION FOR SEQ ID NO:14:                                         
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 217 amino acids                                               
(B) TYPE: amino acid                                                      
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: protein                                               
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:14:                                  
MetGlyThrAsnProLysProGlnLysLysAsnLysArgAsnThrAsn                          
151015                                                                    
ArgArgProGlnAspValLysPheProGlyGlyGlyGlnIleValGly                          
202530                                                                    
GlyValTyrLeuLeuProArgArgGlyProArgLeuGlyValArgAla                          
354045                                                                    
ThrArgLysThrSerGluArgSerGlnProArgGlyArgArgGlnPro                          
505560                                                                    
IleProLysAlaArgArgProGluGlyArgThrTrpAlaGlnProGly                          
65707580                                                                  
TyrProTrpProLeuTyrGlyAsnGluGlyCysGlyTrpAlaGlyTrp                          
859095                                                                    
LeuLeuSerProArgGlySerArgProSerTrpGlyProThrAspPro                          
100105110                                                                 
ArgArgArgSerArgAsnLeuGlyLysValIleAspThrLeuThrCys                          
115120125                                                                 
GlyPheAlaAspLeuMetGlyTyrIleProLeuValGlyAlaProLeu                          
130135140                                                                 
GlyGlyAlaAlaArgAlaLeuAlaHisGlyValArgValLeuGluAsp                          
145150155160                                                              
GlyValAsnTyrAlaThrGlyAsnLeuProGlyCysSerPheSerIle                          
165170175                                                                 
PheLeuLeuAlaLeuLeuSerCysLeuThrValProAlaSerAlaTyr                          
180185190                                                                 
GlnValArgAsnSerThrGlyLeuTyrHisValThrAsnAspCysPro                          
195200205                                                                 
AsnSerSerIleValTyrGluGlySer                                               
210215                                                                    
(2) INFORMATION FOR SEQ ID NO:15:                                         
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 453 base pairs                                                
(B) TYPE: nucleic acid                                                    
(C) STRANDEDNESS: double                                                  
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: cDNA to mRNA                                          
(iii) HYPOTHETICAL: NO                                                    
(iv) ANTI-SENSE: NO                                                       
(vi) ORIGINAL SOURCE:                                                     
(A) ORGANISM: Hepatitis C Virus                                           
(B) STRAIN: CDC                                                           
(vii) IMMEDIATE SOURCE:                                                   
(B) CLONE: C1NC450                                                        
(ix) FEATURE:                                                             
(A) NAME/KEY: CDS                                                         
(B) LOCATION: 1..453                                                      
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:15:                                  
ATGGGCACGAATCCTAAACCTCAGAAGAAGAACAAACGTAACACCAAC48                        
MetGlyThrAsnProLysProGlnLysLysAsnLysArgAsnThrAsn                          
151015                                                                    
CGTCGCCCACAGGACGTCAAGTTCCCGGGTGGCGGTCAGATCGTTGGT96                        
ArgArgProGlnAspValLysPheProGlyGlyGlyGlnIleValGly                          
202530                                                                    
GGAGTTTACTTGTTGCCGCGCAGGGGCCCTAGATTGGGTGTGCGCGCG144                       
GlyValTyrLeuLeuProArgArgGlyProArgLeuGlyValArgAla                          
354045                                                                    
ACGAGAAAGACTTCCGAGCGGTCGCAACCTCGAGGTAGACGTCAGCCT192                       
ThrArgLysThrSerGluArgSerGlnProArgGlyArgArgGlnPro                          
505560                                                                    
ATCCCCAAGGCTCGTCGGCCCGAGGGCAGGACCTGGGCTCAGCCCGGG240                       
IleProLysAlaArgArgProGluGlyArgThrTrpAlaGlnProGly                          
65707580                                                                  
TACCCTTGGCCCCTCTATGGCAATGAGGGCTGCGGGTGGGCGGGATGG288                       
TyrProTrpProLeuTyrGlyAsnGluGlyCysGlyTrpAlaGlyTrp                          
859095                                                                    
CTCCTGTCTCCCCGTGGCTCTCGGCCTAGCTGGGGCCCCACAGACCCC336                       
LeuLeuSerProArgGlySerArgProSerTrpGlyProThrAspPro                          
100105110                                                                 
CGGCGTAGGTCGCGCAATTTGGGTAAGGTCATCGATACCCTTACGTGC384                       
ArgArgArgSerArgAsnLeuGlyLysValIleAspThrLeuThrCys                          
115120125                                                                 
GGCTTCGCCGACCTCATGGGGTACATACCGCTCGTCGGCGCCCCTCTT432                       
GlyPheAlaAspLeuMetGlyTyrIleProLeuValGlyAlaProLeu                          
130135140                                                                 
GGAGGCGCTGCCAGGGCCTAA453                                                  
GlyGlyAlaAlaArgAla                                                        
145150                                                                    
(2) INFORMATION FOR SEQ ID NO:16:                                         
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 150 amino acids                                               
(B) TYPE: amino acid                                                      
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: protein                                               
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:16:                                  
MetGlyThrAsnProLysProGlnLysLysAsnLysArgAsnThrAsn                          
151015                                                                    
ArgArgProGlnAspValLysPheProGlyGlyGlyGlnIleValGly                          
202530                                                                    
GlyValTyrLeuLeuProArgArgGlyProArgLeuGlyValArgAla                          
354045                                                                    
ThrArgLysThrSerGluArgSerGlnProArgGlyArgArgGlnPro                          
505560                                                                    
IleProLysAlaArgArgProGluGlyArgThrTrpAlaGlnProGly                          
65707580                                                                  
TyrProTrpProLeuTyrGlyAsnGluGlyCysGlyTrpAlaGlyTrp                          
859095                                                                    
LeuLeuSerProArgGlySerArgProSerTrpGlyProThrAspPro                          
100105110                                                                 
ArgArgArgSerArgAsnLeuGlyLysValIleAspThrLeuThrCys                          
115120125                                                                 
GlyPheAlaAspLeuMetGlyTyrIleProLeuValGlyAlaProLeu                          
130135140                                                                 
GlyGlyAlaAlaArgAla                                                        
145150                                                                    
(2) INFORMATION FOR SEQ ID NO:17:                                         
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 360 base pairs                                                
(B) TYPE: nucleic acid                                                    
(C) STRANDEDNESS: double                                                  
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: cDNA to mRNA                                          
(iii) HYPOTHETICAL: NO                                                    
(iv) ANTI-SENSE: NO                                                       
(vi) ORIGINAL SOURCE:                                                     
(A) ORGANISM: Hepatitis C Virus                                           
(B) STRAIN: CDC                                                           
(vii) IMMEDIATE SOURCE:                                                   
(B) CLONE: C1NC360                                                        
(ix) FEATURE:                                                             
(A) NAME/KEY: CDS                                                         
(B) LOCATION: 1..360                                                      
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:17:                                  
ATGGGCACGAATCCTAAACCTCAGAAGAAGAACAAACGTAACACCAAC48                        
MetGlyThrAsnProLysProGlnLysLysAsnLysArgAsnThrAsn                          
151015                                                                    
CGTCGCCCACAGGACGTCAAGTTCCCGGGTGGCGGTCAGATCGTTGGT96                        
ArgArgProGlnAspValLysPheProGlyGlyGlyGlnIleValGly                          
202530                                                                    
GGAGTTTACTTGTTGCCGCGCAGGGGCCCTAGATTGGGTGTGCGCGCG144                       
GlyValTyrLeuLeuProArgArgGlyProArgLeuGlyValArgAla                          
354045                                                                    
ACGAGAAAGACTTCCGAGCGGTCGCAACCTCGAGGTAGACGTCAGCCT192                       
ThrArgLysThrSerGluArgSerGlnProArgGlyArgArgGlnPro                          
505560                                                                    
ATCCCCAAGGCTCGTCGGCCCGAGGGCAGGACCTGGGCTCAGCCCGGG240                       
IleProLysAlaArgArgProGluGlyArgThrTrpAlaGlnProGly                          
65707580                                                                  
TACCCTTGGCCCCTCTATGGCAATGAGGGCTGCGGGTGGGCGGGATGG288                       
TyrProTrpProLeuTyrGlyAsnGluGlyCysGlyTrpAlaGlyTrp                          
859095                                                                    
CTCCTGTCTCCCCGTGGCTCTCGGCCTAGCTGGGGCCCCACAGACCCC336                       
LeuLeuSerProArgGlySerArgProSerTrpGlyProThrAspPro                          
100105110                                                                 
CGGCGTAGGTCGCGCAATTTGTAA360                                               
ArgArgArgSerArgAsnLeu                                                     
115120                                                                    
(2) INFORMATION FOR SEQ ID NO:18:                                         
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 119 amino acids                                               
(B) TYPE: amino acid                                                      
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: protein                                               
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:18:                                  
MetGlyThrAsnProLysProGlnLysLysAsnLysArgAsnThrAsn                          
151015                                                                    
ArgArgProGlnAspValLysPheProGlyGlyGlyGlnIleValGly                          
202530                                                                    
GlyValTyrLeuLeuProArgArgGlyProArgLeuGlyValArgAla                          
354045                                                                    
ThrArgLysThrSerGluArgSerGlnProArgGlyArgArgGlnPro                          
505560                                                                    
IleProLysAlaArgArgProGluGlyArgThrTrpAlaGlnProGly                          
65707580                                                                  
TyrProTrpProLeuTyrGlyAsnGluGlyCysGlyTrpAlaGlyTrp                          
859095                                                                    
LeuLeuSerProArgGlySerArgProSerTrpGlyProThrAspPro                          
100105110                                                                 
ArgArgArgSerArgAsnLeu                                                     
115                                                                       
(2) INFORMATION FOR SEQ ID NO:19:                                         
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 273 base pairs                                                
(B) TYPE: nucleic acid                                                    
(C) STRANDEDNESS: double                                                  
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: cDNA to mRNA                                          
(iii) HYPOTHETICAL: NO                                                    
(iv) ANTI-SENSE: NO                                                       
(vi) ORIGINAL SOURCE:                                                     
(A) ORGANISM: Hepatitis C Virus                                           
(B) STRAIN: CDC                                                           
(vii) IMMEDIATE SOURCE:                                                   
(B) CLONE: C1NC270                                                        
(ix) FEATURE:                                                             
(A) NAME/KEY: CDS                                                         
(B) LOCATION: 1..273                                                      
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:19:                                  
ATGGGCACGAATCCTAAACCTCAGAAGAAGAACAAACGTAACACCAAC48                        
MetGlyThrAsnProLysProGlnLysLysAsnLysArgAsnThrAsn                          
151015                                                                    
CGTCGCCCACAGGACGTCAAGTTCCCGGGTGGCGGTCAGATCGTTGGT96                        
ArgArgProGlnAspValLysPheProGlyGlyGlyGlnIleValGly                          
202530                                                                    
GGAGTTTACTTGTTGCCGCGCAGGGGCCCTAGATTGGGTGTGCGCGCG144                       
GlyValTyrLeuLeuProArgArgGlyProArgLeuGlyValArgAla                          
354045                                                                    
ACGAGAAAGACTTCCGAGCGGTCGCAACCTCGAGGTAGACGTCAGCCT192                       
ThrArgLysThrSerGluArgSerGlnProArgGlyArgArgGlnPro                          
505560                                                                    
ATCCCCAAGGCTCGTCGGCCCGAGGGCAGGACCTGGGCTCAGCCCGGG240                       
IleProLysAlaArgArgProGluGlyArgThrTrpAlaGlnProGly                          
65707580                                                                  
TACCCTTGGCCCCTCTATGGCAATGAGGGCTAA273                                      
TyrProTrpProLeuTyrGlyAsnGluGly                                            
8590                                                                      
(2) INFORMATION FOR SEQ ID NO:20:                                         
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 90 amino acids                                                
(B) TYPE: amino acid                                                      
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: protein                                               
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:20:                                  
MetGlyThrAsnProLysProGlnLysLysAsnLysArgAsnThrAsn                          
151015                                                                    
ArgArgProGlnAspValLysPheProGlyGlyGlyGlnIleValGly                          
202530                                                                    
GlyValTyrLeuLeuProArgArgGlyProArgLeuGlyValArgAla                          
354045                                                                    
ThrArgLysThrSerGluArgSerGlnProArgGlyArgArgGlnPro                          
505560                                                                    
IleProLysAlaArgArgProGluGlyArgThrTrpAlaGlnProGly                          
65707580                                                                  
TyrProTrpProLeuTyrGlyAsnGluGly                                            
8590                                                                      
(2) INFORMATION FOR SEQ ID NO:21:                                         
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 183 base pairs                                                
(B) TYPE: nucleic acid                                                    
(C) STRANDEDNESS: double                                                  
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: cDNA to mRNA                                          
(iii) HYPOTHETICAL: NO                                                    
(iv) ANTI-SENSE: NO                                                       
(vi) ORIGINAL SOURCE:                                                     
(A) ORGANISM: Hepatitis C Virus                                           
(B) STRAIN: CDC                                                           
(vii) IMMEDIATE SOURCE:                                                   
(B) CLONE: C100NC270                                                      
(ix) FEATURE:                                                             
(A) NAME/KEY: CDS                                                         
(B) LOCATION: 1..183                                                      
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:21:                                  
ATGGGTGGAGTTTACTTGTTGCCGCGCAGGGGCCCTAGATTGGGTGTG48                        
MetGlyGlyValTyrLeuLeuProArgArgGlyProArgLeuGlyVal                          
151015                                                                    
CGCGCGACGAGAAAGACTTCCGAGCGGTCGCAACCTCGAGGTAGACGT96                        
ArgAlaThrArgLysThrSerGluArgSerGlnProArgGlyArgArg                          
202530                                                                    
CAGCCTATCCCCAAGGCTCGTCGGCCCGAGGGCAGGACCTGGGCTCAG144                       
GlnProIleProLysAlaArgArgProGluGlyArgThrTrpAlaGln                          
354045                                                                    
CCCGGGTACCCTTGGCCCCTCTATGGCAATGAGGGCTAA183                                
ProGlyTyrProTrpProLeuTyrGlyAsnGluGly                                      
505560                                                                    
(2) INFORMATION FOR SEQ ID NO:22:                                         
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 60 amino acids                                                
(B) TYPE: amino acid                                                      
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: protein                                               
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:22:                                  
MetGlyGlyValTyrLeuLeuProArgArgGlyProArgLeuGlyVal                          
151015                                                                    
ArgAlaThrArgLysThrSerGluArgSerGlnProArgGlyArgArg                          
202530                                                                    
GlnProIleProLysAlaArgArgProGluGlyArgThrTrpAlaGln                          
354045                                                                    
ProGlyTyrProTrpProLeuTyrGlyAsnGluGly                                      
505560                                                                    
(2) INFORMATION FOR SEQ ID NO:23:                                         
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 270 base pairs                                                
(B) TYPE: nucleic acid                                                    
(C) STRANDEDNESS: double                                                  
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: cDNA to mRNA                                          
(iii) HYPOTHETICAL: NO                                                    
(iv) ANTI-SENSE: NO                                                       
(vi) ORIGINAL SOURCE:                                                     
(A) ORGANISM: Hepatitis C Virus                                           
(B) STRAIN: CDC                                                           
(vii) IMMEDIATE SOURCE:                                                   
(B) CLONE: C100NC360                                                      
(ix) FEATURE:                                                             
(A) NAME/KEY: CDS                                                         
(B) LOCATION: 1..270                                                      
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:23:                                  
ATGGGTGGAGTTTACTTGTTGCCGCGCAGGGGCCCTAGATTGGGTGTG48                        
MetGlyGlyValTyrLeuLeuProArgArgGlyProArgLeuGlyVal                          
151015                                                                    
CGCGCGACGAGAAAGACTTCCGAGCGGTCGCAACCTCGAGGTAGACGT96                        
ArgAlaThrArgLysThrSerGluArgSerGlnProArgGlyArgArg                          
202530                                                                    
CAGCCTATCCCCAAGGCTCGTCGGCCCGAGGGCAGGACCTGGGCTCAG144                       
GlnProIleProLysAlaArgArgProGluGlyArgThrTrpAlaGln                          
354045                                                                    
CCCGGGTACCCTTGGCCCCTCTATGGCAATGAGGGCTGCGGGTGGGCG192                       
ProGlyTyrProTrpProLeuTyrGlyAsnGluGlyCysGlyTrpAla                          
505560                                                                    
GGATGGCTCCTGTCTCCCCGTGGCTCTCGGCCTAGCTGGGGCCCCACA240                       
GlyTrpLeuLeuSerProArgGlySerArgProSerTrpGlyProThr                          
65707580                                                                  
GACCCCCGGCGTAGGTCGCGCAATTTGTAA270                                         
AspProArgArgArgSerArgAsnLeu                                               
85                                                                        
(2) INFORMATION FOR SEQ ID NO:24:                                         
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 89 amino acids                                                
(B) TYPE: amino acid                                                      
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: protein                                               
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:24:                                  
MetGlyGlyValTyrLeuLeuProArgArgGlyProArgLeuGlyVal                          
151015                                                                    
ArgAlaThrArgLysThrSerGluArgSerGlnProArgGlyArgArg                          
202530                                                                    
GlnProIleProLysAlaArgArgProGluGlyArgThrTrpAlaGln                          
354045                                                                    
ProGlyTyrProTrpProLeuTyrGlyAsnGluGlyCysGlyTrpAla                          
505560                                                                    
GlyTrpLeuLeuSerProArgGlySerArgProSerTrpGlyProThr                          
65707580                                                                  
AspProArgArgArgSerArgAsnLeu                                               
85                                                                        
(2) INFORMATION FOR SEQ ID NO:25:                                         
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 106 base pairs                                                
(B) TYPE: nucleic acid                                                    
(C) STRANDEDNESS: double                                                  
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: cDNA to mRNA                                          
(iii) HYPOTHETICAL: NO                                                    
(iv) ANTI-SENSE: NO                                                       
(vi) ORIGINAL SOURCE:                                                     
(A) ORGANISM: Hepatitis C Virus                                           
(B) STRAIN: CDC                                                           
(vii) IMMEDIATE SOURCE:                                                   
(B) CLONE: C1NC105                                                        
(ix) FEATURE:                                                             
(A) NAME/KEY: CDS                                                         
(B) LOCATION: 1..106                                                      
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:25:                                  
ATGGGCACGAATCCTAAACCTCAGAAGAAGAACAAACGTAACACCAAC48                        
MetGlyThrAsnProLysProGlnLysLysAsnLysArgAsnThrAsn                          
151015                                                                    
CGTCGCCCACAGGACGTCAAGTTCCCGGGTGGCGGTCAGATCGTTGGT96                        
ArgArgProGlnAspValLysPheProGlyGlyGlyGlnIleValGly                          
202530                                                                    
GGAGTTTTAA106                                                             
GlyValLeu                                                                 
35                                                                        
(2) INFORMATION FOR SEQ ID NO:26:                                         
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 35 amino acids                                                
(B) TYPE: amino acid                                                      
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: protein                                               
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:26:                                  
MetGlyThrAsnProLysProGlnLysLysAsnLysArgAsnThrAsn                          
151015                                                                    
ArgArgProGlnAspValLysPheProGlyGlyGlyGlnIleValGly                          
202530                                                                    
GlyValLeu                                                                 
35                                                                        
__________________________________________________________________________
</pre>
    
    
  </div>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(12)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result" hidden="">translated from </div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><div mxw-id="PCLM5323760" lang="EN" load-source="patent-office" class="claims style-scope patent-text">
    <claim-statement class="style-scope patent-text">It is claimed:</claim-statement>
    <div class="claim style-scope patent-text"> <div num="1" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">1. A recombinant polypeptide which is specifically immunoreactive with sera from humans infected with hepatitis C virus (HCV), where said polypeptide includes the peptide sequence presented as SEQ ID NO:8.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="2" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">2. The polypeptide of claim 1 that is encoded by the polynucleotide sequence presented as SEQ ID NO:7.</div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="3" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">3. A method of detecting hepatitis C virus (HCV) infection in an individual comprising<div class="claim-text style-scope patent-text">reacting serum from an HCV-infected test individual with a peptide antigen which is specifically immunoreactive with sera from humans infected with hepatitis C virus (HCV), where said peptide antigen includes the peptide sequence presented as SEQ ID NO:8, and</div> <div class="claim-text style-scope patent-text">examining the antigen for the presence of bound antibody.</div> </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="4" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">4. The method of claim 3, wherein the peptide antigen is attached to a solid support, said reacting includes reacting the peptide antigen with the support, and subsequently reacting the support with a reporter-labeled anti-human antibody, and said examining includes detecting the presence of reporter-labeled antibody on the solid support.</div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="5" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">5. A method of producing a polypeptide which is specifically immunoreactive with sera from humans infected with hepatitis C virus (HCV), comprising<div class="claim-text style-scope patent-text">introducing into a suitable host, a recombinant expression vector containing an open reading frame (ORF) having a polynucleotide sequence which encodes a polypeptide which is specifically immunoreactive with sera from humans infected with hepatitis C virus (HCV), where said polypeptide includes the peptide sequence presented as SEQ ID NO:8 and where the vector is designed to express the ORF in said host, and</div> <div class="claim-text style-scope patent-text">culturing said host under conditions resulting in the expression of the ORF sequence.</div> </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="6" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">6. The method of claim 5, wherein the polynucleotide has the sequence presented as SEQ ID NO:7.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="7" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">7. The method of claim 6, wherein the expression vector is a lambda gt11 phage vector, the host is E. coli, and the host containing the introduced vector is identified by ATCC No. 40792.</div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="8" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">8. An expression system for expressing a recombinant peptide antigen which is specifically immunoreactive with sera from humans infected with hepatitis C virus (HCV), comprising<div class="claim-text style-scope patent-text">a host capable of supporting expression of an open reading frame in a selected expression vector, and</div> <div class="claim-text style-scope patent-text">the selected expression vector containing an open reading frame (ORF) having a polynucleotide sequence which encodes said peptide antigen, where said peptide antigen includes the peptide sequence presented as SEQ ID NO:8.</div> </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="9" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">9. The expression system of claim 8, wherein the polynucleotide has the sequence presented as SEQ ID NO:7.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="10" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">10. The expression system of claim 9, wherein the expression vector is a lambda gt11 phage vector, the host is E. coli, and the host containing the introduced vector is identified by ATCC No. 40792.</div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="11" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">11. A polynucleotide which encodes a polypeptide which is specifically immunoreactive with sera from humans infected with hepatitis C virus (HCV), where said polypeptide includes the peptide sequence presented as SEQ ID NO:8.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="12" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">12. The polynucleotide of claim 11, which includes the polynucleotide sequence presented as SEQ ID NO:7.</div>
    </div>
  </div> </div>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (21)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5350671A/en"><a id="link" href="#" class="style-scope state-modifier">US5350671A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1987-11-18</span>
                    <span class="td style-scope patent-result">1994-09-27</span>
                    <span class="td style-scope patent-result">Chiron Corporation</span>
                    <span class="td style-scope patent-result">HCV immunoassays employing C domain antigens 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5371017A/en"><a id="link" href="#" class="style-scope state-modifier">US5371017A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-04-04</span>
                    <span class="td style-scope patent-result">1994-12-06</span>
                    <span class="td style-scope patent-result">Chiron Corporation</span>
                    <span class="td style-scope patent-result">Hepatitis C virus protease 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4464474A/en"><a id="link" href="#" class="style-scope state-modifier">US4464474A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1980-07-09</span>
                    <span class="td style-scope patent-result">1984-08-07</span>
                    <span class="td style-scope patent-result">Connaught Laboratories Limited</span>
                    <span class="td style-scope patent-result">Non-A, non-B hepatitis assay and vaccine 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4702909A/en"><a id="link" href="#" class="style-scope state-modifier">US4702909A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1982-05-05</span>
                    <span class="td style-scope patent-result">1987-10-27</span>
                    <span class="td style-scope patent-result">Louisiana State University A &amp; M</span>
                    <span class="td style-scope patent-result">Non-A, non-B hepatitis antigen, antigen compositions, vaccine and diagnostic reagent 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4777245A/en"><a id="link" href="#" class="style-scope state-modifier">US4777245A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1984-01-06</span>
                    <span class="td style-scope patent-result">1988-10-11</span>
                    <span class="td style-scope patent-result">Genelabs Incorporated</span>
                    <span class="td style-scope patent-result">Non-human primate monoclonal antibodies and methods 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4683195A/en"><a id="link" href="#" class="style-scope state-modifier">US4683195A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1986-01-30</span>
                    <span class="td style-scope patent-result">1987-07-28</span>
                    <span class="td style-scope patent-result">Cetus Corporation</span>
                    <span class="td style-scope patent-result">Process for amplifying, detecting, and/or-cloning nucleic acid sequences 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4683202A/en"><a id="link" href="#" class="style-scope state-modifier">US4683202A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1985-03-28</span>
                    <span class="td style-scope patent-result">1987-07-28</span>
                    <span class="td style-scope patent-result">Cetus Corporation</span>
                    <span class="td style-scope patent-result">Process for amplifying nucleic acid sequences 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CH664606A5/en"><a id="link" href="#" class="style-scope state-modifier">CH664606A5</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1985-07-25</span>
                    <span class="td style-scope patent-result">1988-03-15</span>
                    <span class="td style-scope patent-result">Roger Maurer</span>
                    <span class="td style-scope patent-result">Theft device for fixing. 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPS63502962A/en"><a id="link" href="#" class="style-scope state-modifier">JPS63502962A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1986-04-01</span>
                    <span class="td style-scope patent-result">1988-11-02</span>
                    <span class="td style-scope patent-result">ジーンラブズ　インコーポレイテッド</span>
                    <span class="td style-scope patent-result">
  Virus-specific permanently proliferating tissue cells
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5032511A/en"><a id="link" href="#" class="style-scope state-modifier">US5032511A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1987-03-31</span>
                    <span class="td style-scope patent-result">1991-07-16</span>
                    <span class="td style-scope patent-result">Mitsubishi Kasei Corporation</span>
                    <span class="td style-scope patent-result">DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU624105B2/en"><a id="link" href="#" class="style-scope state-modifier">AU624105B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1987-11-18</span>
                    <span class="td style-scope patent-result">1992-06-04</span>
                    <span class="td style-scope patent-result">Novartis Vaccines And Diagnostics, Inc.</span>
                    <span class="td style-scope patent-result">Nanbv diagnostics and vaccines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/HU220204B/en"><a id="link" href="#" class="style-scope state-modifier">HU220204B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1987-11-18</span>
                    <span class="td style-scope patent-result">2001-11-28</span>
                    <span class="td style-scope patent-result">Chiron Corp.</span>
                    <span class="td style-scope patent-result">Hcv polipeptides, hcv polinucleotides-containing such polinucleotides vectors and host cells-transformed with those diagnostics for detecting hcv infections, and immunoassay kit 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1990000597A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1990000597A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1988-07-06</span>
                    <span class="td style-scope patent-result">1990-01-25</span>
                    <span class="td style-scope patent-result">Genelabs Incorporated</span>
                    <span class="td style-scope patent-result">Post-transfusion, non-a, non-b hepatitis virus and antigens 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/NZ232640A/en"><a id="link" href="#" class="style-scope state-modifier">NZ232640A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1989-02-24</span>
                    <span class="td style-scope patent-result">1992-09-25</span>
                    <span class="td style-scope patent-result">Southwest Found Biomed Res</span>
                    <span class="td style-scope patent-result">Non-a, non-b hepatitis (nanbh) cell culture and method of use in supporting virus replication 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/HU225068B1/en"><a id="link" href="#" class="style-scope state-modifier">HU225068B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1989-03-17</span>
                    <span class="td style-scope patent-result">2006-05-29</span>
                    <span class="td style-scope patent-result">Chiron Corp</span>
                    <span class="td style-scope patent-result">Process for producing diagnostics and vaccine of nanbh 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ATE161041T1/en"><a id="link" href="#" class="style-scope state-modifier">ATE161041T1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1989-08-25</span>
                    <span class="td style-scope patent-result">1997-12-15</span>
                    <span class="td style-scope patent-result">Chiron Corp</span>
                    <span class="td style-scope patent-result">
  METHOD FOR CULTIVATION OF HCV IN CELL LINES FROM B OR T LYMPHOCYTES
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2029171A6/en"><a id="link" href="#" class="style-scope state-modifier">ES2029171A6</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1989-12-18</span>
                    <span class="td style-scope patent-result">1992-07-16</span>
                    <span class="td style-scope patent-result">Wellcome Found</span>
                    <span class="td style-scope patent-result">PT-NANB hepatitis polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU638304B2/en"><a id="link" href="#" class="style-scope state-modifier">AU638304B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1989-12-22</span>
                    <span class="td style-scope patent-result">1993-06-24</span>
                    <span class="td style-scope patent-result">Abbott Laboratories</span>
                    <span class="td style-scope patent-result">Hepatitis c assay 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR940000755B1/en"><a id="link" href="#" class="style-scope state-modifier">KR940000755B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-02-16</span>
                    <span class="td style-scope patent-result">1994-01-29</span>
                    <span class="td style-scope patent-result">유나이티드 바이오메디칼 인코오포레이티드</span>
                    <span class="td style-scope patent-result">Synthetic peptides specific for the detection of antibodies to hcv 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5106726A/en"><a id="link" href="#" class="style-scope state-modifier">US5106726A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-02-16</span>
                    <span class="td style-scope patent-result">1992-04-21</span>
                    <span class="td style-scope patent-result">United Biomedical, Inc.</span>
                    <span class="td style-scope patent-result">Synthetic peptides specific for the detection of antibodies to HCV 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2733138B2/en"><a id="link" href="#" class="style-scope state-modifier">JP2733138B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-04-04</span>
                    <span class="td style-scope patent-result">1998-03-30</span>
                    <span class="td style-scope patent-result">カイロン  コーポレイション</span>
                    <span class="td style-scope patent-result">
  Hepatitis C virus (HCV) antigen combinations for use in immunoassays for anti-HCV antibodies
 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (133)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20060275260A1/en"><a id="link" href="#" class="style-scope state-modifier">US20060275260A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-06-04</span>
                    <span class="td style-scope patent-result">2006-12-07</span>
                    <span class="td style-scope patent-result">Phillippe Riviere</span>
                    <span class="td style-scope patent-result">Use of imatinib to treat liver disorders and viral infections 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6861212B1/en"><a id="link" href="#" class="style-scope state-modifier">US6861212B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1987-11-18</span>
                    <span class="td style-scope patent-result">2005-03-01</span>
                    <span class="td style-scope patent-result">Chiron Corporation</span>
                    <span class="td style-scope patent-result">NANBV diagnostics and vaccines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6171782B1/en"><a id="link" href="#" class="style-scope state-modifier">US6171782B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1987-11-18</span>
                    <span class="td style-scope patent-result">2001-01-09</span>
                    <span class="td style-scope patent-result">Chiron Corporation</span>
                    <span class="td style-scope patent-result">Antibody compositions to HCV and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5350671A/en"><a id="link" href="#" class="style-scope state-modifier">US5350671A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1987-11-18</span>
                    <span class="td style-scope patent-result">1994-09-27</span>
                    <span class="td style-scope patent-result">Chiron Corporation</span>
                    <span class="td style-scope patent-result">HCV immunoassays employing C domain antigens 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5712088A/en"><a id="link" href="#" class="style-scope state-modifier">US5712088A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1987-11-18</span>
                    <span class="td style-scope patent-result">1998-01-27</span>
                    <span class="td style-scope patent-result">Chiron Corporation</span>
                    <span class="td style-scope patent-result">Methods for detecting Hepatitis C virus using polynucleotides specific for same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5698390A/en"><a id="link" href="#" class="style-scope state-modifier">US5698390A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1987-11-18</span>
                    <span class="td style-scope patent-result">1997-12-16</span>
                    <span class="td style-scope patent-result">Chiron Corporation</span>
                    <span class="td style-scope patent-result">Hepatitis C immunoassays 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5714596A/en"><a id="link" href="#" class="style-scope state-modifier">US5714596A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1987-11-18</span>
                    <span class="td style-scope patent-result">1998-02-03</span>
                    <span class="td style-scope patent-result">Chiron Corporation</span>
                    <span class="td style-scope patent-result">NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5827821A/en"><a id="link" href="#" class="style-scope state-modifier">US5827821A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1987-12-10</span>
                    <span class="td style-scope patent-result">1998-10-27</span>
                    <span class="td style-scope patent-result">The Burnham Institute</span>
                    <span class="td style-scope patent-result">Conformationally stabilized cell adhesion peptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU639409B2/en"><a id="link" href="#" class="style-scope state-modifier">AU639409B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1987-12-10</span>
                    <span class="td style-scope patent-result">1993-07-29</span>
                    <span class="td style-scope patent-result">La Jolla Cancer Research Foundation</span>
                    <span class="td style-scope patent-result">Conformationally stabilized cell adhesion peptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6124107A/en"><a id="link" href="#" class="style-scope state-modifier">US6124107A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1988-06-10</span>
                    <span class="td style-scope patent-result">2000-09-26</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Assay for marker of human polymorphonuclear leukocyte elastase activity 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6027729A/en"><a id="link" href="#" class="style-scope state-modifier">US6027729A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1989-04-20</span>
                    <span class="td style-scope patent-result">2000-02-22</span>
                    <span class="td style-scope patent-result">Chiron Corporation</span>
                    <span class="td style-scope patent-result">NANBV Diagnostics and vaccines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5639594A/en"><a id="link" href="#" class="style-scope state-modifier">US5639594A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-02-16</span>
                    <span class="td style-scope patent-result">1997-06-17</span>
                    <span class="td style-scope patent-result">United Biomedical, Inc.</span>
                    <span class="td style-scope patent-result">Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5582968A/en"><a id="link" href="#" class="style-scope state-modifier">US5582968A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-02-16</span>
                    <span class="td style-scope patent-result">1996-12-10</span>
                    <span class="td style-scope patent-result">United Biomedical, Inc.</span>
                    <span class="td style-scope patent-result">Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH05509294A/en"><a id="link" href="#" class="style-scope state-modifier">JPH05509294A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-04-06</span>
                    <span class="td style-scope patent-result">1993-12-22</span>
                    <span class="td style-scope patent-result">ラ　ホヤ　キャンサー　リサーチ　ファウンデーション</span>
                    <span class="td style-scope patent-result">
  Methods and compositions for thrombosis treatment
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5648330A/en"><a id="link" href="#" class="style-scope state-modifier">US5648330A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-04-06</span>
                    <span class="td style-scope patent-result">1997-07-15</span>
                    <span class="td style-scope patent-result">La Jolla Cancer Research Foundation</span>
                    <span class="td style-scope patent-result">Method and composition for treating vascular graft occlusion 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6521594B1/en"><a id="link" href="#" class="style-scope state-modifier">US6521594B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-04-06</span>
                    <span class="td style-scope patent-result">2003-02-18</span>
                    <span class="td style-scope patent-result">La Jolla Cancer Research Foundation</span>
                    <span class="td style-scope patent-result">Method and composition for treating thrombosis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5612311A/en"><a id="link" href="#" class="style-scope state-modifier">US5612311A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-04-06</span>
                    <span class="td style-scope patent-result">1997-03-18</span>
                    <span class="td style-scope patent-result">La Jolla Cancer Research Foundation</span>
                    <span class="td style-scope patent-result">Method and composition for treating thrombosis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5672585A/en"><a id="link" href="#" class="style-scope state-modifier">US5672585A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-04-06</span>
                    <span class="td style-scope patent-result">1997-09-30</span>
                    <span class="td style-scope patent-result">La Jolla Cancer Research Foundation</span>
                    <span class="td style-scope patent-result">Method and composition for treating thrombosis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5780303A/en"><a id="link" href="#" class="style-scope state-modifier">US5780303A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-04-06</span>
                    <span class="td style-scope patent-result">1998-07-14</span>
                    <span class="td style-scope patent-result">La Jolla Cancer Research Foundation</span>
                    <span class="td style-scope patent-result">Method and composition for treating thrombosis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR920703640A/en"><a id="link" href="#" class="style-scope state-modifier">KR920703640A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-11-29</span>
                    <span class="td style-scope patent-result">1992-12-18</span>
                    <span class="td style-scope patent-result">테루카츄 아리마</span>
                    <span class="td style-scope patent-result">
  Non-A Hepatitis B Virus Antigen Protein
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ATE144993T1/en"><a id="link" href="#" class="style-scope state-modifier">ATE144993T1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-12-14</span>
                    <span class="td style-scope patent-result">1996-11-15</span>
                    <span class="td style-scope patent-result">Innogenetics Nv</span>
                    <span class="td style-scope patent-result">
  SYNTHETIC ANTIGENS FOR DETECTING ANTIBODIES AGAINST HEPATITIS C VIRUS
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5574132A/en"><a id="link" href="#" class="style-scope state-modifier">US5574132A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-04-05</span>
                    <span class="td style-scope patent-result">1996-11-12</span>
                    <span class="td style-scope patent-result">Biochem Immunosystems Inc.</span>
                    <span class="td style-scope patent-result">Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR100193801B1/en"><a id="link" href="#" class="style-scope state-modifier">KR100193801B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-05-08</span>
                    <span class="td style-scope patent-result">1999-06-15</span>
                    <span class="td style-scope patent-result">케네스 엠. 골드만</span>
                    <span class="td style-scope patent-result">
  Hepatitis C virus (HCV) genome sequence for diagnosis and treatment
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6190864B1/en"><a id="link" href="#" class="style-scope state-modifier">US6190864B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-05-08</span>
                    <span class="td style-scope patent-result">2001-02-20</span>
                    <span class="td style-scope patent-result">Chiron Corporation</span>
                    <span class="td style-scope patent-result">HCV genomic sequences for diagnostics and therapeutics 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/UA40572C2/en"><a id="link" href="#" class="style-scope state-modifier">UA40572C2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-06-24</span>
                    <span class="td style-scope patent-result">2001-08-15</span>
                    <span class="td style-scope patent-result">Чірон Корпорейшн</span>
                    <span class="td style-scope patent-result">Polypeptide containing truncated sequence of hepatitis c virus, isolated epitope, reagent for immunoanalysis to hepatitis c virus, method for identification of availability of antibodies (variants) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DE4209215A1/en"><a id="link" href="#" class="style-scope state-modifier">DE4209215A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-07-04</span>
                    <span class="td style-scope patent-result">1993-01-07</span>
                    <span class="td style-scope patent-result">Boehringer Mannheim Gmbh</span>
                    <span class="td style-scope patent-result">
  HCV PEPTIDE ANTIGEN AND METHOD FOR DETERMINING HCV
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0573624A4/en"><a id="link" href="#" class="style-scope state-modifier">EP0573624A4</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-11-07</span>
                    <span class="td style-scope patent-result">1997-09-17</span>
                    <span class="td style-scope patent-result">Baxter Diagnostics Inc</span>
                    <span class="td style-scope patent-result">Epitope mapping ot the c33c region of hcv 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1993011158A2/en"><a id="link" href="#" class="style-scope state-modifier">WO1993011158A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-12-06</span>
                    <span class="td style-scope patent-result">1993-06-10</span>
                    <span class="td style-scope patent-result">Akzo Nobel N.V.</span>
                    <span class="td style-scope patent-result">Non-a, non-b peptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH05176773A/en"><a id="link" href="#" class="style-scope state-modifier">JPH05176773A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-12-27</span>
                    <span class="td style-scope patent-result">1993-07-20</span>
                    <span class="td style-scope patent-result">Imuno Japan:Kk</span>
                    <span class="td style-scope patent-result">Oligonucleotide, oligopeptide, and detection and differentiation of anti-hepatitis c virus antibody 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7611713B2/en"><a id="link" href="#" class="style-scope state-modifier">US7611713B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-03-05</span>
                    <span class="td style-scope patent-result">2009-11-03</span>
                    <span class="td style-scope patent-result">Pharmexa Inc.</span>
                    <span class="td style-scope patent-result">Inducing cellular immune responses to hepatitis B virus using peptide compositions 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6667387B1/en"><a id="link" href="#" class="style-scope state-modifier">US6667387B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-09-30</span>
                    <span class="td style-scope patent-result">2003-12-23</span>
                    <span class="td style-scope patent-result">N.V. Innogenetics S.A.</span>
                    <span class="td style-scope patent-result">HCV core peptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6709828B1/en"><a id="link" href="#" class="style-scope state-modifier">US6709828B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-03-06</span>
                    <span class="td style-scope patent-result">2004-03-23</span>
                    <span class="td style-scope patent-result">N.V. Innogenetics S.A.</span>
                    <span class="td style-scope patent-result">Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/UA39944C2/en"><a id="link" href="#" class="style-scope state-modifier">UA39944C2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-07-07</span>
                    <span class="td style-scope patent-result">2001-07-16</span>
                    <span class="td style-scope patent-result">Чірон Корпорейшн</span>
                    <span class="td style-scope patent-result">
  METHOD FOR DETERMINATION OF EARLY SEROCONVERSION IN MAMMAL-TO-MACHINE TO HEPATITIS C VIRUS AND KIT FOR USE IN THE METHOD
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6153378A/en"><a id="link" href="#" class="style-scope state-modifier">US6153378A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-10-16</span>
                    <span class="td style-scope patent-result">2000-11-28</span>
                    <span class="td style-scope patent-result">Bionova Corporation</span>
                    <span class="td style-scope patent-result">Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2778886B2/en"><a id="link" href="#" class="style-scope state-modifier">JP2778886B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-10-16</span>
                    <span class="td style-scope patent-result">1998-07-23</span>
                    <span class="td style-scope patent-result">エバーニュー  バイオテック  インコーポレイティド</span>
                    <span class="td style-scope patent-result">
  Hepatitis C virus core antigen protein and diagnostic method and kit using the same
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU6769594A/en"><a id="link" href="#" class="style-scope state-modifier">AU6769594A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-04-22</span>
                    <span class="td style-scope patent-result">1994-11-08</span>
                    <span class="td style-scope patent-result">Genelabs Technologies, Inc.</span>
                    <span class="td style-scope patent-result">Hepatitis c virus immunodiagnostic antigens and antibodies 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DE4402756A1/en"><a id="link" href="#" class="style-scope state-modifier">DE4402756A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-01-31</span>
                    <span class="td style-scope patent-result">1995-08-03</span>
                    <span class="td style-scope patent-result">Boehringer Mannheim Gmbh</span>
                    <span class="td style-scope patent-result">
  Specific binding substances for antibodies and their use for immunoassays or vaccines
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR19990008122A/en"><a id="link" href="#" class="style-scope state-modifier">KR19990008122A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-04-28</span>
                    <span class="td style-scope patent-result">1999-01-25</span>
                    <span class="td style-scope patent-result">곤도도시유키</span>
                    <span class="td style-scope patent-result">
  Antigen Peptide Compounds and Immunological Assays
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5616460A/en"><a id="link" href="#" class="style-scope state-modifier">US5616460A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-06-07</span>
                    <span class="td style-scope patent-result">1997-04-01</span>
                    <span class="td style-scope patent-result">Abbott Laboratories</span>
                    <span class="td style-scope patent-result">Buffer composition for reagents for immunoassay 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6127116A/en"><a id="link" href="#" class="style-scope state-modifier">US6127116A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-08-29</span>
                    <span class="td style-scope patent-result">2000-10-03</span>
                    <span class="td style-scope patent-result">Washington University</span>
                    <span class="td style-scope patent-result">Functional DNA clone for hepatitis C virus (HCV) and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7235394B1/en"><a id="link" href="#" class="style-scope state-modifier">US7235394B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-08-29</span>
                    <span class="td style-scope patent-result">2007-06-26</span>
                    <span class="td style-scope patent-result">Washington University</span>
                    <span class="td style-scope patent-result">Functional DNA clone for hepatitis C virus (HCV) and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7785842B2/en"><a id="link" href="#" class="style-scope state-modifier">US7785842B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-03-26</span>
                    <span class="td style-scope patent-result">2010-08-31</span>
                    <span class="td style-scope patent-result">Oncomedx, Inc.</span>
                    <span class="td style-scope patent-result">Comparative analysis of extracellular RNA species 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8043835B1/en"><a id="link" href="#" class="style-scope state-modifier">US8043835B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-03-26</span>
                    <span class="td style-scope patent-result">2011-10-25</span>
                    <span class="td style-scope patent-result">Oncomedx, Inc.</span>
                    <span class="td style-scope patent-result">Methods for detecting and monitoring cancer using extracellular RNA 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0938320B2/en"><a id="link" href="#" class="style-scope state-modifier">EP0938320B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-03-26</span>
                    <span class="td style-scope patent-result">2014-06-18</span>
                    <span class="td style-scope patent-result">Michael S. Kopreski</span>
                    <span class="td style-scope patent-result">Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR19980069021A/en"><a id="link" href="#" class="style-scope state-modifier">KR19980069021A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-02-26</span>
                    <span class="td style-scope patent-result">1998-10-26</span>
                    <span class="td style-scope patent-result">성재갑</span>
                    <span class="td style-scope patent-result">
  Histidine-labeled Korean Non-Structural Protein 3 of Hepatitis C Virus and Its Preparation Method
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7049428B1/en"><a id="link" href="#" class="style-scope state-modifier">US7049428B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-03-04</span>
                    <span class="td style-scope patent-result">2006-05-23</span>
                    <span class="td style-scope patent-result">Washington University</span>
                    <span class="td style-scope patent-result">HCV variants 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7338759B1/en"><a id="link" href="#" class="style-scope state-modifier">US7338759B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-03-04</span>
                    <span class="td style-scope patent-result">2008-03-04</span>
                    <span class="td style-scope patent-result">Washington University</span>
                    <span class="td style-scope patent-result">HCV variants 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8440396B2/en"><a id="link" href="#" class="style-scope state-modifier">US8440396B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-03-14</span>
                    <span class="td style-scope patent-result">2013-05-14</span>
                    <span class="td style-scope patent-result">Oncomedx, Inc.</span>
                    <span class="td style-scope patent-result">Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6143496A/en"><a id="link" href="#" class="style-scope state-modifier">US6143496A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-04-17</span>
                    <span class="td style-scope patent-result">2000-11-07</span>
                    <span class="td style-scope patent-result">Cytonix Corporation</span>
                    <span class="td style-scope patent-result">Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6030771A/en"><a id="link" href="#" class="style-scope state-modifier">US6030771A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-08-25</span>
                    <span class="td style-scope patent-result">2000-02-29</span>
                    <span class="td style-scope patent-result">Centers For Disease Control And Prevention</span>
                    <span class="td style-scope patent-result">Mosaic protein and restriction endonuclease assisted ligation method for making the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1037636A4/en"><a id="link" href="#" class="style-scope state-modifier">EP1037636A4</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-12-11</span>
                    <span class="td style-scope patent-result">2004-08-18</span>
                    <span class="td style-scope patent-result">Univ Oxford</span>
                    <span class="td style-scope patent-result">Inhibition of membrane-associated viral replication 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6465488B1/en"><a id="link" href="#" class="style-scope state-modifier">US6465488B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-12-11</span>
                    <span class="td style-scope patent-result">2002-10-15</span>
                    <span class="td style-scope patent-result">Chancellor, Masters &amp; Scholars Of The University Of Oxford</span>
                    <span class="td style-scope patent-result">Inhibition of glycolipid biosynthesis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/FR2775690B1/en"><a id="link" href="#" class="style-scope state-modifier">FR2775690B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-03-09</span>
                    <span class="td style-scope patent-result">2001-12-14</span>
                    <span class="td style-scope patent-result">Bio Merieux</span>
                    <span class="td style-scope patent-result">
  MONOCLONAL ANTIBODIES AND USES TO DETECT CORE PROTEIN ANTIGENS OF HCV
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1113777B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1113777B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-06-09</span>
                    <span class="td style-scope patent-result">2007-01-10</span>
                    <span class="td style-scope patent-result">Andrea D. Branch</span>
                    <span class="td style-scope patent-result">Novel hepatitis c virus peptides and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7052830B1/en"><a id="link" href="#" class="style-scope state-modifier">US7052830B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-06-09</span>
                    <span class="td style-scope patent-result">2006-05-30</span>
                    <span class="td style-scope patent-result">Branch Andrea D</span>
                    <span class="td style-scope patent-result">Hepatitis C virus peptides and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20080261292A1/en"><a id="link" href="#" class="style-scope state-modifier">US20080261292A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-09-22</span>
                    <span class="td style-scope patent-result">2008-10-23</span>
                    <span class="td style-scope patent-result">Oncomedx, Inc.</span>
                    <span class="td style-scope patent-result">Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7091324B2/en"><a id="link" href="#" class="style-scope state-modifier">US7091324B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-11-05</span>
                    <span class="td style-scope patent-result">2006-08-15</span>
                    <span class="td style-scope patent-result">Board Of Trustees Of Leland Stanford Junior University</span>
                    <span class="td style-scope patent-result">Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MY164523A/en"><a id="link" href="#" class="style-scope state-modifier">MY164523A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-05-23</span>
                    <span class="td style-scope patent-result">2017-12-29</span>
                    <span class="td style-scope patent-result">Univ Degli Studi Cagliari</span>
                    <span class="td style-scope patent-result">Methods and compositions for treating hepatitis c virus 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1178116A1/en"><a id="link" href="#" class="style-scope state-modifier">EP1178116A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-08-03</span>
                    <span class="td style-scope patent-result">2002-02-06</span>
                    <span class="td style-scope patent-result">Hybrigenics S.A.</span>
                    <span class="td style-scope patent-result">Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7101683B2/en"><a id="link" href="#" class="style-scope state-modifier">US7101683B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-26</span>
                    <span class="td style-scope patent-result">2006-09-05</span>
                    <span class="td style-scope patent-result">Abbott Laboratories</span>
                    <span class="td style-scope patent-result">Methods for the simultaneous detection of HCV antigens and HCV antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP4353793B2/en"><a id="link" href="#" class="style-scope state-modifier">JP4353793B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-26</span>
                    <span class="td style-scope patent-result">2009-10-28</span>
                    <span class="td style-scope patent-result">アボット・ラボラトリーズ</span>
                    <span class="td style-scope patent-result">
  Method for simultaneous detection of HCV antigen and HCV antibody
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2005504087A/en"><a id="link" href="#" class="style-scope state-modifier">JP2005504087A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-28</span>
                    <span class="td style-scope patent-result">2005-02-10</span>
                    <span class="td style-scope patent-result">イデニクス（ケイマン）リミテツド</span>
                    <span class="td style-scope patent-result">
  Methods and compositions for the treatment of hepatitis C virus using 4 'modified nucleosides
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20100159464A1/en"><a id="link" href="#" class="style-scope state-modifier">US20100159464A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-11-05</span>
                    <span class="td style-scope patent-result">2010-06-24</span>
                    <span class="td style-scope patent-result">Oncomedx, Inc.</span>
                    <span class="td style-scope patent-result">Method for Detection of DNA Methyltransferase RNA in Plasma and Serum 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2799442A1/en"><a id="link" href="#" class="style-scope state-modifier">EP2799442A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-28</span>
                    <span class="td style-scope patent-result">2014-11-05</span>
                    <span class="td style-scope patent-result">IDENIX Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Modified 2' and 3' -nucleoside prodrugs for treating flaviridae infections 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2586668T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2586668T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-05-30</span>
                    <span class="td style-scope patent-result">2016-10-18</span>
                    <span class="td style-scope patent-result">Gilead Pharmasset Llc</span>
                    <span class="td style-scope patent-result">
  Modified fluorinated nucleoside analogs
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005010035A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2005010035A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-07-22</span>
                    <span class="td style-scope patent-result">2005-02-03</span>
                    <span class="td style-scope patent-result">Branch Andrea D</span>
                    <span class="td style-scope patent-result">Alternate reading frame polypeptides derived from hepatitis c and methods of their use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2004258750A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2004258750A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-07-25</span>
                    <span class="td style-scope patent-result">2005-02-03</span>
                    <span class="td style-scope patent-result">Centre National De La Recherche Scientifique -Cnrs</span>
                    <span class="td style-scope patent-result">Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis C 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0500020D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0500020D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-01-04</span>
                    <span class="td style-scope patent-result">2005-02-09</span>
                    <span class="td style-scope patent-result">Novartis Ag</span>
                    <span class="td style-scope patent-result">Organic compounds 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN101023094B/en"><a id="link" href="#" class="style-scope state-modifier">CN101023094B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-07-21</span>
                    <span class="td style-scope patent-result">2011-05-18</span>
                    <span class="td style-scope patent-result">法莫赛特股份有限公司</span>
                    <span class="td style-scope patent-result">Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MX2007003085A/en"><a id="link" href="#" class="style-scope state-modifier">MX2007003085A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-09-14</span>
                    <span class="td style-scope patent-result">2007-08-02</span>
                    <span class="td style-scope patent-result">Pharmasset Inc</span>
                    <span class="td style-scope patent-result">Preparation of 2' ifluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN101242842A/en"><a id="link" href="#" class="style-scope state-modifier">CN101242842A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-06-17</span>
                    <span class="td style-scope patent-result">2008-08-13</span>
                    <span class="td style-scope patent-result">诺瓦提斯公司</span>
                    <span class="td style-scope patent-result">Use of SANGLIFEHRIN in HCV 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/NZ571826A/en"><a id="link" href="#" class="style-scope state-modifier">NZ571826A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-04-11</span>
                    <span class="td style-scope patent-result">2012-01-12</span>
                    <span class="td style-scope patent-result">Novartis Ag</span>
                    <span class="td style-scope patent-result">HCV/HIV inhibitors and their uses 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DK2426220T3/en"><a id="link" href="#" class="style-scope state-modifier">DK2426220T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-05-19</span>
                    <span class="td style-scope patent-result">2016-09-26</span>
                    <span class="td style-scope patent-result">Dupont Nutrition Biosci Aps</span>
                    <span class="td style-scope patent-result">Labeled microorganisms, and methods for labeling 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2008219622A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2008219622A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-02-28</span>
                    <span class="td style-scope patent-result">2008-09-04</span>
                    <span class="td style-scope patent-result">Conatus Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Methods for the treatment of liver diseases using specified matrix metalloproteinase (MMP) inhibitors 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2008106167A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2008106167A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-02-28</span>
                    <span class="td style-scope patent-result">2008-09-04</span>
                    <span class="td style-scope patent-result">Conatus Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7964580B2/en"><a id="link" href="#" class="style-scope state-modifier">US7964580B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-03-30</span>
                    <span class="td style-scope patent-result">2011-06-21</span>
                    <span class="td style-scope patent-result">Pharmasset, Inc.</span>
                    <span class="td style-scope patent-result">Nucleoside phosphoramidate prodrugs 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2009099596A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2009099596A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-02-04</span>
                    <span class="td style-scope patent-result">2009-08-13</span>
                    <span class="td style-scope patent-result">Idenix Pharamaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Macrocyclic serine protease inhibitors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2713400A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2713400A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-02-08</span>
                    <span class="td style-scope patent-result">2009-08-13</span>
                    <span class="td style-scope patent-result">Intercell Ag</span>
                    <span class="td style-scope patent-result">Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW200946541A/en"><a id="link" href="#" class="style-scope state-modifier">TW200946541A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-03-27</span>
                    <span class="td style-scope patent-result">2009-11-16</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals Inc</span>
                    <span class="td style-scope patent-result">Solid forms of an anti-HIV phosphoindole compound 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8173621B2/en"><a id="link" href="#" class="style-scope state-modifier">US8173621B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-06-11</span>
                    <span class="td style-scope patent-result">2012-05-08</span>
                    <span class="td style-scope patent-result">Gilead Pharmasset Llc</span>
                    <span class="td style-scope patent-result">Nucleoside cyclicphosphates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20110065440A/en"><a id="link" href="#" class="style-scope state-modifier">KR20110065440A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-07-02</span>
                    <span class="td style-scope patent-result">2011-06-15</span>
                    <span class="td style-scope patent-result">아이데닉스 파마슈티칼스, 인코포레이티드</span>
                    <span class="td style-scope patent-result">Compounds and pharmaceutical compositions for the treatment of viral infections 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/NZ593647A/en"><a id="link" href="#" class="style-scope state-modifier">NZ593647A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-12-23</span>
                    <span class="td style-scope patent-result">2013-08-30</span>
                    <span class="td style-scope patent-result">Gilead Pharmasset Llc</span>
                    <span class="td style-scope patent-result">Synthesis of purine nucleosides 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MX2011006891A/en"><a id="link" href="#" class="style-scope state-modifier">MX2011006891A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-12-23</span>
                    <span class="td style-scope patent-result">2011-10-06</span>
                    <span class="td style-scope patent-result">Pharmasset Inc</span>
                    <span class="td style-scope patent-result">Nucleoside phosphoramidates. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2376514A2/en"><a id="link" href="#" class="style-scope state-modifier">EP2376514A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-12-23</span>
                    <span class="td style-scope patent-result">2011-10-19</span>
                    <span class="td style-scope patent-result">Pharmasset, Inc.</span>
                    <span class="td style-scope patent-result">Nucleoside analogs 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8102720B2/en"><a id="link" href="#" class="style-scope state-modifier">US8102720B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-02-02</span>
                    <span class="td style-scope patent-result">2012-01-24</span>
                    <span class="td style-scope patent-result">Qualcomm Incorporated</span>
                    <span class="td style-scope patent-result">System and method of pulse generation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2403860B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2403860B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-03-04</span>
                    <span class="td style-scope patent-result">2015-11-04</span>
                    <span class="td style-scope patent-result">IDENIX Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Phosphothiophene and phosphothiazole as hcv polymerase inhibitors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2417134B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2417134B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-04-08</span>
                    <span class="td style-scope patent-result">2017-05-17</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals LLC.</span>
                    <span class="td style-scope patent-result">Macrocyclic serine protease inhibitors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8512690B2/en"><a id="link" href="#" class="style-scope state-modifier">US8512690B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-04-10</span>
                    <span class="td style-scope patent-result">2013-08-20</span>
                    <span class="td style-scope patent-result">Novartis Ag</span>
                    <span class="td style-scope patent-result">Derivatised proline containing peptide compounds as protease inhibitors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20110182850A1/en"><a id="link" href="#" class="style-scope state-modifier">US20110182850A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-04-10</span>
                    <span class="td style-scope patent-result">2011-07-28</span>
                    <span class="td style-scope patent-result">Trixi Brandl</span>
                    <span class="td style-scope patent-result">Organic compounds and their uses 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8618076B2/en"><a id="link" href="#" class="style-scope state-modifier">US8618076B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-05-20</span>
                    <span class="td style-scope patent-result">2013-12-31</span>
                    <span class="td style-scope patent-result">Gilead Pharmasset Llc</span>
                    <span class="td style-scope patent-result">Nucleoside phosphoramidates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TWI576352B/en"><a id="link" href="#" class="style-scope state-modifier">TWI576352B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-05-20</span>
                    <span class="td style-scope patent-result">2017-04-01</span>
                    <span class="td style-scope patent-result">基利法瑪席特有限責任公司</span>
                    <span class="td style-scope patent-result">Nucleoside phosphoramidates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2011017389A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2011017389A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-08-05</span>
                    <span class="td style-scope patent-result">2011-02-10</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20110117055A1/en"><a id="link" href="#" class="style-scope state-modifier">US20110117055A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-11-19</span>
                    <span class="td style-scope patent-result">2011-05-19</span>
                    <span class="td style-scope patent-result">Macdonald James E</span>
                    <span class="td style-scope patent-result">Methods of Treating Hepatitis C Virus with Oxoacetamide Compounds 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN102822175A/en"><a id="link" href="#" class="style-scope state-modifier">CN102822175A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-12-18</span>
                    <span class="td style-scope patent-result">2012-12-12</span>
                    <span class="td style-scope patent-result">埃迪尼克斯医药公司</span>
                    <span class="td style-scope patent-result">5,5-fused arylene or heteroarylene hepatitis C virus inhibitors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8563530B2/en"><a id="link" href="#" class="style-scope state-modifier">US8563530B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-03-31</span>
                    <span class="td style-scope patent-result">2013-10-22</span>
                    <span class="td style-scope patent-result">Gilead Pharmassel LLC</span>
                    <span class="td style-scope patent-result">Purine nucleoside phosphoramidate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2011235112B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2011235112B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-03-31</span>
                    <span class="td style-scope patent-result">2015-07-09</span>
                    <span class="td style-scope patent-result">Gilead Pharmasset Llc</span>
                    <span class="td style-scope patent-result">Nucleoside phosphoramidates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MX2012011222A/en"><a id="link" href="#" class="style-scope state-modifier">MX2012011222A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-01</span>
                    <span class="td style-scope patent-result">2013-01-18</span>
                    <span class="td style-scope patent-result">Centre Nat Rech Scient</span>
                    <span class="td style-scope patent-result">Compounds and pharmaceutical compositions for the treatment of viral infections. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MX2013003945A/en"><a id="link" href="#" class="style-scope state-modifier">MX2013003945A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-10-08</span>
                    <span class="td style-scope patent-result">2013-06-05</span>
                    <span class="td style-scope patent-result">Novartis Ag</span>
                    <span class="td style-scope patent-result">Vitamin e formulations of sulfamide ns3 inhibitors. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2011336632B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2011336632B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-11-30</span>
                    <span class="td style-scope patent-result">2015-09-03</span>
                    <span class="td style-scope patent-result">Gilead Pharmasset Llc</span>
                    <span class="td style-scope patent-result">Compounds 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AR085352A1/en"><a id="link" href="#" class="style-scope state-modifier">AR085352A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-02-10</span>
                    <span class="td style-scope patent-result">2013-09-25</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals Inc</span>
                    <span class="td style-scope patent-result">
  MACROCICLIC INHIBITORS OF SERINA PROTEASA, ITS PHARMACEUTICAL COMPOSITIONS AND ITS USE TO TREAT HCV INFECTIONS
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20120252721A1/en"><a id="link" href="#" class="style-scope state-modifier">US20120252721A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-03-31</span>
                    <span class="td style-scope patent-result">2012-10-04</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9243025B2/en"><a id="link" href="#" class="style-scope state-modifier">US9243025B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-03-31</span>
                    <span class="td style-scope patent-result">2016-01-26</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Llc</span>
                    <span class="td style-scope patent-result">Compounds and pharmaceutical compositions for the treatment of viral infections 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013039920A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013039920A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-09-12</span>
                    <span class="td style-scope patent-result">2013-03-21</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013039855A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013039855A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-09-12</span>
                    <span class="td style-scope patent-result">2013-03-21</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Compounds and pharmaceutical compositions for the treatment of viral infections 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW201331221A/en"><a id="link" href="#" class="style-scope state-modifier">TW201331221A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2013-08-01</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals Inc</span>
                    <span class="td style-scope patent-result">Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8889159B2/en"><a id="link" href="#" class="style-scope state-modifier">US8889159B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-11-29</span>
                    <span class="td style-scope patent-result">2014-11-18</span>
                    <span class="td style-scope patent-result">Gilead Pharmasset Llc</span>
                    <span class="td style-scope patent-result">Compositions and methods for treating hepatitis C virus 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN104185420B/en"><a id="link" href="#" class="style-scope state-modifier">CN104185420B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-11-30</span>
                    <span class="td style-scope patent-result">2017-06-09</span>
                    <span class="td style-scope patent-result">埃默里大学</span>
                    <span class="td style-scope patent-result">Antiviral JAK inhibitor for treating or preventing retrovirus and other virus infection 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8809354B2/en"><a id="link" href="#" class="style-scope state-modifier">US8809354B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-12-31</span>
                    <span class="td style-scope patent-result">2014-08-19</span>
                    <span class="td style-scope patent-result">Sheikh Riazuddin</span>
                    <span class="td style-scope patent-result">3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20130217644A1/en"><a id="link" href="#" class="style-scope state-modifier">US20130217644A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-02-13</span>
                    <span class="td style-scope patent-result">2013-08-22</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Pharmaceutical Compositions of 2'-C-Methyl-Guanosine, 5'-[2[(3-Hydroxy-2,2-Dimethyl-1-Oxopropyl)Thio]Ethyl N-(Phenylmethyl)Phosphoramidate] 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013177188A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013177188A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-05-22</span>
                    <span class="td style-scope patent-result">2013-11-28</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">3',5'-cyclic phosphoramidate prodrugs for hcv infection 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2852605B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2852605B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-05-22</span>
                    <span class="td style-scope patent-result">2018-01-31</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals LLC</span>
                    <span class="td style-scope patent-result">3',5'-cyclic phosphate prodrugs for hcv infection 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2013266393B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2013266393B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-05-22</span>
                    <span class="td style-scope patent-result">2017-09-28</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals Llc</span>
                    <span class="td style-scope patent-result">D-amino acid compounds for liver disease 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GEP201706723B/en"><a id="link" href="#" class="style-scope state-modifier">GEP201706723B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-08</span>
                    <span class="td style-scope patent-result">2017-08-25</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals Llk</span>
                    <span class="td style-scope patent-result">2'-chloro nucleoside analogs for hcv infection 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014063019A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014063019A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-19</span>
                    <span class="td style-scope patent-result">2014-04-24</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Dinucleotide compounds for hcv infection 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014066239A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014066239A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-22</span>
                    <span class="td style-scope patent-result">2014-05-01</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">2',4'-bridged nucleosides for hcv infection 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014078436A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014078436A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-11-14</span>
                    <span class="td style-scope patent-result">2014-05-22</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">D-alanine ester of sp-nucleoside analog 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20140140951A1/en"><a id="link" href="#" class="style-scope state-modifier">US20140140951A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-11-14</span>
                    <span class="td style-scope patent-result">2014-05-22</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">D-Alanine Ester of Rp-Nucleoside Analog 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014099941A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014099941A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-12-19</span>
                    <span class="td style-scope patent-result">2014-06-26</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">4'-fluoro nucleosides for the treatment of hcv 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014137926A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014137926A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-03-04</span>
                    <span class="td style-scope patent-result">2014-09-12</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">3'-deoxy nucleosides for the treatment of hcv 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9339541B2/en"><a id="link" href="#" class="style-scope state-modifier">US9339541B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-03-04</span>
                    <span class="td style-scope patent-result">2016-05-17</span>
                    <span class="td style-scope patent-result">Merck Sharp &amp; Dohme Corp.</span>
                    <span class="td style-scope patent-result">Thiophosphate nucleosides for the treatment of HCV 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014165542A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014165542A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-04-01</span>
                    <span class="td style-scope patent-result">2014-10-09</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">2',4'-fluoro nucleosides for the treatment of hcv 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3004130B1/en"><a id="link" href="#" class="style-scope state-modifier">EP3004130B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-06-05</span>
                    <span class="td style-scope patent-result">2019-08-07</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals LLC.</span>
                    <span class="td style-scope patent-result">1',4'-thio nucleosides for the treatment of hcv 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015017713A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015017713A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-08-01</span>
                    <span class="td style-scope patent-result">2015-02-05</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/NZ716840A/en"><a id="link" href="#" class="style-scope state-modifier">NZ716840A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-08-27</span>
                    <span class="td style-scope patent-result">2017-06-30</span>
                    <span class="td style-scope patent-result">Gilead Pharmasset Llc</span>
                    <span class="td style-scope patent-result">Combination formulation of two antiviral compounds 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015042375A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015042375A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-09-20</span>
                    <span class="td style-scope patent-result">2015-03-26</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Hepatitis c virus inhibitors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015061683A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015061683A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-25</span>
                    <span class="td style-scope patent-result">2015-04-30</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">D-amino acid phosphoramidate and d-alanine thiophosphoramidate pronucleotides of nucleoside compounds useful for the treatment of hcv 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015066370A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015066370A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-11-01</span>
                    <span class="td style-scope patent-result">2015-05-07</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">D-alanine phosphoramidate pronucleotides of 2'-methyl 2'-fluoro guanosine nucleoside compounds for the treatment of hcv 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015081297A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015081297A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-11-27</span>
                    <span class="td style-scope patent-result">2015-06-04</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">2'-dichloro and 2'-fluoro-2'-chloro nucleoside analogues for hcv infection 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10683321B2/en"><a id="link" href="#" class="style-scope state-modifier">US10683321B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-12-18</span>
                    <span class="td style-scope patent-result">2020-06-16</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals Llc</span>
                    <span class="td style-scope patent-result">4′-or nucleosides for the treatment of HCV 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015134561A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015134561A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-03-05</span>
                    <span class="td style-scope patent-result">2015-09-11</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Pharmaceutical compositions comprising a 5,5-fused heteroarylene flaviviridae inhibitor and their use for treating or preventing flaviviridae infection 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015134780A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015134780A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-03-05</span>
                    <span class="td style-scope patent-result">2015-09-11</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Solid prodrug forms of 2'-chloro-2'-methyl uridine for hcv 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3114122A1/en"><a id="link" href="#" class="style-scope state-modifier">EP3114122A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-03-05</span>
                    <span class="td style-scope patent-result">2017-01-11</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals LLC</span>
                    <span class="td style-scope patent-result">Solid forms of a flaviviridae virus inhibitor compound and salts thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10202411B2/en"><a id="link" href="#" class="style-scope state-modifier">US10202411B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-04-16</span>
                    <span class="td style-scope patent-result">2019-02-12</span>
                    <span class="td style-scope patent-result">Idenix Pharmaceuticals Llc</span>
                    <span class="td style-scope patent-result">3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party, ‡ Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5843636A/en"><a id="link" href="#" class="style-scope state-modifier">US5843636A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-12-01</span>
                    <span class="td style-scope patent-result">Hepatitis C virus epitopes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/IE83236B1/en"><a id="link" href="#" class="style-scope state-modifier">IE83236B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Hepatitis C virus epitopes 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5856437A/en"><a id="link" href="#" class="style-scope state-modifier">US5856437A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-01-05</span>
                    <span class="td style-scope patent-result">Hepatitis C virus isolate polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP4296174B2/en"><a id="link" href="#" class="style-scope state-modifier">JP4296174B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-07-15</span>
                    <span class="td style-scope patent-result">
  Hepatitis G virus and its molecular cloning
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6210675B1/en"><a id="link" href="#" class="style-scope state-modifier">US6210675B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-03</span>
                    <span class="td style-scope patent-result">PT-NANB hepatitis polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5879904A/en"><a id="link" href="#" class="style-scope state-modifier">US5879904A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-03-09</span>
                    <span class="td style-scope patent-result">Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0419182A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0419182A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-03-27</span>
                    <span class="td style-scope patent-result">New HCV isolates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5766840A/en"><a id="link" href="#" class="style-scope state-modifier">US5766840A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-06-16</span>
                    <span class="td style-scope patent-result">Hepatitis G virus and molecular cloning thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2045323C/en"><a id="link" href="#" class="style-scope state-modifier">CA2045323C</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-23</span>
                    <span class="td style-scope patent-result">Non-a, non-b hepatitis virus genomic cdna and antigen polypeptide 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6692751B1/en"><a id="link" href="#" class="style-scope state-modifier">US6692751B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-02-17</span>
                    <span class="td style-scope patent-result">Methods and systems for producing recombinant viral antigens 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5800982A/en"><a id="link" href="#" class="style-scope state-modifier">US5800982A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-09-01</span>
                    <span class="td style-scope patent-result">Antigenic peptides for growing hepatitis C virus, kit comprising the same and methods for its grouping using the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1995032290A2/en"><a id="link" href="#" class="style-scope state-modifier">WO1995032290A2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-11-30</span>
                    <span class="td style-scope patent-result">Non-a/non-b/non-c/non-d/non-e hepatitis agents and molecular cloning thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5859230A/en"><a id="link" href="#" class="style-scope state-modifier">US5859230A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-01-12</span>
                    <span class="td style-scope patent-result">Non-A/non-B/non-C/non-D/non-E hepatitis agents and molecular cloning thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5437974A/en"><a id="link" href="#" class="style-scope state-modifier">US5437974A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-08-01</span>
                    <span class="td style-scope patent-result">DNA sequence and encoded polypeptide useful in the diagnosis of hepatitis disease 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5866139A/en"><a id="link" href="#" class="style-scope state-modifier">US5866139A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-02-02</span>
                    <span class="td style-scope patent-result">Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1992016543A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1992016543A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-10-01</span>
                    <span class="td style-scope patent-result">NORWALK VIRUS HUMAN GASTROENTERITIS AGENT AND MOLECULAR CLONING OF CORRESPONDING cDNAs 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1994024565A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1994024565A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-10-27</span>
                    <span class="td style-scope patent-result">Hepatitis c virus immunodiagnostic antigens and antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/PT97428B/en"><a id="link" href="#" class="style-scope state-modifier">PT97428B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-11-30</span>
                    <span class="td style-scope patent-result">
  PROCESS FOR THE PREPARATION OF EPITHOPES OF HEPATITIS C VIRUS
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040214163A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040214163A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-10-28</span>
                    <span class="td style-scope patent-result">Methods and systems for producing recombinant viral antigens 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU684177C/en"><a id="link" href="#" class="style-scope state-modifier">AU684177C</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-07-15</span>
                    <span class="td style-scope patent-result">Hepatitis G virus and molecular cloning thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH061799A/en"><a id="link" href="#" class="style-scope state-modifier">JPH061799A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-01-11</span>
                    <span class="td style-scope patent-result">Antigen peptide of hepatitis virus of non-a non-b type, nucleic acid fragment encoding the same peptide and its use 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            
            <h3 id="parentApplications" class="scroll-target style-scope patent-result">
              Parent Applications (1)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Relation</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5443965A/en"><a id="link" href="#" class="style-scope state-modifier">US07/681,703</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1990-04-06</span>
                    <span class="td nowrap style-scope patent-result">1991-04-05</span>
                    <span class="td nowrap style-scope patent-result">
                        Division<template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">Hepatitis C virus epitopes 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="applicationChildApps" class="scroll-target style-scope patent-result">
              Child Applications (1)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Relation</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5843639A/en"><a id="link" href="#" class="style-scope state-modifier">US08/485,500</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1990-04-06</span>
                    <span class="td nowrap style-scope patent-result">1995-06-07</span>
                    <span class="td nowrap style-scope patent-result">
                        Division<template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">Hepatitis C virus epitopes 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="applicationPriorityApps" class="scroll-target style-scope patent-result">
              Priority Applications (2)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5843636A/en"><a id="link" href="#" class="style-scope state-modifier">US08/407,410</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1990-04-06</span>
                    <span class="td nowrap style-scope patent-result">1995-03-17</span>
                    <span class="td style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        Hepatitis C virus epitopes 
       <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5843639A/en"><a id="link" href="#" class="style-scope state-modifier">US08/485,500</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1990-04-06</span>
                    <span class="td nowrap style-scope patent-result">1995-06-07</span>
                    <span class="td style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        Hepatitis C virus epitopes 
       <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (4)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US50561190A<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1990-04-06</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US59485490A<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1990-10-09</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5443965A/en"><a id="link" href="#" class="style-scope state-modifier">US07/681,703</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1991-04-05</span>
                    <span class="td style-scope patent-result">Hepatitis C virus epitopes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5843636A/en"><a id="link" href="#" class="style-scope state-modifier">US08/407,410</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1995-03-17</span>
                    <span class="td style-scope patent-result">Hepatitis C virus epitopes 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">1998-11-24</span>
                    <span class="td nowrap style-scope patent-result">STCF</span>
                    <span class="td nowrap style-scope patent-result">Information on status: patent grant</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: PATENTED CASE</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2002-05-29</span>
                    <span class="td nowrap style-scope patent-result">FPAY</span>
                    <span class="td nowrap style-scope patent-result">Fee payment</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Year of fee payment</strong>: 4</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2006-05-24</span>
                    <span class="td nowrap style-scope patent-result">FPAY</span>
                    <span class="td nowrap style-scope patent-result">Fee payment</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Year of fee payment</strong>: 8</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2009-12-03</span>
                    <span class="td nowrap style-scope patent-result">FEPP</span>
                    <span class="td nowrap style-scope patent-result">Fee payment procedure</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-03-22</span>
                    <span class="td nowrap style-scope patent-result">AS</span>
                    <span class="td nowrap style-scope patent-result">Assignment</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Owner name</strong>: GLAXOSMITHKLINE LLC,PENNSYLVANIA</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GENELABS TECHNOLOGIES INC;REEL/FRAME:024114/0001</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100322</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-05-21</span>
                    <span class="td nowrap style-scope patent-result">FPAY</span>
                    <span class="td nowrap style-scope patent-result">Fee payment</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Year of fee payment</strong>: 12</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.2129202519" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.2129202519" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=534408112" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>